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ABSTRACT
This dissertation presents a systematic study on gold nanoparticles: from their
chemical synthesis, modification of surface functionalities, optical properties studies with
emphasis on the absorption and scattering properties, to applications of gold
nanoparticles in biomolecular detection, imaging and photothermal therapy. In chapter 2,
we studied the kinetics of gold nanoparticle growth under Brust-Shiffrin reaction
conditions. In chapter 3, we further examined the reaction mechanism and growth
kinetics of gold nanoparticles using oleylamine as both a reducing reagent and particle
growth passivation ligand. From these two projects, important understanding was
revealed on gold nanoparticle formation and growth mechanism. Chapter 4 describes the
synthesis of a monofunctional gold nanoparticle through a solid phase place exchange
reaction. From Chapter 5, we moved to the optical property study of gold nanoparticles,
particularly the absorption and scattering phenomenon. In this work a systematic analysis
on the extinction coefficient of gold nanoparticles was performed, providing meaningful
references for applications based on optical absorption properties of gold nanoparticles.
In Chapter 6 and Chapter 7, we developed a one-step homogeneous immunoassay for
protein detection and analysis based on the strong light scattering of gold nanoparticles
and dynamic light scattering detection technique. In Chapter 8, we further improved the
stability of gold nanoparticle bioconjugates using a poly(ethylene glycol)-coated gold
nanoparticles and further tested this nanoparticle in the one-step homogeneous
immunoassay. Finally in Chapter 9, we demonstrated the application of gold
nanoparticles for in vitro bioimaging and photothermal therapy of a lung cancer cell. In
summary, this dissertation presents a comprehensive study on the synthesis, surface
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modification, property study of gold nanoparticles and their applications in biomolecular
imaging and analysis.
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CHAPTER 1. INTRODUCTION TO GOLD
NANOPARTICLES
1.1 Chemical Synthesis of Gold Nanoparticles
Gold nanoparticles (GNPs or AuNPs), also referred as gold colloids, are particles
with sizes in nanometer scale, typically between 1 nm and 100 nm. 1 They have metallic
gold (0) cores, can be capped by various types of surface ligands such as small molecules
or macromolecules, and are different in their shapes. The history of GNPs could trace
back to the 4th or 5th century B.C. in Egypt and China, when GNPs were referred to as
“soluble gold” and used in antibiotic applications.2 Around 4th century AD in Europe, the
famous Lycurgus Cup, which has GNPs embedded in, was created. This cup appears as
green color when irradiated by a white light from outside (reflected lights) but appears to
be red when irradiated from inside (transmitted lights) (Figure 1-1).

Figure 1- 1. Lycurgus cup (4th century A.D.) (left: green color when viewed from
scattered light; right: red color when viewed from transmitted light) (®Trustees of the
British Museum)
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In medieval Europe, GNPs were used as a panacea following the flourish of
alchemy. Since then, chemical synthesis of GNPs was discussed and significant
progresses were made. In 1685, a recipe invented by Andreas Cassius marked the first
reliable method to prepare GNPs in solution. In this recipe, GNPs were prepared by
dissolving gold in aqua regia followed by the addition of an aqua regia solution of tin.
This colorant in glasses, “Purple of Cassius”, became very famous in the 17th century. In
1856, Michael Faraday synthesized the first pure sample of colloidal gold by using
phosphorous dispersed in ether or carbon disulfide as the reductant to reduce a solution of
chloroaurate.3

Figure 1- 2. GNPs with different sizes dispersed in water (Ted Pella, Inc.) (®Copyright
Ted Pella, Inc.)

In 1951, J. Turkevich pioneered and in 1970s G. Frens refined a very simple
method to conveniently synthesize aqueous GNPs.4 This method uses tri-sodium citrate
to reduce HAuCl4 in boiling water and produces nearly mono-dispersed spherical GNPs.
These GNPs are negatively charged with a loose layer of citrate anions on the surface.
This method can be used to synthesize GNPs with pre-chosen sizes in a broad range from
16 nm up to 200 nm (Figure 1-2). The size versatility is achieved by tuning the relative
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ratio of HAuCl4 salt and the reducing agent in the reaction mixture, as well as with
careful control over the reaction temperature and the orders of reagents being added to
the solution.
Since 1980s, chemical synthesis of GNPs has experienced an exponential growth
due to the development of nanoscience and nanotechnology. Novel gold chemistry was
discovered such as phosphate-gold, thiol-gold, and amine-gold bonding and interactions.
In 1981, Schmid et al. reported the small 1.4 nm [Au55(PPh3)12Cl6] gold cluster with a
cuboctahdral structure for the Au55 gold core. The structure and special quantum
electronic properties of these gold culsters were studied extensively. 5 Later on, thiol
ligands were found to have a strong affinity with metal gold surface and can help in
stabilizing GNPs in both solution and dry states. In 1994, Brust and Schiffrin developed a
two-phase reduction process for the synthesis of thiol ligands-protected GNPs. These
GNPs were protected with a self-assembled monolayer of thiol molecules and soluble in
organic solvents. 6 Since then, various modifications of this reaction were made to
synthesize well-dispersed small GNPs in organic solvents. 7 In 1998, Murray et al.
conducted a systematic study on this reaction and adapted the initial Brust-Schiffrin
reaction to synthesize alkanethoil-protected GNPs with diameters between 1.5 to 5.2 nm.
In this two phase synthesis, AuCl4- is transferred from aqueous phase into organic phase
(toluene) by using a phase transfer agent (tetraoctylammonium bromide). Thiol ligands
were dissolved in the organic phase. Following the reduction of the gold anions with
aqueous sodium borohydride solution, GNPs were formed in the organic phase. The
organic phase changes color from orange to deep brown within a few seconds upon
sodium borohydride addition. This approach allows for the convenient synthesis of well
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dispersed stable GNPs in organic solvents. Seed-mediated growth method can be used to
increase the GNP sizes up to 40 nm.8 The narrow size distribution of GNPs could be
improved by digestive ripening treatments, i.e. heating a colloidal suspension near the
boiling point in the presence of excess alkanethiols.9 Other ligands, such as amines which
also have a high affinity with the GNP surface, were reported for the synthesis of GNPs
typically with larger sizes than thiolated GNPs. The amine-stabilized GNPs can be either
water soluble or organic solvents soluble, providing tunable solubilities for different
applications.10
In addition to spherical GNPs, there have been tremendous progresses made in the
synthesis of non-spherical GNPs. El-Sayed M.A. developed a method for the synthesis of
gold nanorods. 11 Xia Y. et al. discovered hollow gold nano-cages. 12 Hallas N. et al.
reported a silica-core and gold-shell nanostructure, while Ostafin A.E. et al. developed a
gold-core with a silica-shell nanostructure. 13 More recently Hafner J. synthesized star
shaped GNPs with interesting optical properties.14 Although the formation mechanism of
these novel structures is not well understood yet, GNPs with tunable size, shape, and
surface chemistry can now be synthesized conveniently through a wide range of chemical
methods.
1.2 Biomolecular Conjugation of GNPs
To use GNPs for biological applications, GNPs are often conjugated with
biomolecules. It is expected that the biomolecule-GNP conjugates remain well dispersed
in aqueous solutions, and maintain the intact activity and specificity of biomolecules.
There are different approaches available for biomolecular conjugation of GNPs.
According to the nature of binding chemistry between the GNP and biomolecules,
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methods to prepare biomolecule-GNP conjugates can be classified to be three types:
physical adsorption, covalent coupling reactions, and bio-recognition reactions.
The most frequently used method to conjugate antibodies or other type of proteins
on GNPs is based on physical adsorption of proteins onto negatively charged citrateprotected GNP surface. This physisorption method was first discovered in 1940s and
became widely used to prepare protein-GNP conjugates in biomedical therapies and cell
imaging applications since then. Through non-covalent and non-specific interactions,
proteins can adsorb onto many inorganic or organic surfaces. Such physisorption of
molecules onto a solid support is a result of the combination of weak bonds between
biomolecules and the substrate surface. These weak bonds include electrostatic
interactions, van der Waals interactions, and/or hydrogen bondings. A classical example
of this physisorption effect is the immobilization of proteins on plastic microtiter plate
used for Enzyme-Linked ImmunoAbsorbant Assay (ELISA). Protein can absorb onto
GNPs through similar interactions.15
The advantages of the physisorption method include its simplicity and
applicability to almost any type of biomolecules. However, these are several limitations
for the physical adsorption method. First, there is a concern about the colloidal stability
of biomolecule-conjugated GNPs prepared through the physisorption method. Indeed,
bare charged GNPs are not stable and tend to precipitate out in high ionic strength
solutions. After GNPs are conjugated with a saturated number of proteins on the surface,
the colloidal stability could be significantly improved in high ionic strength solutions
such as biological fluids. However, non-specific interaction-induced GNP aggregation
can still occur and result in shorter shelf-life and poor reproducibility of the experimental
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results. This is the reason why stabilizing agents, such as bovine serum albumin (BSA) or
surfactants, are present in most commercial products of GNP-protein conjugate
suspensions. Second, there is no control on the orientation of biomolecules which are
physically adsorbed onto the GNP surface. Third, the possible denaturation of proteins is
also a concern for biomolecule-GNP conjugates prepared through the physisorption
method. These limitations of non-covalent physisorption method justify the need of
covalent conjugation method for preparing more robust biomolecule-GNP conjugates.
Covalent coupling through gold-thiol chemistry is one of the most extensively
used methods for making biomolecule-GNP conjugates. Because thiol groups have high
affinity to the GNP surface, when thiol ligands are added into a citrate-protected GNP
solution, thiol ligands will replace the citrate molecules on GNPs and lead to thiol
ligands-protected GNPs. Through this exchange reaction, thiolated deoxynucleic acid
(DNA) molecules could be conjugated covalently onto GNPs. This method was
demonstrated in making single strand DNA-conjugated GNPs by Mirkin C.A. et al. and
Alivisatos A.P. et al. in 1996.
This thiol exchange reaction method was also used to covalently conjugate
proteins or peptides onto GNPs. In this case, a thiolated bi-functional linker molecule is
required. The linker molecule is used as the bridge molecule to covalently couple GNPs
and biomolecules. The linker molecule has two end groups and a variable part in the
middle. The thiol end group on the linker molecule is used to immobilize the linker
molecule onto the GNP surface through the thiol exchange reaction. The second end
group is used to covalently react with proteins or peptides. Commonly used functional
groups are carboxylic acids and amines. The carboxylic acid groups can be activated
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through the carbodiimide chemistry and conjugated to the amine groups exposed on the
protein surface. 16 Through the linker molecule, proteins and peptides can thus be
conjugated covalently to GNPs. As every protein could have several accessible amine
groups from lysine residues, this covalent conjugation approach often results in a random
and multiple orientation of proteins at the surface of GNPs.
Bioconjugated GNPs prepared through covalent coupling usually have much
improved colloidal stability and resistance to non-specific interactions in biological fluids
than noncovalently-conjugated GNPs. Another advantage of the covalent coupling
method is that the middle part of the linker molecule can be varied to further improve the
performance of protein-GNP conjugates. Thiolated poly(ethylene glycol) (PEG)
polymers with end groups such as carboxylic groups are excellent linker molecules.17 The
PEG part could serve multiple functions. First, the polymer molecules form a shielding
layer on the GNP surface and improve the colloidal dispersion and stability of the
bioconjugated-GNPs. Second, the PEG spacer separates biomolecules from the GNP
surface so as to avoid or reduce the possible denaturation of proteins. Third, PEG
polymer can minimize non-specific interactions between GNPs and biomolecules in
biological fluids.18 Because of these advantages, PEG-protected GNPs have been studied
and used extensively for GNP-bioconjugate preparation.19
Despite the several advantages of the covalent conjugation method, there are also
some problems associated with this method. One problem is the lack of control over the
orientation of biomolecules on the GNP surface. Another problem is the possible loss of
bioactivity of the biomolecules after their amine groups are used for the covalent bond
formation. The amine groups may be important for the bioactivity when they are present
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in the active sites or ligand binding sites. These problems can limit the application of the
covalent coupling method.
New methods based on bio-recognition reactions have been developed in order to
prepare robust biomolecule-GNP conjugates while also to avoid or reduce the above
mentioned problems associated with the covalent coupling method. The biotinstreptavidin coupling is an excellent example. Each streptavidin has four biotin binding
sites positioned in pairs on opposite domains of the protein. The biotin-streptavidin
coupling is known to be the strongest bio-interaction with a binding affinity as high as
1015 M-1. To prepared streptavidin-GNP conjugates, thiolated biotin molecules are first
covalently attached to GNPs through thiol-gold chemistry. Streptavidin is then added and
coupled with biotins on the surface of the GNP through the highly specific and strong
biotin-streptavidin interaction.20
The streptavidin-conjugated GNPs can be used as a general GNP platform to
prepare other protein-GNP conjugates. In such cases, the streptavidin molecules on GNPs
are used as anchors to conjugate biotinylated proteins to GNPs. A variety of proteins or
peptides could be conjugated to GNPs by this way. Koh et al. prepared the streptavidincoated GNPs and conjugate them with biotinylated antibodies or biotinylated actin. The
conjugation process was monitored by TEM and the proteins around the GNP were
imaged by using negative staining technique. 21 Other biomolecules, in addition to
streptavidin molecules, could also be used for similar purpose. Brisson A. and Mornet S.
used a modified protein of Annexin-A5 as the anchor molecule to conjugate antibodies to
GNPs.22 The modified Annexin-A5 proteins bind only to the crystallizable fragment (Fc
region) of antibodies. As a result, antibodies may be conjugated to GNPs with controlled
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orientation. The antigen-binding fragments, Fab regions, of the antibodies will be
exposed on the GNP surface. The proper orientation of the Fab regions of the antibodies
ensures a good bioactivity of the conjugates.
The methods to prepare biomolecule-GNP conjugates through bio-recognition
reactions produce conjugates with good colloidal dispersity and stability as well as
desired orientation and bioactivity for conjugated biomolecules. However, the process of
bio-recognition methods is more complex than the physisorption method or the covalentcoupling method. The advantages as well as the limitations of each conjugation method
should be considered in order to select the appropriate method for specific application.
1.3 Optical Properties of GNPs
When one or more dimensions of materials are reduced to the nanometer scale,
properties of materials could change dramatically from their bulk states. In the nanometer
size range, GNPs present many new interesting properties, especially optical
properties.23-25 When irradiated by lights, the coherent collective oscillation of electrons
(6s electrons of the conduction band) on the GNP surface induces large electromagnetic
fields, which will resonate with the incident electromagnetic waves at specific
frequencies. Such effect has been defined as the well-known Surface Plasmon Resonance
(SPR) effect (Figure 1-3).25b
The SPR effect results in much enhanced absorption and scattering for GNPs. The
absorption and scattering cross sections of GNPs are orders of magnitudes larger than
that of non-metallic materials such as polymer latex particles, fluorescent dyes or
biomacromolecules. The absorption cross section of GNPs is 4 to 6 orders of magnitudes
larger than the strongest absorbing small organic molecules.23 The scattering cross
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section is 4 to 9 orders of magnitudes larger than that of the fluorescence of many widely
used organic dyes. These strong absorption and scattering properties make GNPs as ideal
probes for biomolecular imaging and detections.23 As GNPs are not luminescent or not
strong luminescent materials, most of the absorbed photon energy will be dissipated into
the local environment through heat. In other words, GNPs are excellent photon-thermal
energy converters. This property has recently attracted much attention for photothermal
therapy applications.

Figure 1- 3. Schematic of plasmon oscillation for a sphere, showing the displacement of
the conduction electron charge cloud relative to the nuclei. (Copyrigh ® 2007, Springer
New York)

1.3.1 SPR induced absorption property of GNPs
1.3.1.1 SPR absorption of spherical GNPs
Spherical GNPs have a strong SPR absorption band in the visible light region,
typical around 520-600 nm (Figure 1-4).25a The SPR band of spherical GNPs was first
explained by Mie in 1908 and had several derived versions.24 For particles with sizes
much smaller than the wavelength of the incident light (diameter <0.05λ), the absorption
cross section (Cabs) may be expressed as the following according to Rayleigh scattering
theory:
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C abs =

π 2 D 3 nmed  m 2 − 1 

Im 2
λ0
 m + 1

(1-1)

where D is the particle diameter, nmed is the refractive index of the surrounding media, λ0
is the incident light wavelength, and m is the relative refractive index which is defined as
the refractive index of the bulk gold at the incident light wavelength λ0 divided by nmed.
For visible light irradiation from 400 nm to 800 nm, the absorption of GNPs in sizes up to
20-40 nm in diameter can be described well with equation (1-1). For larger spherical
GNPs (diameter >0.05λ), the absorption is dependent on dipole oscillations as well as
higher-order multipole oscillations including quadrupole and octopole modes. As a result,
the full expression of Mie equation should be used to calculate the absorption cross
sections for these large spherical GNPs. 25

Figure 1- 4. Size effects on the SPR absorption of spherical GNPs. The UV-vis
absorption spectra of colloidal GNPs with diameters varying between 9 and 99 nm show
that the absorption maximum red-shifts with increasing particle size in part a, while the
plasmon bandwidth follows the behavior illustrated in part b. In part c the absorption
coefficients of these GNPs at their respective plasmon absorption maxima are plotted
11

against their volume on a double logarithmic scale. The solid line is a linear fit of the data
points. (Copyright ® 1999 American Chemical Society)

According to Mie theory, the peak position, intensity and bandwidth of the SPR
absorption band of GNPs are dependent on the size, shape and dielectric constant of
GNPs as well as the dielectric constant of the surrounding media. El-Sayed et al. reported
the experimental results of the size effect on the SPR absorption band of spherical GNPs
(Figure 1-4). When the size of spherical GNPs increases from 9 to 99 nm, the peak
wavelength of the absorption band shows a red-shift (Figure 1-4a). In addition, the
bandwidth of the SPR band has the minimum at 20 nm and will increase for both smaller
and larger GNP (up to 50 nm) (Figure 1-4b). 25,26 In Figure 1-4c, a linear correlation
between the molar absorption coefficient and the particle volume is shown. Theses results
are in agreement with theoretical calculations based on Mie theory.
Fernig D.G. et al. reported that the SPR absorption spectrum of a monodispersed
spherical GNP solution could be used to calculate the size and concentration of the
GNPs.27 The average diameter of GNPs in aqueous solution can be calculated from their
UV-Vis absorption spectra:
d = exp( B1

Aspr
A450

− B2 )

(1-2)

where Aspr is the SPR peak absorbance value of the GNP solution; A450 is the absorbance
value of the GNP solution at λ=450 nm; B1=3.00, B2=2.20 as determined by curve fitting.
This equation provides a very convenient way to calculate the diameter of monodispersed
GNPs in aqueous solution from 5 to 80 nm. They also derived the following equation to
calculate the number density of the GNPs in aqueous solution:
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N=

A45 0 × 1014

(1-3)

d − 96.8 2
d [−0.295 + 1.36 exp(−(
) )]
78.2
2

where N is the number density (nanoparticles/mL), A450 is the absorbance at λ=450 nm,
and d is the particle diameter in nanometer. Based on this equation, one can conveniently
estimate the concentrations of GNPs in water.

Figure 1- 5. A typical surface plasmon absorption spectrum of gold nanorods. The long
wavelength band in the near infrared region around 800 nm is due to the longitudinal
oscillation of electrons and the short wavelength band in the visible region around 520
nm is due to the transverse electronic oscillation.
1.3.1.2 SPR absorption of gold nanorods (GNRs)
Non-spherical GNPs have different SPR absorption bands from spherical GNPs.
For gold nanorods (GNRs), they have two SPR bands: one weak band peaked at ~530 nm
and another strong band peaked at a longer wavelength in the range from 630 to 1100 nm
(Figure 1-5).28 The weak band is due to the transverse electronic oscillation while the
strong band is due to the longitudinal oscillation of electrons. The peak position of the
longitude SPR band for GNRs is found to be very sensitive to the aspect ratio, which is
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defined as the ratio of the length of the GNR over the width. When the aspect ratio
increased from 2.4 to 7.4, the peak wavelength of the longitude SPR band can be redshifted from 600 nm to 1000 nm (Figure 1-6).28 Such tunability in the near-IR region is
particularly attractive for biological applications as discussed later. 29

(A)
(B)

Figure 1- 6. (A) Gold nanorods mirograph obtained by Transmission Electron
Microscopy (Copyright ® Royal Society of Chemistry 2001).30 (B) Tuning the SPR
bands of gold nanorods by synthetically controlling the aspect ratios. (Copyright ® 1999
American Chemical Society)

The optical absorption spectra of GNRs could be calculated with modified Mie
theory. According to Gans treatment for the dipole approximation, the extinction cross
section for elongated ellipsoids is given by:31,32

σ ext =

ω
3c

ε m3 / 2V ∑
i

{ε

(1 / Pj2 )ε 2

2
1 + [(1 − Pj ) / Pj ]ε m } + ε 2
2

(1-4)

Where Pj are the depolarization factors along the three A, B and C axis of the nanorod,
with A>B=C, defined as:
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PA =

1 − e2 1
1+ e
[ ln(
) − 1]
2
2e 1 − e
e

PB = PC =

(1-5)

1 − PA
2

(1-6)

with the aspect ratio R included in the expression of e as:

B 

e = 1 − ( ) 2 
A 


1/ 2

(

= 1 − 1/ R 2

)

1/ 2

(1-7)

The tunable absorption spectra of GNRs in the near-IR (NIR) region provide a
special advantage in using GNR for biological applications. In the NIR region, especially
650-900 nm, water and tissues (mainly hemoglobin and oxyhemoglobin in the tissue)
have minimal absorption in this window (Figure 1-7). 33 By selectively delivering GNPs
into target cells and tissues, photon irradiation at NIR wavelength will pose minimum
effect on non-targeted cells and tissues. In addition, NIR light can penetrate tissue much
deeper than visible light irradiation. A penetration depth of up to 10 cm could be reached
using NIR laser irradiation.33

Figure 1- 7. Optical absorption spectra of tissue components in the ultraviolet to infrared
range. (Hb: hemoglobin; HbO2: oxyhemoglobin) (Copyright ® Duke University)
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1.3.2 Light scattering property of GNPs
1.3.2.1 Light scattering property of spherical GNPs
GNPs have interesting light scattering properties. When GNPs are illuminated by
a narrow beam of white light, GNPs scatter lights in various colors ranging from green,
yellow to red as the GNP size increases (Figure 1-8A). 34 For example, Figure 1-8B
shows the scattered green lights from 58 nm GNPs and Figure 1-C shows the scattered
yellow lights from 78 nm GNPs. The light scattering property of GNPs and its potential
applications were investigated by Yguerabide J. et al in 1998. Since then the scattering of
GNPs have been studied intensively from both theoretical and experimental aspects.34

A

B

C

Figure 1- 8. (A) Photographs showing the appearance of light-scattering suspensions.
Composition, particle diameter, and particle molar concentration are as follows from left
to right: silver, 40 nm (2×10-12 M); gold, 40 nm (1.3×10-11 M), 78 nm (1.7×10-12 M), 118
nm (5×10-13 M), and 140 nm (3×1013 M); solution of fluorescein (2×10-6 M). Scattering
photographs of the (B) 58-nm and (C) 78-nm diameter GNPs under an optical
microscopy. (Copyright ® 1998 Springer New York)
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Theories have been developed to explain the scattering property of GNPs. For
small nanoparticles (diameter<0.05λ), in this case of GNPs, only dipole oscillations
contribute significantly to the scattering. Rayleigh theory can be used to explain the
scattering phenomena of GNPs and the scattering cross section of a GNP can be
expressed as:
C sca

4
2πD 6 nmed
m2 −1
=
Im
m2 + 1
3λ40

2

(1-8)

where D is the particle diameter, nmed is the refractive index of the surrounding media, λ0
is the incident light wavelength, and m is the relative refractive index of the bulk gold at
irradiation wavelength λ0 divided by nmed.34 For large GNPs (diameter>0.05λ), the
scattering is considered to be the sum of dipole and higher order oscillations. In Mie
theory, the scattering cross section for a GNP can be written as:
C sca =

2π
k2

∝

∑ (2n + 1)( a
n =1

2
n

+ bn )
2

(1-9)

where k = 2πnmed / λ0 . The different terms in the sum correspond to different dielectric
and magnetic multipoles and n is the term index. The term index with n=1 corresponds to
the electric dipole. The coefficients Bessel function a n and Ricatti function bn are
generally complex numbers, which depends on the size- and incident light wavelengthrelated refractive index of the particle.34
In 1998, Yguerabide et al. calculated the scattering and absorption cross sections
of spherical GNPs at different sizes from 20 to 300 nm according to the above theories
and compared them with experimental results.34 They calculated that the scattering peak
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wavelength, intensity and the relative ratio of scattering to absorption were all related
with the GNP size. The results are summarized in Table 1-1, Figure 1-9, and Table 1-2.
The SPR scattering peak wavelength (λmax) has two separated trends when the
GNP size increases. From size 20 to 160 nm, the λmax shows a red-shift from 535 nm to
635 nm. From 160 to 300 nm, the λmax illustrates a blue-shift from 635 nm to 565 nm
when the GNP size increases (Table 1-1 and Figure 1-9).34 Table 1-2 presents the
experimental results of λmax for 52, 78, 87 and 118 nm GNPs, which is in a relatively
good agreement with the red-shift trend as predicted in the theoretical calculations. Thus
by changing the size, the light scattering profile of GNPs can be tuned.34

Table 1- 1. Calculated light absorption and scattering properties of spherical GNPs
from 380 to 700 nm

*IU(0) and IU(90) is the scattering light intensities measured at 0 and 90o with respect to
the direction of an unpolarized incident light beam. φs is the portion of light scattering in
the whole extinction which is the sum of both scattering and absorption. ε is the
extinction coefficient. (Copyright ® 1998 Springer New York)

The scattering cross section (Csca) of GNPs depends dramatically on their
diameter. From equation (1-8), the scattering cross section of a small GNP is proportional
to the 6th power of its diameter. As a result, when the size of GNP increases, the
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scattering intensity increases dramatically. The scattering cross section Csca increases
monotonically from 20 nm to 300 nm, as shown in Table 1-1. A 300 nm GNP has a cross
section which is ~4×104 times larger than that of a 20 nm GNP. It needs to mention that
this number is small than the 6th power of the relative diameter ratio (300 nm/20 nm)6
because at large sizes the Csca is not proportional to the 6th power of the size anymore.
From these results, the light scattering color and power of GNPs can be tuned by varying
the size.34

Figure 1- 9. Normalized calculated light scattering cross section versus wavelength for
homogenous and spherical GNPs with different sizes according to Mie theory. (Copyright
® 1998 Springer New York)

Table 1- 2. Experimentally determined number of fluorescein molecules (NF) needed to
produce the same intensity of light as a GNP at a given diameter (Copyright ® 1998
Springer New York)

*Dia: diameter of GNPs; Cscad is the experimental scattering cross section of GNPs.
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Increasing the size of a GNP not only results in a shift of its SPR scattering peak
and an increase in its scattering cross section, but also increases the relative portion of
scattering in the whole extinction. Comparing equation (1-8) with equation (1-1), the
amplitude increases according to D6 and D3, respectively for the scattering cross section
and the absorption cross section. As a result, when the GNP size increases, the scattering
cross section increases much larger than the absorption cross section. In Table 1-1, the
contribution of scattering to the extinction (ϕs) is only 1.4% at the scattering peak (λ=535
nm) for 20 nm GNPs, but increases to 54.6% at the scattering peak (λ=555 nm) for 50 nm
GNPs.34

Figure 1- 10. Angular dependent scattering intensity diagrams for both small particles
and large particles when irradiated with unpolarized light. (Copyright © 2009 Indian
Academy of Sciences)

In the detection of scattered lights from GNPs, the scattering intensity is the sum
of scattered lights that can be captured by the detector. The angular dependence of the
scattering intensity is related with the polarization of the incident light as well as the GNP
size. When a polarized light is irradiated on small GNPs (diameter<0.05λ), the scattering
intensity I according to Rayleigh theory is:
20

2

4
I0 m2 −1
16π 4 D 6 nmed
I=
sin 2 (α )
2 4
2
r λ0
m +2

(1-10)

where I0 is the intensity of the incident light, r is the distance of the detection point to the
particle, and α is the angle between the detection direction r and the direction of
polarization of the incident beam.34 In the case of unpolarized light illumination, the
scattering intensity can be derived according to equation (1-10) and written as:
2

4
I0 m2 −1
8π 4 D 6 nmed
I=
(1 + cos 2 θ )
2 4
2
r λ0
m +2

(1-11)

where θ is the angle between the incident laser beam and the direction of detection. The
shape of the scattering diagram is determined by the (1+cos2θ) term and plotted in Figure
1-10. 35 It can be seen that the scattered light intensity is two times great at θ=0 than that
at θ =90o and varies according to (1+cos2 θ) at intermediate angles.
For larger particles (diameter within 0.05λ-0.5λ), under unpolarized light
illumination, the scattering intensity can be calculated based on Mie theory:
I=

λ20
8π n
2

2
med

( S1 + S 2 )
2

r

2

2

(1-12)

where S1 and S2 are functions depending on the scattering angle and the Bessel functions
an and Ricatti functions bn (equation 1-9).35 In this case, the scattered light from different
parts of the particle will reach the detector by traveling different path lengths. The net
effect is that the scattering diagram for large particles is reduced intensity at back
scattering angles (Figure 1-10). The scattering intensity is not symmetric for back and
forward scattering. As a result, larger GNPs can be more sensitively detected at forward
angles than at 90o or back scattering angles.
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Figure 1- 11. Logarithmic plots showing the dependence of relative light scattering
intensity on GNP concentration for GNPs with different sizes (in the unit of nm)
(Copyright ® 1998 Springer New York)

The light scattering property of GNPs can be used to detect GNPs. In fact, the
strong light scattering of GNPs comparing with other materials makes them to be
detected very sensitively. The scattering cross sections of spherical GNPs is 4-6 orders of
magnitude larger than that of small fluorescence molecules, polystyrene beads or
biomacromolecules, as shown in Table 1-2.34 For example, a 52 nm GNP produces the
same light intensity from scattering as the luminescence light emitted by 4.4×104
fluorescein molecules. GNPs can be detected at very low concentrations, as shown in
Figure 1-11.34 For mono-dispersed GNPs in solution, it was reported that their scattering
intensity is linearly correlated to the GNP concentration in log scales with a dynamic
range of ~3 orders. Detection limits for spherical GNPs as low as 10-14 M (52 nm),
2.5×10-15 M (78 nm), 1.6×10-16 M (87 nm) and 4×10-16 M (118 nm) were reported.
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The very low detection limits of GNPs by light scattering make them
advantageous to be used as ultra sensitive probes for biological applications. Another
advantage of GNPs in these applications is the tunability of their scattering peak
wavelengths by changing their size and shape.

Figure 1- 12. Calculated SPR scattering spectra of GNRs at various aspect ratios.
(Copyright ® 2005 Elsevier B.V.)
1.3.2.2 Scattering property of gold nanorods
Lu et al. calculated the theoretical resonant light scattering property of GNRs at
various sizes and aspect ratios using the quasi-static theory.36 The scattering cross section
can be written as:

σ sca =

128π 5 a 2 b 4
A + iB
3λ4

(1-12)

where a is the half of the rod length, b is the half of the rod width, A and B are functions
depending on the dielectric constants of the rod and the surrounding media as well as a
and b. The numerical calculation results of the light scattering spectra of GNRs are
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shown in Figure 1-12.36 It can be seen that the SPR peak red-shifts with increased GNR
aspect ratio.
El-Sayed et al. calculated the effects of GNR size and aspect ratio on the relative
ratio of scattering to absorption by using the discrete dipole approximation (DDA)
method. As shown in Figure 1-13, the relative ratio of scattering to absorption increases
along the size increase of GNRs, but not changes much by varying the aspect ratio. 37
These results show that the scattering and absorption property of GNRs can be tuned by
changing the size and/or the aspect ratio.

Figure 1- 13. Effects of GNR effective radius (a) and aspect ratio (b) on the relative ratio
of scattering to absorption. (the effect radius reff for GNRs is defined by
reff = (3V / 4π )1 / 3 , where V is the volume of a GNR)

1.3.3 Photothermal energy conversion of GNPs under laser irradiation
When irradiated with a laser beam at a wavelength around the SPR band, GNPs
absorb photon energy strongly due to their large absorption cross sections. Because GNPs
are not strong luminescent materials, most of the absorbed energy will be released as heat
to the local environment of GNPs. This energy dissipation process involves the initial
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ultrafast electron-electron scattering (<20 fs), followed by the relative slower cooling due
to electron-phonon (~2 ps) and phonon-phonon coupling (>50 ps).38 According to Fermi
liquid theory, for electrons with an initial energy E close to the Fermi energy EF, the
electron-electron scattering time ( τ e−e ) is reversely related with the square of the energy
difference:
1

τ e −e

∝ (E − EF ) 2

(1-13)

For single scattering process, τ e−e is usually on the order of 10 fs. However, the sum of all
electron-electron scattering events before the formation of a Fermi electron distribution
makes τ e−e to be several hundreds of femtoseconds. As reported by El-Sayed et al, the
internal electron-electron thermalization has a fast lifetime of 500 and 450 fs,
respectively for 9 nm and 48 nm spherical GNPs. The following slower external electron
thermalization (electron-phonon interactions) takes place in a time regime of 1.6 and 1.7
ps, respectively. These results are shown in Figure 1-14. 25
Because the energy dissipation rate is much slower comparing with the energy
absorption rate, as a consequence, the absorbed energy from the laser cannot be
dissipated quickly enough from the GNP surface to the environment. This leads to a large
increase of the temperature around the GNP surface as well as its vicinity environment.
In the case of pulsed laser irradiations, the temperature on the GNP surface could reach as
high as more than 1000 oC. In such a high temperature, GNPs may change their shapes,
for example, from gold nanorods to spheres.39
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Figure 1- 14. Electron-electron and electron-phonon relaxation times for spherical GNPs
at 530 nm after excitation with 630 nm femosecond pulses. (Copyright @ 1999 American
Chemical Society)

In the case of continuous wave laser irradiations, the photothermal conversion of
GNPs and the following thermal effect to their local environment have also been studied.
Govorov et al. calculated the surface temperature increases of a spherical GNP as a
function of the particle size and the illumination power according to the usual heat
transfer equation:

ρ (r )c(r )

∂T (r, t )
= ∇k (r )∇T (r, t ) + Q(r, t )
∂t

(1-14)

where T(r, t) is temperature as a function of coordinate r and time t, ρ(r), c(r), and k(r)
are the mass density, specific heat, and thermal conductivity, respectively. Q(r, t) is the
local heat intensity function and partially depends on the dielectric constants of GNP and
also the media. The effects of GNP size, laser wavelength and power to photothermal
conversion reaction are shown in Figure 1-15. 40 The surface temperature of GNPs
increases along with increased GNP size or laser power density. Following the
26

temperature increases on the GNP surface, the surrounding media can be heated up due to
heat transfer. Water around a GNP can be heated up within a distance of 10s nm to the
GNP surface (Figure 1-15a, insert). In another example, Huang et al. calculated that cells
loaded with GNPs will be affected by the photothermal conversation reaction of GNPs.40
This results in an elevated temperature around 70-80oC for cells. These theoretical
calculations agree with experimental results obtained from cells which loaded with GNPs,
GNRs or gold nanoshells.41

Figure 1- 15. Calculated temperature increase at the surface of a single GNP in water as
a function of the irradiation wavelength (a) and the illumination power at the plasmon
resonance (b). (insert: spatial distribution of temperature at different time) (Copyright ®
2007 Elsevier B.V.)
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1.4 Applications of GNPs in Biological Systems
Advances in the synthesis, modification, biomolecular conjugation, and further
understanding of the properties of GNPs have enabled many important applications of
GNPs in biological systems. This is a fast growing field since last decade. In addition to
biomolecular detection, GNPs are also used in bio-imaging and photothermal therapy.
GNPs have been shown to be very promising to help in the diagnostic and treatment of
diabetes, cancer, Alzheimer’s diseases, and rheumatoid arthritis. 42 The following is a
brief review on examples of GNPs applied in biological systems.
1.4.1 Applications of GNPs in biomolecular detection and assays
Biomolecular detection in biofluids or tissue samples is very important for early
detection, diagnosis and prognosis of diseases, as well as in drug development. Proteins
are one type of biomolecules produced by human body and can be within or located on
the cell surface or released into body fluids. An abnormal change of protein levels is
often a sign of disease occurrence. For example, a large increase on the level of protstate
specific antigen (PSA) in human serum from the normal range (<4 ng/mL) may be
associated with the occurrence and progression of prostate cancer. DNAs are another type
of important biomolecules which has a significant role in diagnosis and therapy. For
example, screening the gene sequences of a patient is necessary to determine the position
of mutated genes. This process requires analytical methods with ultra-sensitivity, fast
procedure, and using small volumes of samples. Traditional methods such as Enzyme
Linked Immunosorbent Assay (ELISA) and Polymerase Chain Reaction (PCR)
techniques have been used for decades for protein or DNA detection. Since 1990s, new
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analytical have been investigated and developed by introducing GNPs as novel optical
probes with better sensitivity, simpler procedure and less cost than traditional methods.

Figure 1- 16. (A) Schematic representation of GNP aggregation reactions (B) SPR band
shows a red-shift when GNPs form aggregates in a colorimetric assay. (Copyright ®
2008 John Wiley & Sons, Inc.)
1.4.1.1 Biomolecular assays based on the light absorption property of GNPs
Aggregation of individual GNPs in solution usually introduces a red-shift and
broadening of the SPR band. This is a result of surface plasmon coupling between
neighboring GNPs when the distance between them is reduced to be within 2-3 times of
the particle size. An example is shown in Figure 1-16.43 The aggregation of GNPs is
introduced by bimolecular recognition reactions between the receptor molecules on the
GNP surface and the analyte molecules in solution. As a consequence, the SPR peak of
the GNP solution shifts from ~520 nm to a higher wavelength around 600 nm. This
change is also visible as the solution color changes from purplish to blue. The extent of
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the aggregation reaction, and thus the spectrum shift, is associated to the available analyte
molecules in the solution. In 1996, Mirkin et al. showed that thiolated ssDNA conjugated
13 nm GNPs could form aggregates through hybridization of ssDNA on GNPs surface
with target DNA molecules in solution. 44 Since then, bimolecular assays based on
detecting the SPR absorption spectra changes after the aggregation reaction of GNP
probes have been applied for a large variety of biomolecules, including nucleic acids,
proteins, saccharides. 45

Figure 1- 17. Absorption spectra enhancement effect of aptamer-conjugated GNPs with
CCRF-CEM cells (CCL-119 T-cell, human acute lymphoblastic leukemia) at various cell
concentrations. (data presented were subtracted from the pure GNP absorption spectrum)
(Copyright ® 2008 American Chemical Society)

In addition to the detection of small biomolecules, GNPs are also applied in cell
detection. Tan et al. recently applied the spherical GNPs for cancerous cell detection
using aptamers-coated GNPs. The aptamers bound specifically to cancer cell surface and
bring GNPs to form aggregates on cell surface. As shown in Figure 1-17, this local
30

aggregation resulted in two effects on the SPR band: a red-shift of the SPR band and an
intensity enhancement of the SPR band intensity. Such GNP probes based assay had very
high sensitivity for cell detection as few as 90 cells in 300 µL sample solution.46

440 ng/mL
44 ng/mL

4.4 ng/mL
0 ng/mL

Figure 1- 18. Whole blood tests for rabbit IgG using gold nanoshells (106 nm core
diameter with a 25 nm thick gold shell) (Copyright ® 2003 American Chemical Society)
Besides spherical GNPs, nanoshells and nanorods are also used in biomolecular
assays. As discussed in 1.3.1.2, these non-spherical GNP probes have a unique advantage
because they have SPR band in the NIR region. Figure 1-18 shows an example of using
gold nanoshells for the detection of rabbit IgG in whole blood by Hafner et al. Antibody
conjugated gold nanoshells formed aggregates through crosslinking with rabbit IgG
molecules in the blood sample. This introduced a decrease of the SPR peak absorbance at
720 nm. After 10 minutes of incubation, the absorbances decreases were statistically
distinguishable in samples with different rabbit IgG concentrations ranging from 440
ng/mL to 0 ng/mL.47
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Tailoring the aggregation reaction yields versatile formats for GNPs-based
biomolecular assays. As shown in Figure 1-19,43 there are a variety of designs used in the
GNP aggregation assay. In a most common format, shown as pathway A, receptorconjugated GNPs form aggregates through crosslinking by target molecules. Other
formats of assays, such as competitive assays (shown as Figure 1-19B), are also reported.
In this case, two GNP probes which have a pair of recognizing biomolecules were used.
Without the addition of analyte, these two GNP probes will form aggregates and
introduce red-shift of the SPR band. Because the analyte has a specific binding with one
of the two GNP probes through bio-recognition reactions, the aggregation reaction is
partially or fully hindered by the addition of the analyte depending on its
concentrations.43
These assays have higher sensitivity than conventional biomolecular assays but
easier. Typically, the detection limit is in the range of nM to µM when performed without
any signal amplification steps. The detection limit varies with the design of the system,
the binding affinity between the receptor molecule on GNP surface and the analyte
molecule, as well as other assay conditions. If extra signal amplification steps are used
the sensitivity can be further improved to fM for DNA or low pM range for protein
detection. 48 However, these amplification steps complicate the assay procedure and often
cause problems in the reproducibility of the assays. To solve this problem, alternative
methods based on the light scattering property of GNPs have been explored.
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Figure 1- 19. GNP aggregation reaction applied in biomolecules detection. A) GNPs are
brought together by crosslinking molecules that have multiple binding sites for the
corresponding receptors on GNPs (pathway A). Biological recognition events (or
processes) that remove (or break) crosslinking molecules cause GNP de-aggregation
(pathway B). Biological recognition events (or processes) that can modify crosslinking
molecules (pathway C) or receptors on GNP surface (pathway D) can indirectly control
GNP aggregation and dissociation. (B) Competitive GNP assays based on GNP probe
aggregation reaction. Without analyte molecules, the two types of multi-valent GNP
probes aggregate. With analyte molecules, the aggregation reaction was hindered.
(Copyright ® 2008 Elsevier B.V.)
1.4.1.2 Biomolecular assays based on the light scattering property of GNPs
The strong light scattering property of GNPs enables GNPs to be detected by light
scattering techniques sensetively. In 1998, Vance et al. found that the hyper-Rayleigh
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scattering (the scattering produces frequency doubled light) intensity of spherical GNPs
is linearly dependent on GNP concentrations.49 When GNPs form aggregates, the light
scattering intensity increases dramatically due to the SPR coupling of neighboring GNPs.
The aggregation reaction detected by light scattering techniques is correlated to the
analyte concentration, similarly in absorption property based GNP assays. In 2006, Ray
et al. first demonstrated that the hyper-Rayleigh light scattering intensity could be used
for DNA detection. 50 As shown in Figure 1-20, when target DNA was present and
hybridized with single-strand DNA (ssDNA) on GNP probes, the hyper-Rayleigh
scattering intensity at 650 nm (with a 1300 nm incident laser irradiation) was increased
dramatically. This assay also had very good selectivity. In the comparison study, the
sample which added by single-base mismatched target DNA showed no increases in the
scattering intensity (Figure 1-20).51

Figure 1- 20. Plot of hyper-Rayleigh scattering intensity versus concentration of target
DNA. (Squares: target DNA; circles: target DNA with one base-pair mismatch).
(Copyright ® 2006 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim)

34

Other than the nonlinear hyper-Rayleigh scattering, other scattering phenomena of
GNPs such as the resonance scattering can also be used in biomolecular detection
applications. In 2006, Qin et al. used an antibody-labeled 9 nm GNPs to detect proteins
Apolopoprotein Al (ApoAl) and Apolipoprotein B by measuring the resonance light
scattering intensity. Detections limit were determined to be 2 ng/mL and 0.96 ng/mL,
respectively for these two proteins. 51 Liu et al. reported the ssDNA-stabilized GNP
probes for target DNA detection with a linear response between the light scattering
intensity and the concentration of target DNA from 0.7-110 pM. 52 Du et al. reported a
better sensitivity of 10 fM-1 nM for DNA detection by adding a silver enhancement step
before the light scattering intensity detection.53 As shown in Figure 1-21, the scattering
light intensity at 315 nm is increased linearly with the target DNA concentration.

Figure 1- 21. Light scattering spectra of GNPs modified with two probe DNAs for the
detection of the complementary DNA target at different concentrations. (Copyright ®
2006 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim)
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Other than their use for homogenous solution assays, GNPs can also be used as
for heterogeneous biomolecular assays. Such heterogeneous format assays are similar to
the design of solid phase sandwich type immunoassays (such as ELISA) but use
biomolecules labeled GNPs as the detection probes. Figure 1-22 is an example to use
GNPs in a heterogeneous assay for DNA detection. DNA hybridization reaction is used
for target DNA binding. The substrate was washed extensively to lower down the back
ground scattering intensities. After that, the light intensity from the resonance light
scattering is collected and used for target DNA quantifications. This technique was first
invented by Yguerabide et al. in 1998 and now commercially available from Invitrogen
Similar concept in a heterogeneous format was also demonstrated by Wang et al. for
protein detection with sensitivity in the range of ng/mL.54

Figure 1- 22. Schematic light scattering detection assay of the GeniconRLSTM twocolor DNA microarray kit.55

Dynamic light scattering (DLS), also known as photon correlation spectroscopy
or quasi elastic light scattering, is a technique used widely for particle size and size
distribution studies based on monitoring the scattering intensity variation of the sample
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solution at a specific angle. DLS is used routinely to analyze the size and size distribution
of polymers, proteins, colloids and nanoparticles. Recently, DLS is used to measure the
light scattering intensity in GNPs-based light scattering assays. In 2007, O’Neal et al.
used DLS to measure the light scattering intensity of gold nanoshells in whole blood. As
shown in Figure 1-23, DLS can detect gold nanoshells down to pM range. The same
group also did in vivo study on the uptake of gold nanoshells by mice using DLs as the
detection technique. A linear increase in scattering intensity was found when more gold
nanoshells were injected into the mouse. These studies show that DLS is a very sensitive
and convenient technique in detecting GNPs. 56

Figure 1- 23. Dynamic Light Scattering intensity area ratio of gold nanoshells to Triton
X-100 in 3% murine blood versus gold nanoshells concentrations. (Copyright ® 2007
Elsevier B.V.)

1.4.2 Application of GNPs for enhanced cell imaging and analysis
GNPs have been used as immuno-staining agents in cell studies under Scanning
Electron Microscopy (SEM) and Transmission Electron Microscopy (TEM) since 1950s
due to the high contrast of gold under electron beam. These techniques are cumbersome
in the sample preparation procedure and require well-trained professionals in the
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operation. In 1998, Yguerabide et al. used a different imaging technique, dark field
optical imcroscopy, to observe the cells stained with GNPs. Due to the strong light
scattering of GNPs, cells stained with GNPs can be seen much more clearly under an
optical microscopy.34

Figure 1- 24. Dark filed imaging for cells after uptake of anti-EGFR (Epithermal Growth
Factor Receptor) antibody conjugated spherical GNPs (upper row) and gold nanorods
(bottom row). Micrographs are shown for noncancerous cells (left column), and two
cancerous cells (middle and right columns) (Copyright ® 2006 Amrican Chemical
Society)

Figure 1-24 is an example reported by El-Sayed et al.on cancer cell imaging using
GNPs.29 Epithelial Growth Factor Receptor (EGFR) is a cell-surface receptor. The over
expression of EGFR can be associated with a number of cancers. In this example, antiEGFR antibody conjugated GNPs were used to stain both noncancerous and cancerous
cells. The cancerous cells which over-expressed EGFR on the surface showed much
brighter color under a dark field microscopy.57 Clear differences can be seen in the dark
field images from cancerous and noncancerous cells. For cancerous cells, GNPs
selectively aggregated on the cell surface due to the specific binding of the antibodies on
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the GNP surface to EGFR on cell surface. For noncancerous cells, GNPs did not form
aggregates as severe as for cancerous cells due to fewer EGFR on cell surface. As a result,
cancerous cells were much brighter than noncancerous cells.
There are many unique advantages to use GNPs in cell imaging and analysis,
comparing with other cell imaging agents such as fluorescence dyes. For example, GNPs
are resistant to photobleaching. Photobleaching is a serious problem for fluorescence
dyes especially if a long observation time is required in certain cell studies. In contrast,
GNPs are much stable and thus very suitable to trace cell-related reactions at long time
scales. Another advantage of GNPs is the much larger light scattering coefficient than the
light emission efficiency of fluorescence dyes. A single GNP could be easily seen under
dark field imaging using an optical microscopy with simple setups. These unique
advantages enable GNPs as very promising imaging contrast agents for cell studies.

Figure 1- 25. Cells irradiated in the absence of gold nanoshells maintained both viability
(a) (as indicated by the calcein fluorescence) and membrane integrity (c) (as indicated by
the lack of intracellular flouroscein dextran uptake), while cells irradiated in the presence
of gold nanoshells showed cell death and membrane corrupt. (Copyright ® 2003, The
National Acedemy of Sciences)
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1.4.3 GNPs enhanced photothermal therapy
The photothermal conversion property of GNPs makes them very promising to be
used as “cellular bombs” in destroying disease cells through photothermal therapy. When
GNPs are delivered specifically to disease cells by bio-recognition reactions, a laser
irradiation can introduce photothermal conversion and create a high temperature around
GNPs. Cells nearby the GNPs will be affected and then lose their biological activity
during the laser irradiation process.
In 2003, Halas et al. used antibody-conjugated gold nanoshells for
photothermalysis of human breast cancer cells. In an in-vitro test, as shown in Figure 125, tumor cells loaded with gold nanoshells were found to become dead after laser
irradiation, while normal cells were not affected under the same experimental condition.
In an in-vivo study, solid tumors treated with gold nanoshells had an increase in the
temperature up to∆T=37.4 oC. Tumors showed irreversible tissue damage within 4-6
minutes of laser irradiation by a 4 W/cm2 laser at 820 nm irradiation. 58
El-Sayed et al. also used both 40 nm spherical GNPs and 40 GNRs for in-vitro
photothermalysis of two squamous carcinoma cells lines. The uptake of the 40 nm GNPs
was confirmed by dark field imaging. When irradiated by a laser at 430 nm, the
cancerous HOC and HSC cells (two oral squamous carcinoma cells) suffered damage
within 4 minutes of irraditation at laser energy thresholds (19 W/cm2 and 25 W/cm2),
while damage was observed from healthy HaCaT cells (one benign epithelia cell) at a
much higher laser energy threshold (57 W/cm2). 59
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Figure 1- 26. Plots of celluar damage versus laser power density (left) and laser exposure
time (right) for SK-BR-3 cells loaded with gold nanocages.

In 2008, Xia et al. reported a quantitative study on the cellular damage of breast
cancer in the GNP-assisted photothermalysis. Gold nanocages with average length of 65
nm and SPR band at 800 nm were conjugated with anti-HER2 antibodies to target breast
cancer cells (SK-BR-3) through the over-expressed EGFR on cell surface. As shown in
Figure 1-26, cells loaded with gold nanocages responded immediately to the laser
irradiation and the cellular damage was irreversible at power densities greater than 1.6
W/cm2. The percentage of dead cells increased with increasing exposure time up to 5 min
and then became steady.60
1.5 Summary of the Dissertation
The synthesis, surface modification, biomolecular conjugation, and applications
of GNPs in bio-sensing, bioimaging and photothermal therapy have been studied
extensively over the last two decades and these research areas are still in fast growing.
However, there are remaining many questions and challenges.
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First, the synthetic mechanism of GNPs with respect to reaction conditions is not
well-understood. Nanoparticle growth in solution is a rather complicated process
governed by many thermodynamic and kinetics factors. We addressed these questions in
Chapter 2 and Chapter 3.
In Chapter 2, we conducted both experimental and theoretical study on the
kinetics of Brust-Schiffrin reaction for the synthesis of gold nanoparticles. Using a large
excessive amount of thiol ligands, the nanoparticle growth was stopped at different
intermediate stages. Our study revealed and confirmed that the reproducibility of BrustSchiffrin reaction for the synthesis of gold nanoparticles with diameter around 2 nm is
rather poor due to the intrinsic complexity of this two-phase reaction. The analysis results
of each intermediate product by TEM showed that nanoparticles grew very rapidly at
early stage of reaction and reached a maximum value of 2.6 nm at reaction time of
around 10 minutes. Further increase of reaction time led to a decrease of nanoparticle
size. In addition to the experimental study, we proposed a kinetic model for nanoparticle
growth in solution by assuming that the nanoparticle core expands through incremental
addition of gold atoms to the existing nanoparticle nuclei. This model not only gave a
relatively good fitting to the experimental data, but also provided further insight into the
nucleation and core expansion stage of the nanoparticle growth, which has not been
revealed in previous modeling studies.
In Chapter 3, we investigated the kinetic growth procedure of the 7.8 nm
oleylamine protected GNPs. The time-dependent size and SPR band changes of GNPs
were monitored by UV-Vis and TEM, respectively. The chemical structure changes of
these oleylamine ligands before and after the GNPs synthesis reaction was investigated in
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detail. It was found that experimental results supported the transition of oleylamine to
oleyamide during the reaction. Oleylamine ligands formed large complex aggregates with
gold salt instantly upon mixing these two agents together. At an elevated temperature of
80 oC, the complex decomposed first into very small particles and then the small particles
recombined together into larger and thermally stable particles with an average core size
around 9-10 nm. The oleylamide ligands formed a protecting monolayer around the
nanoparticles through a hydrogen bonding network between the amide groups. The
recombination of small particles into larger ones was found to follow a logistic model, as
confirmed by a nonlinear regression fitting of the UV-Vis absorption data of the reaction
solution with the mathematical model.
Second, to have controlled surface functionality on the GNP surface, especially
mono-functionality, remains difficult. The well-known place exchange reaction in
solution produces multiple functionalized GNPs. In Chapter 4, we used a solid phase
assisted place exchange reaction in the preparation of single-functional GNPs. This is
based on the ligands absorbing property of solid resins and the place exchange reaction of
thiol molecules to GNPs. Bi-functional thiol ligands are first trapped by the ionic resin.
This is due to electrostatic interactions between the carboxylic groups on one end of these
ligands and the surface charged groups on ionic resin surface. GNPs at size ~2 nm were
then added and the place exchange reaction was performed in such condition where the
mobility of the bi-functioal thiol ligans was restricted. As a result, single carboxyl group
functional GNPs were synthesized and verified by diamine coupling reactions. These
novel mono-functional GNPs could be used as the building blocks for functionalized
materials syntheses and applications.
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Third, the optical property of GNPs, especially in the analytical perspective, has
more to be revealed out. In Chapter 5, we investigated systematically the SPR absorption
and scattering property of GNPs, and determined the detection limits of GNPs in DLS
measurements. Three different types of GNPs with sizes range from 3.76 nm to 250 nm
were prepared and studied: citrate-stabilized nanoparticles in eleven different sizes;
oleylamide-protected gold nanoparticles with a core diameter of 8 nm, and a decanethiolprotected nanoparticle with a diameter of around 4 nm. A linear relationship between the
logarithms of extinction coefficients and core diameters of gold particles was found
independent of the capping ligands on the particle surface and the solvents used to
dissolve the nanoparticles. This linear relation may be used as a calibration curve to
determine the concentration or average size of an unknown nanoparticle or nanoparticlebiomolecule conjugate sample. Detection of GNPs by DLS revealed out that DLS is a
very sensitive technique in measuring GNP size, concentration and aggregations.
The last challenge is to prepare stable and also bio-functionalized GNPs and apply
to biological applications. Current reports already demonstrated that GNPs have great
potentials in biological applications. However, robust and reproducible GNPs-based
techniques have not been very successful. Motivated by to develop GNPs-based
techniques for realistic applications, we explored the great potential applications of GNPs
in immunoassay (Chapter 6, Chapter 7 and Chapter 8), bio-imaging and photothermal
therapy (Chapter 9) based on the strong light scattering property of GNPs.
In Chapter 6, we developed a one-step, washing-free and amplification-free assay
for protein analysis using GNPs and DLS technique. Specific biomolecular interactioninduced nanoparticle aggregation is monitored by DLS, and the degree of aggregation is
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correlated to protein analyte concentration. We then investigated the kinetics of
nanoparticle aggregation and developed two formats of assays using mouse IgG as the
target protein. Effects of reaction time, temperature, and GNP probe concentration on the
aggregation process were revealed. In this one-step assay, mouse IgG can be detected at
concentrations from 7.8 pg/mL to 50 ng/mL (or approximately 52 fM to 0.33 nM)
without any amplification process. A second format of assay developed in this study is a
competitive assay conducted by using both mouse IgG and goat anti-mouse IgGconjugated GNPs. This competitive assay avoided the problem of “hook effect” as often
encountered in non-competitive assays. In this work, we demonstrated here that by using
GNPs as a light scattering enhancer and selecting the proper assay formats, low cost,
easy-to-conduct, and highly sensitive bioassays can be developed for protein detection
and analysis.
In Chapter 7, GNPs were used for in-vitro diagnostic of protein cancer
biomarkers. The concept was proved by using two GNP probes, 40 nm spherical GNPs
and 40 nm by 10 nm gold nanorods, with two paired antibodies for prostate specific
antigen (PSA) conjugated onto each probe respectively. When the two probes were added
into the PSA antigen solutions, the two GNP probes formed aggregates through the
sandwich type conjunction with the bi-valent antigen in the center. The extent of the
aggregation reaction was found to be correlated with PSA concentrations. Such
aggregation reaction was detected by Dynamic Light Scattering (DLS) very sensitively.
This work demonstrated a one-step washing-free and amplification-free immunoassay for
cancer biomarker PSA detection. The novel immunoassay showed advantages of higher
sensitivity, simplified procedure and cost reduction over conventional assays.
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In Chapter 8, robust PEG-coated GNPs were prepared through the place exchange
reaction of thiolated PEG polymers and citrate-protected GNPs. These robust GNPs were
subjected to test their resistance from aggregation in solutions with a high ionic strength
or at different pH values. The robust 40 nm and 100 nm PEG-coated GNPs were used to
covalently bond with free-PSA antibodies to form robust GNP probes. The conjugate of
antibodies to GNPs were verified by DLS. These probes were used in the development of
free-PSA immunoassays. Better sensitivity down to 0.046 ng/mL for f-PSA was achieved.
In Chapter 9, GNPs were used for in-vitro bio-imaging and photothermal therapy
of tumor cells. Based on their strong scattering properties, antibody coated 40 nm GNPs
were conjugated with A547 lung cancer cells. This can be imaged clearly under dark field
microscopy. Cells after GNPs uptake were irradiated with a continuous laser beam with
the wavelength at 633 nm. The viability loss of cancer cells during the laser irradiation
was monitored in real time under a confocal microscopy. It is found that GNPs can
accelerate the death of cells as soon as the laser irradiation started. Power and irradiation
time were found to greatly affect the cell death rate. At a 3.75 mW/cm2 irradiation power
density, the fastest cell death rate was observed. The irradiation time of 60 seconds was
found to introduce 98% viability drop of cells, with much reduced irradiation time and
much higher viability drop comparing with literature results for other cancer cells. In
contrast, cells without GNPs maintained a high bio-activity. In this work, the combined
bio-imaging and photothermal therapy of lung cancer cell A549 were demonstrated.
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CHAPTER 2. KINETIC STUDY OF GOLD
NANOPARTICLE GROWTH IN SOLUTION BY BRUSTSCHIFFRIN REACTION
2.1 Introduction
GNPs represent one of the most extensively studied nanomaterials because of
their many unique size- and aggregation-dependent properties such as surface plasmon
resonance, surface enhanced Raman scattering, quantized charging effect, etc.1-3 A
convenient wet chemical method to prepare GNPs is through Brust-Schiffrin reaction.4,5
This reaction leads to thiolate monolayer-protected GNPs with sizes typically in the range
of 1-5 nm. The size of the nanoparticles can be controlled by adjusting the ratio of thiol
ligands and gold salts in the reaction mixture, the reaction conditions,5 or by postsynthesis thermal annealing treatment.6,7 The thiolate-protected GNPs exhibit good
solubility in a wide range of solvents, and are sufficiently stable for most application
purposes. Therefore, alkanethiol monolayer-protected GNPs have gained significant
attention since its first report.
However, despite the extensive use of Brust-Schiffrin reaction for gold
nanoparticle synthesis, many aspects of this reaction are still not well understood. One of
the remaining significant challenges in nanoparticle synthesis is the precise control of
nanoparticle size and size distribution. This problem arises from the rather complicated
kinetics and thermodynamics of the nanoparticle growth in solution.8-12 In general, a
nanoparticle growth in solution includes three basic steps: nucleation, core size expansion,
and passivation.13 As for Brust-Schiffrin reaction, this reaction involves a multi-step
process:5,13 First, in the presence of thiol ligands, Au (III) is reduced to Au(I) by
oxidizing thiols to disulfides. If more than 2 equiv of thiols are present, the resulting
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Au(I) and excess thiol will combine into a polymeric Au(I)-thiolate complex. In the
presence of sodium borohydride, all Au(I) are reduced to gold atoms. The free gold atoms
quickly coalesce together into small nuclei. Free gold atoms are then continuously added
to the existing nuclei or small nanoparticles coalesce together into larger particles. The
role of thiol ligands in this reaction is to passivate nanoparticle growth and to protect the
so-formed nanoparticles from aggregation by forming an alkanethiolate monolayer on the
nanoparticle surface.
AuCl4- + RSH → (AuISR)n (polymer)

(2-1)

(AuISR)n + NaBH4 → Aux(SR)y

(2-2)

Among all the steps involved in this reaction, each step alone poses significant
challenges for kinetic study. The nucleation process often occurs extremely fast and
cannot be easily monitored by commonly available instrumentation techniques. For the
core size expansion stage, an important question is whether the incremental addition of
gold atoms to the existing nuclei plays a dominant role or whether the coalescence of
smaller nanoparticles into larger nanoparticles is the major expansion pathway.14,15
Finally, the passivation of nanoparticle growth by thiol ligands is also a rather
complicated issue. Despite the fact that the self-assembled monolayer process has been
studied extensively,16-21 the kinetics of thiol ligand adsorption onto gold substrates
remains unclear in many cases. With the substrate dimension reduced from twodimensional flat surface to highly curved three-dimensional nanosphere, the kinetic study
of thiol adsorption to GNPs becomes even more challenging.22-24
As a first step leading to a further understanding of nanoparticle growth in
solution, we designed and conducted a simplified experiment to study the kinetics of
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Brust-Schiffrin reaction. Recently, it was reported by Murray and coworkers that ultra
small gold nanoclusters with diameters below 1 nm could be synthesized by the addition
of large excess amount of thiol ligands or under very low temperature reaction
condition.25 The purpose of large excess amount of thiol ligands is to increase the
passivation speed of thiol ligands so that the nanoparticle growth can be stopped at a very
early stage. Referring to this concept, we conducted the following experiment. Using the
conditions as reported in Murray’s work,5 a room temperature Brust-Schiffrin reaction
was set up using one to one ratio of 1-butanethiol ligands versus gold salt. After the
addition of reducing agent, sodium borohydride, a portion of the reaction mixture was
taken out from time to time and added with approximately 300 fold excess of more
butanethiol. The reaction was continued for another one hour to allow completion of the
reaction. The purpose for adding large excessive thiol ligands to the reaction mixture was
to increase the adsorption rate of thiol ligands to the nanoparticles, so as to stop the
nanoparticle growth effectively at different reaction stages. In this way, we can exclude
or minimize the kinetic effect of thiol ligands adsorption on nanoparticle growth and
obtain a better picture on the nucleation and core size expansion stages. Following the
experimental study, two kinetic models were proposed to explain the kinetic behavior of
Brust-Schiffrin reaction. Both models showed a fairly good fit with the experimental data,
with one model revealing more detailed information on nanoparticle growth mechanism.
2.2 Materials and Methods
2.2.1 Chemicals, solvents and materials
All Solvents and organic chemicals (ACS Reagents) were purchased from Aldrich
(Milwaukee,

WI)

or

VWR

(West

Chester,
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PA)

except

for

the

hydrogen

tetrachloroaurate(III) hydrate (HAuCl4), which was purchased from Strem Chemicals
(Newburyport, MA).
2.2.2 Synthesis of butanethiolate-protected GNPs (BtGNP)
Butanethiolate-protected GNPs (BtGNP) were synthesized according to the BrustSchiffrin reaction.4,5 All the reactions were conducted at room temperature. Briefly,
tetraoctylammonium bromide (1500 mg, 2.74 mmol, 2.5 equivalents) was stirred
vigorously in 80 ml toluene in a 500 mL round bottom flask. HAuCl4•xH2O (310 mg,
0.912 mmol, 1 equivalent) in 25 mL deionized water was added. As the AuCl4- was
transferred from the aqueous phase to the organic phase, the solution changed from a
bright yellow to a red-brown color. The organic phase was separated and 1.1 equiv. of 1butanethiol (74.9 mg, 0.832 mmol) was added to the solution. The solution was stirred at
room temperature for 10 min followed by the addition of NaBH4 (380 mg, 7.84 mmol, 10
equivalents) in 25 ml deionized water over 10 s. The resulting solution quickly turned
dark black. Following the complete addition of NaBH4, 10 mL aliquots were removed
from the reaction solution at time intervals of: 1, 2, 3, 5, 10, 30 60, and 180 min and
added to a separate flask followed by the addition of 3 mL 1-butanethiol (2.526 g, 28.00
mmol). Each reaction was allowed to continue for 1 h at room temperature with
continuous stirring. Nanoparticles were collected by removing the solvent using a rotary
evaporator under vacuum at 48°C. The dark nanoparticle product was then purified by
successive washing with 25 mL of ethanol and centrifugation. After four to five times of
washing, the residual ethanol was blown off using a stream of nitrogen gas and the
BtGNPs

were dispersed in dichloromethane for size analysis.

2.2.3 Particle size analysis
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For TEM analysis, approximately 1  L of sample in dichloromethane was added
on a 300 mesh Formvar-coated copper grid using an Eppendorf micropipette and
immediately wicked off using filter paper. After allowing the sample to air dry for 5-10
min, images were obtained using a JEOL 100CX transmission electron microscope at 80
keV. The average particle core diameter D and standard deviation σ were determined
according to equation (2-3) and (2-4) from the analysis of 100 particles randomly
appeared on TEM image. The diameters were measured using a LUPE 30X magnifier
(Ted Pella Inc. CA) with a built-in ruler.
r

D=

∑N
i =1

i

× Di

(2-3)

r

∑N

i

i =1

i =r

σ=

∑ (D
i =1

i

− D )2
(2-4)

N −1

2.3 Results and Discussions
2.3.1 Average core diameter
According to the previous work by Hostetler et al,5 using a one-to-one ratio of
thiol ligands versus gold salt and a room temperature reaction condition, nanoparticles
with approximately 2 nm core diameters can be obtained as the major product. We have
also used this condition routinely in our own lab to synthesize butanethiolate-protected
nanoparticles.26-29 Therefore we chose this condition as an example in our kinetic study.
After the extraction of gold salt into organic solvent using tetraoctylammonium bromide
and immediately following the addition of sodium borohydride into the solution, aliquots
of the reaction mixture were taken out after 1, 2, 3, 5, 10, 30, 60, and 180 minutes of
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reaction and added to approximately 300-fold excess of additional butanethiol ligand. At
the end of the reaction, each product was collected and purified by washing and
centrifugation. Each sample was characterized by a transmission electron microscope and
the average size and size distribution of each product were analyzed according to the
method described in the experimental section.
Table 2- 1. Average core diameter (d), standard deviation (σ), and number of Au atoms
per particle (N) of nanoparticles collected at different reaction stages
Batch 1

Batch 2

t (min)

d (nm)

σ (nm)

N

d (nm)

σ (nm)

N

d (nm)

Batch 3
σ (nm)

1

2.10

0.29

286

2.26

0.35

355

2.36

0.47

403

2

2.48

0.35

469

2.29

0.38

375

2.35

0.38

400

3

-

-

-

2.41

0.36

426

2.45

0.40

453

5

2.43

0.35

442

2.48

0.36

467

2.48

0.36

467

10

2.60

0.37

541

2.56

0.34

516

2.60

0.33

541

30

2.45

0.33

450

2.54

0.34

504

2.33

0.41

387

60

2.58

0.28

527

2.19

0.36

325

2.38

0.38

415

180

2.59

0.57

534

2.21

0.31

330

2.39

0.38

420

N

This experiment was repeated three times. The average diameters of each
nanoparticle product collected at different reaction times were summarized in Table 2-1
and Figure 2-1. From the comparison of these three experimental data sets, there are three
results to be noticed: first, from one batch of sample to the other batch of sample, the
average diameter of the nanoparticles under the same reaction conditions varies
significantly. In other words, the reproducibility of Brust-Schiffrin reaction for the
synthesis of GNPs in the range of 2 nm is very poor. As a matter of fact, we have noticed
such poor reproducibility in our extensive previous studies.26-29 Second, despite the large
variation of nanoparticle size from one batch of synthesis to the other, it was observed
that the nanoparticles core diameter exhibited a general trend of fast increase within a few
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minutes of reaction time and all three samples reached a maximum average core diameter
of 2.6 nm after 10 minutes of reaction. At a reaction time of one minute, the nanoparticle
diameter has already increased to more than 2 nm. Third, after the nanoparticle size
reached this maximum value, the nanoparticle size either decreased or remained at this
maximum value with elongated reaction time. The average diameter of nanoparticles
obtained after three hours of reaction is around 2.2 nm.

2.7

Diameter (nm)

2.6
2.5
2.4
2.3
2.2
Batch 1
Batch 2
Batch 3

2.1
2.0
0

50

100

150

Time (min)

Figure 2- 1. Diagram of nanoparticle average core diameter change over reaction time.
(Copyright ® 2006 American Scientific Publishesr)

The poor reproducibility of Brust-Schiffrin synthesis is due to the rather
complicated kinetics of this reaction.5, 8-13 First of all, this reaction is an inhomogeneous
two-phase reaction (water plus toluene), which means that the stirring speed has a great
effect on the reaction kinetics. Second, it was also noticed that the rate of addition of
reducing agents in solution could affect the concentration of nuclei formed in solution,12
therefore, the size of the nanoparticle product. Third, the nucleation is a fast process and
any slight variation of the experimental condition such as stirring speed of the reaction
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solution could change the nuclei concentration, so as to the size of the nanoparticles
dramatically. A very small experimental error from the reagent concentration could also
bring such dramatic effects. This poor reproducibility makes the scale up for industrial
production of nanoparticles using Brust-Schiffrin reaction very challenging.
Although the variation of nanoparticle size from one sample to the other is large,
one can still see a general trend of rapid size increase within 10 minutes of reaction time.
From the data collected here, it is difficult to judge when the nucleation process started.
Because of the very rapid size increase, it is difficult to control the nanoparticle size at
this stage of reaction. However, it is interesting to note that all three samples reached the
same maximum diameter of 2.6 nm at 10 minutes of reaction time. This suggests that the
maximum nanoparticle size in a Brust-Schiffrin reaction is mainly determined by the
ratio of chemical agents used in the study, but not much affected by the specific reaction
conditions. After reaching the maximum size, the nanoparticles either remained at this
size or even decreased. It is unclear at this time what is the exact mechanism behind the
size decrease, however, we believe this is possibly due to the etching effect of thiol
ligands, as pointed in some previous reports.30-32 Because of the rather complicated nature
of self-assembled monolayer formation on three-dimensional nanocluster surface, the
mathematic modeling study described in this paper will not address this effect.
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Figure 2- 2. The particle size distributions of batch 2 synthesis product obtained after (a)
5 minutes, (b) 10 minutes, and (c) 30 minutes of reaction time. (Copyright ® 2006
American Scientific Publishesr)
2.3.2 Nanoparticle polydispersity
The polydispersity of each nanoparticle sample collected at reaction time of 5, 10
and 30 minutes was analyzed and summarized in Table 2-1 and Figure 2-2. Only the

59

results from batch 2 synthesis are shown here. Essentially, it was noticed that the
polydispersity for all the samples collected at different reaction time intervals and from
different batches of synthesis is approximately 14%. Different from the average core
diameter of the nanoparticles, the polydispersity of the nanoparticle product is much less
affected by the conditions applied to the reaction, such as stirring speed, the addition rate
of reducing agents, the concentration of each agents, etc. A statistical model governed by
a certain nanoparticle growth mechanism such as coalescence of smaller nanoparticles
into larger ones may play a more important role in polydispersity property of nanoparticle
product grown in solution.
2.3.3 Kinetic modeling study
We used two kinetic models in this work to explain the observed experimental
results. The first one was proposed by Hiramatsu et al. based on the synthesis of
oleylamine-protected GNPs.10 In this model, the nanoparticle growth is expressed as the
AuCl4- concentration change that follows a first-order kinetic. This model also assumes a
constant gold nanoparticle concentration throughout the whole reaction, which was
estimated from the maximum size of nanoparticles in the final product. The number of
gold atoms in a nanoparticle at a give reaction time is:
n (t) =

[AuCl ] (1 − e )
4 0

− kt

[AuNP]

(2-5)

[AuCl4-]0 is the initial concentration of gold salt or gold atom concentration. [AuNP] is
the concentration of GNPs, also nanoparticle nuclei concentration at any given reaction
time.
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Figure 2- 3. Non-linear regression fitting curve from kinetic equation (5) with respect to
experimental data. (k=0.007s-1) (Copyright ® 2006 American Scientific Publishesr)

existing gold atoms or nanoparticle nuclei
additional gold atoms
Figure 2- 4. The incremental addition model of nanoparticle growth process

We used the implementation of non-linear regression found in the software
program MATHEMATICA for the curve fitting. This implementation uses the
Levenberg-Marquart gradient search method to find the least squares minimum for the
model.33 The fitting result of this model to the experimental results is shown in Figure 2-3.
In the graph, the experimentally obtained average diameters of nanoparticles were
converted to number of gold atoms by assuming a spherical geometry as shown in Figure
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2-4.34,35 The k value obtained from this fitting is 0.007s-1. The 95% confidence interval
for the value of k is (0.0058, 0.0082). For the fitting, the F-statistics is 161.58, which
yields a p-statistic value36 less than 0.00001, an indication of good non-linear regression
fitting. Although this model fits well into the experimental results, it does not provide
more detailed information on the mechanism of nanoparticle growth. For example, this
model cannot tell whether nanoparticles grow mainly by incremental addition of gold
atoms to the existing nuclei or by coalescence of smaller nanoparticles into larger ones.
This model also failed to identify and explain the nucleation process. To obtain a further
understanding on these questions, we proposed a second kinetic model by assuming that a
nanoparticle grows by incremental addition of gold atoms to existing nuclei as shown in
Figure 2-4. The concentration of nuclei remains constant throughout the reaction. In this
case, the number of gold atoms in a nanoparticle at any reaction time can be expressed in
equation (2-6):

([

dn
= kn 2 / 3 AuCl 4−
dt

] − [AuNP]n)
0

(2-6)


 2b1/ 3n1/ 3

1+
2/3
1/ 3 1/ 3 1/ 3
2/3 2/3


a
a
b
n
b
n
1
+
+
a1 / 3


t = 2 / 3 1/ 3  3 ln 2 / 3
Arc
+
6
3
tan

6a b k   a − 2a1/ 3b1/ 3n1/ 3 + b 2 / 3n 2 / 3 
3




a = [AuCl4-]0

b = [AuNP]





 −π 3






(2-7)

The number of gold atoms added to an existing nanoparticle nuclei per unit time
is related to the concentration of gold atoms in solution, which is [AuCl4-]0-[AuNP]n, and
the number of reactive sites on an existing gold nanoparticle surface. The number of
reactive sites is roughly equivalent to the number of gold atoms on the surface, which is
equivalent to ρn2/3 (ρ is a constant), assuming a nearly spherical structure of the
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nanoparticle core. Here k is the product of reaction rate constant and ρ, therefore, is also a
constant. The solution of this kinetic equation is given in equation (2-7).
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Figure 2- 5. Non-linear regression fitting curve from kinetic equation (6) with respect to
experimental data. (k=15.2712, a= 0.01 M, b= 0.000018812 M) (Copyright ® 2006
American Scientific Publishesr)

The value of a was set at 0.01 M, as used in the experiment. The non-linear
regression found in the software program MATHEMATICA was used to find the
optimum values for b and k. The value obtained for b from curve fitting was 0.000018812
M and the value obtained for k was 15.2712. The fitting curve and the experimental data
are shown in Figure 2-5. The 95% confidence interval for b is (0.000018465,
0.000018497). The 95% confidence interval for k is (9.9416, 20.6008). The F-statistic for
this model is 44.2477, which provides a p value for the F-distribution of less than
0.00001. This indicates a relatively good fit of the model to the data. Experimentally, the
b value, the concentration of GNPs, was found to be 0.0000181 M, very close to the
results obtained by the model.
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The good fitting between the model and the experimental data indeed suggests
that incremental addition of gold atoms onto existing nanoparticle nuclei is likely a major
pathway for nanoparticle growth. At later stage of the reaction, nanoparticle-nanoparticle
aggregation and coagulation may start to present a significant effect on the growth
process. It is interesting to note that the incremental addition model proposed here reveals
clearly a “nucleation” stage of the nanoparticle growth (Figure 2-5). The time for nuclei
formation was found to be around 10-20 seconds according to the model. Within 20
seconds, the rate of nanoparticle growth is almost zero. After about 50 seconds, the
nanoparticle starts to grow rapidly. The mechanism for nucleation is due to or at least
partially associated with the number of surface sites available for addition of more gold
atoms. Since gold atoms coalesce together by van der Waals interactions, a larger surface
area will attract more gold atoms to the nanoparticle surface per unit time.
2.4 Conclusion
In summary, we conducted both experimental and modeling studies to understand
the nanoparticle growth kinetics in solution. These studies revealed and confirmed that
the reproducibility of Brust-Schiffrin reaction for the synthesis of GNPs with diameter
around 2 nm is rather poor due to the intrinsic complexity of this two-phase reaction.
Although it is unlikely that a single mathematical model can be found to explain the
kinetics of such complex reaction, the incremental addition model proposed in our study
revealed some important information on the nucleation and growth stage. From this study,
we also conclude that in order to gain a more comprehensive understanding on wet
chemical synthesis of nanoparticle materials, it is important to first disseminate and
examine the different stages of nanoparticle growth separately and then collectively. With
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Brust-Schiffrin reaction being used extensively for gold nanoparticle synthesis, a full
understanding of this process is critical for both fundamental research as well as mass
production of nanoparticle materials for practical applications.
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CHAPTER 3. A STUDY ON GOLD NANOPARTICLE
SYNTHESIS USING OLEYLAMINE AS BOTH REDUCING
AGENT AND PROTECTING LIGAND
3.1 Introduction
GNPs have promising application potentials in many fields, ranging from
bioconjugate probes, sensors, electronics and optics, to photon-thermal energy converters,
and catalysis.1-5 Since the first synthesis of gold colloids 150 years ago,6 there have been
numerous methods developed for the wet chemical synthesis of gold nanoclusters,
nanoparticles, and colloids.7-9 To list a few, Turkevich et al used sodium citrate as the
reducing agent to make citrate-stabilized GNP with size ranging from a few nanometers
to tens of nanometers.10 Brust and Schiffrin developed a two-phase reaction to prepare
alkanethiolate-protected GNP with core size ranging from 2 to 5 nm.11,12 Other than thiol
ligands, other types of ligands have also been used extensively as capping agents for gold
nanoparticle synthesis.13-15 Recently, a study was reported on the use of an amine-borane
complex as a mild reducing agent to make monodispersed gold and silver nanoparticles.16
In spite of these extensive work, understanding on the mechanism and growth kinetics of
nanoparticles under different chemical environment and conditions is still very limited.
Such understandings are critical for the development of nanoparticles with controlled
sizes, shapes and expectant properties.
Among the different methods for gold nanoparticle synthesis as mentioned above,
we are particularly interested in amine compound-based gold nanoparticle synthesis.
Gomez et al revealed that Au(I) complex could undergo decomposition with alkylamines
and form amine-protected GNPs.17 Osterloh et al. synthesized nearly monodispersed
amine-protected gold and silver nanoparticles using an oleylamine ligand.18 Aslam et al
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recently reported the synthesis of an oleylamine (OA)-stabilized GNPs which were
soluble in both water and organic solvents.19 A significant difference between amine
chemistry versus thiol chemistry-based synthesis is that amine ligands can serve as both
the reducing agent and capping ligands for nanoparticle synthesis. This means aminebased gold nanoparticle synthesis can often be conducted in a single-phase reaction
system. For thiol chemistry-based synthesis, an additional reducing agent other than thiol
ligands, usually sodium borohydride, needs to be added to the reaction. Since sodium
borohydride is only soluble in a polar solvent such as water and most thiol ligands are
only soluble in nonpolar organic solvents such as toluene, thiol chemistry-based
nanoparticle synthesis are often conducted on a two-phase reaction system, such as the
case of Brust-Schiffrin reaction.11,12 The kinetic control of a two-phase reaction is
typically much more difficult than single-phase reactions. As revealed in one of our
recent studies, the average core size of the nanoparticles synthesized using BrustSchiffrin reaction varies significantly from batch to batch.20 This difficulty poses
significant challenges to the understanding of nanoparticle growth kinetics.
We herein report a mechanism and kinetic study of an oleylamine-protected gold
nanoparticle growth using a procedure reported by Aslam et al.19 Although this method
was reported a few years ago, not much is understood on the growth process and the
monolayer structure of the nanoparticles. The interesting aspect of this synthetic protocol
is that the reaction is done using water as a single phase solvent: both gold salt and
oleylamine were dissolved in water, and the product is soluble in both water and organic
solvents. After the reaction, relatively monodispersed GNPs in the size range of tens of
nanometers were obtained in high yield by precipitation. Because of the simplicity of the
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procedure and the use of water as solvent, this reaction may become a very useful method
for large scale commercial production of GNPs. From our study, we obtained important
and detailed information on the nanoparticle growth process, as well as the chemical
structural change of the amine ligands during the reaction. Our results lead to a different
explanation on the protecting effect of oleylamine ligands on the nanoparticles than some
reported studies. We also found for the first time that the nanoparticle growth kinetics
follows a logistic model,21 a model that has been used to explain many natural growth
and decay processes.22-24 Results obtained from our study will be valuable in assisting
further design and synthesis of nanoparticle materials with controlled sizes and properties.
3.2 Experimental
3.2.1 Chemicals, solvents and materials
Oleylamine (C19H37NH2; tech., 70%) and all solvents (ACS Reagents) were
purchased from Aldrich (Milwaukee, WI) except for the hydrogen tetrachloroaurate (III)
hydrate (HAuCl4·xH2O), which was purchased from Strem Chemicals (Newburyport,
MA).
3.2.2 Synthesis and kinetic study of oleylamine-protected GNPs (OAGNPs)
Nanoparticles

were

synthesized

according

to

a

reported

procedure.19

HAuCl4·xH2O (51.5 mg, 0.15 mmol) was dissolved in 120 mL nanopure water and
heated up to 80 oC. An aliquot of 2 mL yellow gold salt solution was taken out and UVVis spectrum of the solution was recorded immediately. Oleylamine (300 μL, 0.66 mmol)
was then added to the solution and at time intervals of 5 s, 3, 6, 9, 12, 17, 22, 27, 32, 37,
42, 47, 52, 57, 62, 72, 82, 92, 102, 112, 122, 132, 142, 152, 162, 172, 182, 192, 202, 212
min following the addition, 2 mL of reaction mixture were taken out and UV-Vis spectra
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were recorded from 200 to 800 nm for each sample at a scanning rate of 600 nm/min. To
obtain the final product, after reacting for three hours, the reaction mixture was cooled
down to room temperature and 300 mL of methanol was added to the solution to allow
the product precipitate out. After placing the solution at room temperature for 24 hours,
the product was collected by centrifugation, washing with copious amount of methanol
and drying in air.
3.2.3 Infrared spectroscopy
The infrared spectrum of the nanoparticle product was recorded using a
PerkinElmer Spectrum™ 100 FT-IR spectrometer with a universal ATR sampling
accessory. Analyses were performed on solid samples deposited on a diamond coated
ZnSe crystal (d = 1 mm) by evaporation of several drops of nanoparticle solution in
toluene. A background was taken without sample deposited before each measurement.
3.2.4 Nuclear Magnetic Resonance (NMR)
1

H NMR spectra of free ligand oleylamine and

OAGNPs

in CDCl3 were obtained

on a Varian Mercury 300 MHz spectrometer using a line-broadening factor of 1 Hz and
relaxation delay of 1 s at pulse 45 degrees and an acquisition time of 1.997 s.
3.2.5 UV-Vis Spectroscopy
UV-Vis absorption spectra of the nanoparticle product and reaction intermediates
were recorded on sample solution using a Cary 300 Bio double-beam UV-Vis
spectrophotometer with a scan range of 200-800 nm and a 1 nm resolution. Sample cell
used in the study was a 1 cm quartz curvette. All experimental data were corrected for
water background absorption.
3.2.6 Transmission Electron Microscopy (TEM)
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TEM images were obtained by a FEI TECNAI F30 electron microscope. The
accelerating voltage during measurement was 300 keV. The 400 mesh carbon/formvarcoated copper grids were first treated with a poly-L-lysine (M.W. 93800, Sigma) solution
(0.0381 g/mL in 1:3 H2O: MeOH mixture solvents). TEM sample grids were then
prepared by extracting 5 μL reaction solution from the reaction mixture after oleylamine
addition at reaction time intervals of 1, 4, 7, 10, 15, 20, 25, 30, 35, 40, 60, 80, 100, 120,
140, 160 and 180 min, casting the solution onto polylysine treated grids and vacuum
dried. ImageJ software was used to analyze the average size and size distribution of
nanoparticles in TEM images for each sample.
3.2.7 Modeling of OAGNPs growth kinetics by MATHEMATICA
The UV-Vis absorption spectra of nanoparticle intermediate product were further
analyzed using Cary WinUV software and the reaction kinetic was modeled using the
nonlinear

regression

functions

of

the

Statistics

package

of

the

program

MATHEMATICA.25 For samples collected at different time intervals, the absorbance of
the samples at the surface plasmon resonance band 530 nm were recorded. The
absorbance of the reaction solution versus reaction time was plotted and the data was
fitted with a logistic model using MATHEMATICA.
3.3 Results and Discussions
3.3.1. Monolayer structure of the OAGNP
As described in the experimental section, the synthesis of GNPs in aqueous
solution using oleylamine as both reducing agent and stabilization agent is an extremely
simple protocol. After three hours of reaction at 80 oC, the nanoparticle product was
collected by simple precipitation and washing. Different from what was reported by
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Aslam et al.,19 we found that after the nanoparticles were precipitated out from methanol,
the nanoparticles lost their solubility in water. The dried nanoparticles have good
solubility in THF, toluene, and relatively good solubility in dichloromethane. TEM
analysis of the end reaction product revealed mainly spherical nanoparticles with an
average core diameter around 9.5 nm, with a polydispersity around ± 1 nm. The
reproducibility of this reaction is very good. The average core size of the nanoparticles
from three different batches of synthesis is 9.5 ± 1.1 nm.

Figure 3- 1. IR spectra of (a) oleylamine and (b) oleylamide-protected GNPs. (Copyright
® 2007 American Scientific Publishers)
To better understand the nanoparticle growth and passivation by organic ligands,
we first analyzed the ligand monolayer structure of the nanoparticles using FT-IR and
NMR spectroscopy. Figure 3-1a and b are the IR spectra of neat oleylamine and

OAGNP

product. The IR spectrum of oleylamine contains the following major bands: N-H stretch
around 3380-3250 cm-1, C-H stretch at 3100-2850 cm-1, N-H bending at 1615 cm-1, C-H
bending at 1500-1300 cm-1, and weak C-N stretch at 1100-1050 cm-1. Two major
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differences were observed from the IR spectrum of

OAGNP:

the N-H bending of

oleylamine at 1615 cm-1 disappeared, and two new peaks appeared at 1654 and 1567 cm-1.
These two peaks are representative vibration bands of amide bonds, as typically seen in
the IR spectra of peptides and proteins.26 The comparison of Figure 3-1a and b suggests
that the amine group from free ligands was converted into amide when Au (III) was
reduced to Au (I) or Au (0). Amide is an oxidized form of amine. In both Osterloh18 and
Aslam’s19 studies, the structural change of the oleylamine ligand during gold nanoparticle
formation was not mentioned. However, Sun et al. discovered in a polyamine-induced
gold nanoparticle formation that the amine groups were converted to amide groups.27 Our
finding not only corroborates with this reported study, but is also further supported by the
NMR spectroscopic analysis as discussed in the following.

Figure 3- 2. NMR spectra of oleylamine (left) and oleylamide-protected GNPs (right).
(Copyright ® 2007 American Scientific Publishers)
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Figure 3- 3. The hydrogen bonding network formed between oleylamide ligands as a
protecting layer on the GNPs. (Copyright ® 2007 American Scientific Publishers)
The 1H NMR spectra of oleyamine and

OAGNP

product are shown in Figure 3-2.

The major peak assignment for pure oleylamine is the following: a small broad single
peak at 1.13 ppm for NH2, a triplet at 2.61 ppm for CH2-NH2, a multiplet at 1.37 ppm for
CH2-CH2-NH2, a triplet at 5.25 ppm for -CH=CH-, a quartet at 1.96 ppm for CH2CH=CH- and a triplet at 0.86 ppm for the CH3 groups. In the spectrum of OAGNP, a few
major changes were observed: first, the NH2 peak at 1.13 ppm disappeared and a new
broad peak at 8.27 ppm appeared. The relative intensity of this new peak versus the CH3
peak is about 2:3. It is known that the chemical shift of amide NH2 is generally around 6
ppm. However, amides tend to form intermolecular hydrogen bonding in solid state, and
the hydrogen bonding can cause the downfield shift of the proton NMR signal.28 In
addition to the direct observation of amide bond formation, a few other changes were also
noticed to accompany this conversion: for example, a triplet at 2.61 ppm that belongs to
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CH2-NH2 disappeared, and a new multiplet can be attributed to CH2-CO-NH2 appeared at
2.97 ppm. Judging from both NMR and FT-IR spectrum of

OAGNP,

we believe that

oleylamine was converted to oleylamide during nanoparticle formation and oleylamide
ligands formed a complementary hydrogen bonding network around the gold nanoparticle
surface as shown in Figure 3-3. The network formed a protective ligand monolayer to
stabilize the nanoparticles. To further verify the existence of H-bonding network, 200 μL
trifluoroacetic acids were added into 4 mL as-prepared

OAGNP

water solution.

Nanoparticles were instantly precipitated out of the solution. Trifluoroacetic acids
destroyed the H-bonding network and destabilized the nanoparticles.
It was further noticed that each proton peak in the spectrum of OAGNP, including
the α proton next to the amide group, is rather sharp, suggesting that the amide groups
are not directly complexed to the surface gold atoms. The oleylamide-protected gold
nanoparticle is more like a nano-sphere floating inside a hydrophilic micelle-like
compartment formed by oleylamide ligands. This is a distinct difference from thiol
ligands-protected GNPs. As described in many reported studies, when thiol ligands are
directly chemically bonded or complexed with surface gold atoms, the α proton NMR
signals next to thiol groups are generally broadened significantly due to Knights shift or
electromagnetic coupling interactions of the proton nuclei in close proximity to a metal
surface.29-32 The results observed from our study bear some significant differences from
some reported studies, where it is believed that the amine ligands are bound on
nanoparticle surface by weak covalent bonds or electrostatic interactions.13, 33
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Figure 3- 4. Color change of the reaction solution observed during OAGNPs growth at
different reaction time (unit in minutes). (Copyright ® 2007 American Scientific
Publishers)

Figure 3- 5. (left) UV-Vis Spectra of gold salt HAuCl4·xH2O solution in deionized water
at 80 oC (-■-) and the reaction solution after oleylamine was added to the solution for 10
s (-▲-) and 3 min (-○-); (right) UV-Vis spectra of the reaction solution taken at different
time from 32 to 212 min (time increased from 32 to 37, 42, 47, 52, 57, 62, 72, 82, 92, 102,
112, 122, 132, 142, 152, 162, 172, 182, 192, 202, 212 min along the arrow). (Copyright
® 2007 American Scientific Publishers)
3.3.2 Growth kinetics and mechanism study of the OAGNP product
During the nanoparticle synthesis, a continuous color change was observed from
the reaction solution as shown in Figure 3-4. The aqueous solution of gold salt is a bright
yellow colored solution. After the addition of oleylamine, the solution immediately
changed to light brown, and then to burgundy with increasing intensity throughout the
reaction. UV-Vis absorption spectra of the reaction solution were recorded at very early
stages of reaction and shown in Figure 3-5 (left). From the spectra, one can see that after
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oleylamine was added to the solution, the absorption band of gold (III) salts at 320 nm
disappeared very quickly. This is due to the complex formation of oleylamine with gold
(III).17,19 The UV-Vis spectra presented here confirmed that the complexation of
oleylamine with Au (III) is a rather fast process. Within 1 minute of reaction time, the
reduction and complexation should be completed. After the addition of oleylamine, the
UV-Vis absorption spectra of the reaction solution was collected at different time
intervals and presented in Figure 3-5 (right). From these spectra, one can see that at a
reaction time of around 40 minutes, a surface plasmon resonance band appeared at 530
nm. The absorbance of the band continued to increase during the reaction. The
wavelength of the SPR band did not show much significant shift during the reaction.
From the absorbance increase of the SPR band, it is difficult to judge whether the
increase was only due to the concentration increase of the nanoparticles or also reflected
the size change of the nanoparticles. It is known that the SPR absorption of GNPs
increases with increased size.12

Figure 3- 6. Transmission electron microscopy images of intermediate product of gold
nanoparticle growth collected at different reaction stages (unit in minutes, indicated in
left-top corner for each one). (Copyright ® 2007 American Scientific Publishers)
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To answer this question, we analyzed the reaction intermediate product using
TEM. During the reaction, a small aliquot (~ 2 µL) of reaction mixture was taken out of
the reaction flask and immediately deposited on formvar-coated copper grids. TEM
images of reaction intermediates collected at different reaction stages are shown in Figure
3-6. At early stages of reaction, only very large non-spherical aggregates were observed.
The size of the aggregates varies from a few hundreds of nanometers to even microns.
The density of the aggregates appeared on the TEM grids was very scarce. After a few
minutes of reaction, the size of the aggregates started to decrease, at the same time, some
small particles (less than 1-3 nm) started to appear. At reaction time of around 20 min, all
the large aggregates disappeared and only small particles were present. Then the small
particles started to recombine together into larger nanoparticles with an average diameter
around 10 nm. In the next 20 min of reaction time, we saw from the TEM images a large
number of small particles (1-3 nm) and a very small amount of larger particles around 10
nm. At reaction time of about 40 minutes, the number of nanoparticles at 10 nm size
range increased dramatically and the number of small particles decreased. Referring to
the UV-Vis absorption spectroscopic study of the reaction solution, this is also the stage
where one started to observe obvious Surface Plasmon Resonance (SPR) band in the UVVis absorption spectra. As the reaction continues, the number of nanoparticles at 9-10 nm
size range in the reaction solution would continue to increase, as seen from Figure 3-5 at
time 40, 80, 100 and 180 minutes. This result indeed suggests that the observed SPR band
absorbance increase from the UV-Vis absorption spectra of the reaction solution was due
to the increased concentration of GNPs in the size range of 10 nm, since GNPs less than 3
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nm do not exhibit obvious SPR band.12 It should be the case that small particles
combined together into larger nanoparticles of which the final size was controlled by an
equilibrium state. To summarize the results obtained from TEM and UV-Vis
spectroscopic analysis, we believe the nanoparticle growth follows a process as outlined
in Figure 3-7.
Referring to reported work,17 the large aggregates formed at very early stage of
the reaction should be an amine-Au (III) or amide-Au (I) or Au (0) complex. The
disappearance of Au (III) salt absorption band at 340 nm at very early stage of the
reaction also pointed out this possibility. The amine or amide-Au complex is a kinetically
controlled product rather than a thermally stable product. Upon continuous heating, the
thermally unstable complex was converted into thermally more stable nanoparticle
product. The size of the final product of nanoparticles is determined by the stabilization
effect of oleylamide ligands. Indeed, as noted by Aslam et al,19 the average core size of
the nanoparticles synthesized from this reaction can be tuned using different ratio of
oleylamine ligands versus gold salt added to the reaction.
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Figure 3- 7. An illustration of the gold nanoparticle formation process using oleylamine
as both reducing and capping agents. (Copyright ® 2007 American Scientific Publishers)

3.3.3. Modeling of the nanoparticle growth kinetics
Using the UV-Vis absorption data presented in Figure 3-5, we plotted the
absorbance change of the reaction solution at 530 nm versus reaction time as shown in
Figure 3-8. At a glance, it appears that the SPR band absorbance increase of the reaction
solution follows a well known mathematical model, the logistic model. The logistic
model was first proposed by P. F. Verhulst21 and has been found to be applicable to many
scientific phenomena such as population dynamics.22-24 We repeated the synthesis of
OAGNP

under exactly the same conditions two additional times and the absorbance of the

SPR bands of the solution at different reaction stage are included in Figure 3-8. From the
three batches of data, it can be seen that the reproducibility of the reaction is very good.
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The average of the three sets of data was fit to a logistic model by a nonlinear regression
function and the fitting curve is shown in Figure 3-8 (solid line).

Figure 3- 8. Plots of the SPR band absorbance of reaction solution versus reaction time
(min) for three different batches of nanoparticle synthesis and the curve fitting of the
experimental data with a logistic model. (Copyright ® 2007 American Scientific
Publishers)

The best fit for the combined data sets was found to be the function
f(t)=0.0301696/(0.00554857+e-1.80796+0.0301696t). This gives a p-value34 of less than .00001,
which is indicative of a very good fit. The good fitting of experimental data with the
logistic model suggests that the final size of the nanoparticle product is controlled by an
equilibrium state. After the nanoparticle growth reaches a certain size, the combination of
the particles into larger ones will form equilibrium with the dissociation of larger
particles into smaller ones. This equilibrium state is achieved when the oleylamide
ligands form a most stable protecting monolayer around the GNPs through combined
hydrogen bonding network formation between the amide groups and the van der Waals
interactions between the long hydrocarbon chains of oleylamide ligands.
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3.4 Conclusions
From this study, we discovered some interesting details on the structure and growth
mechanism of a gold nanoparticle product that was synthesized in solution using an
organic amine ligand as both reducing agent and capping agent. This reaction has
promising potential for large scale and environmental friendly production of gold
nanoparticle materials due to its simplicity and the use of water as reaction solvent. The
important findings of this work include: (1) the amine ligands were oxidized into amides
when gold (III) was reduced and the amide ligands formed a hydrogen bonding network
as a protecting layer around the GNPs; (2) the nanoparticle growth follows a process of
thermal decomposition of large amine or amide-Au complex aggregates into smaller
particles and the recombination of these smaller particles into more thermally stable
larger particles; and (3) the concentration (population) increase of the thermally stable
nanoparticles in solution follows a logistic model. Although the detailed reason behind
the last finding remains unclear, it is interesting to note that the growth of nanoparticles
in solution bears some close resemblance to natural population growth models. A further
study along this line may lead to a better understanding and methods for controlled
nanoparticle synthesis.
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CHAPTER 4. MONOFUNCTIONAL GOLD
NANOPARTICLES PREPARED FROM A NONCOVALENT
INTERACTION-BASED SOLID PHASE MODIFICATION
APPROACH
4.1 Introduction
The ability to prepare gold and other metal nanoparticles with a controlled surface
chemistry is critically important for the preparation of more complex nanostructures.
Since the initial results by Brust and Schiffrin, numerous methods have been published
for the preparation of monolayer protected GNPs of different sizes with a variety of
surface functional groups.1-3 Until recently, the ability to control the surface functionality
has been limited to the place exchange reaction between existing bound ligands on the
nanoparticle surface and bifunctional ligands in solution.3,4 It has recently been
demonstrated by several authors that polymeric solid supports such as Wang resin may be
used for the controlled surface functionalization of GNPs.4-8 Previous techniques relied
on the covalent bonding of a bifunctional ligand onto the solid support and subsequent
place exchange with GNPs in solution. Under the proper conditions, nanoparticles with a
single or very small number of functional groups can be cleaved from the solid support as
the major product.
In this communication we present an alternative method for the solid-phase
preparation of monofunctionalized GNPs using noncovalent interactions. The purpose of
this work was to reduce the cost and time for the synthesis and to find milder reaction
conditions so that a wider range of nanoparticles could be modified by this method.
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4.2 Experimental
4.2.1 Preparation of monofunctional

BtGNPCOOH

particles using amine-functional

silica Gel
Electrostatic

absorption

of

11-mercaptoundecanoic

acid

onto

amino

functionalized silica gel was performed by suspending 3 g of silica gel in 10 mL of 1:1
dichloromethane with methanol followed by addition of the appropriate amount of 11mercaptoundecanoic acid as indicated in Table 4-1. The reaction mixtures were then
shaken vigorously for 30 minutes at room temperature. The silica gel was then filtered
and thoroughly washed with dichloromethane and methanol to remove any unbound free
thiol ligands. Ellman’s agent (5,5’-dithio-bisnitrobenzoic acid) was used to monitor the
absorption of thiol ligands to dried silica gel. The dried silica gel with bound 11mercaptoundecanoic acid was suspended in 2 mL of dichloromethane. To the suspension,
30 mg of 2.2 nm BtGNP in 6 mL of dichloromethane was added. The exchange reaction
was allowed to proceed for 8-12 hours at room temperature with gentle shaking. During
this time the silica gel turned dark black. After filtering and washing with warm
dichloromethane to remove unbound nanoparticles, the silica gel was dried under vacuum.
The nanoparticles were then cleaved from the gel by suspending the gel in 4.0 mL of 5%
acetic acid in dichloromethane and shaking the suspension for 5 minutes at room
temperature. Functionalized GNPs were collected by filtration and dried by gentle
nitrogen flow.
The crude product was purified by washing the sample several times with
petroleum ether with occasional sonication followed by centrifugation. After each cycle,
the wash solution was tested for organic impurities by spotting a TLC plate and checked
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for impurities with a UV lamp. After drying, the nanoparticles were further purified by
GPC using Sephadex LH-20 gel. Using dichloromethane as the solvent, Sample A (which
had the highest concentration of 11-mercaptoundecanoic acid) split into two bands. The
first band (about half of the sample) consisted of nanoparticles which could be collected
in pure dichloromethane. About half of the second band could be collected when the
solvent mixture was changed to 9:1 dichloromethane with acetic acid. The remaining
sample could not be collected unless pure acetic acid was added to the column. For
sample B, most of the sample was soluble in pure dichloromethane while a small portion
was collected when a 9:1 solution of dichloromthane with acetic acid was added to the
column. Sample C was found to be soluble in pure dichloromethane and was collected in
one portion. The total yield of the BtGNPCOOH nanoparticles obtained for sample C was
about 50% (calculated from the amount of nanoparticles added to the solid phase place
exchange reaction. For 3g of silica gel, 15mg of monofunctional GNPs were obtained
from 30 mg of nanoparticles added in the solid phase place exchange reaction).
4.2.2 Preparation of monofunctional BtGNP COOH nanoparticles using Rink resin
Solid phase synthesis using Rink resin was performed using the same procedure
as for the silica gel except for the following changes. First, the resin was initially
suspended for 30 minutes in a. 20% solution of piperidine in DMF to remove the
fluorenylmethyloxycarbonyl (FMOC) protecting groups. Second, a 50:1 molar ratio
between the amino groups on the resin and the 11-mercaptoundecanoic acid was used to
load the resin. Third, the nanoparticles were cleaved from the resin using a 20% acetic
acid in dichloromethane for 5 minutes with stirring. It was estimated that about half the
nanoparticles could be cleaved off the resin.
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The crude product was further purified by the following procedure. The dark
residue was washed with petroleum ether 10-15 times with occasional sonication
followed by centrifugation. After each cycle, the washing solution was tested for organic
impurities by spotting a TLC plate and checked for impurities with a UV lamp. To the
sample, a solvent mixture of 9:1 dichloromethane:methanol was added and the sample
was briefly sonicated. It was found that approximately half the sample was soluble in this
solvent mixture. The remaining portion only became soluble when a trace amount of
acetic acid was added to the sample. The sample in the 9:1 dichloromethane:methanol
solution was further purified by passing the sample through a small column of reverse
phase C18-modified silica gel in the same solvent mixture. It was found that more than
90% of the samples could be recollected.
4.3 Results and Discussions
The synthetic strategy used in this investigation is shown in Figure 4-1. The solid
support used in this study was amino group functionalized silica gel. The bifunctional
ligands, 11-mercaptoundecanoic acid, were then loaded onto the support directly through
electrostatic interaction between the positively charged amino groups from silica gel and
negatively charged carboxylic acid groups from the 11-mercaptoundecanoic acid ligands.
The solid-phase modification was performed using three different ratios of 11mercaptoundecanoic acid relative to that of the total number of amino groups on the silica
gel as shown in Table 4-1. The amine to thiol ratio was calculated according to the
weight percentage of nitrogen (2.1%) of the modified silica gel provided by the supplier.
It is to be noted that the amino group to thiol ligand ratio is very high to ensure that only
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one thiol ligand will be attached to one gold nanoparticle during the place exchange
reaction.

-

+

+

+
+

-

+

+

+

+

-

Alkanethiolate AuNP

+
+
+

-+

+

-

+

-

+

-

+
+

+

-

+

+

+

+
+

+

+

+
+
+

Amine-functionalized
polymer beads

-

+

+

+
+

+

+

-

+

+

+

-

+

+
+
+

-+

+

-

-

-

+

+

5% acetic acid

11-mercaptoundecanoic acid

Figure 4- 1. Solid-phase method for the preparation of monofunctional GNPs using
noncovalent interactions. (Copyright ® 2006 Wiley-VCH-Verlag Gmbh & Co. KgaA,
Weinheim)
Table 4- 1. Experimental conditions used for the solid phase modification of GNPs
Sampl
A
B
C

Concentration of 11-mercaptoundecanoic acid (mol
1
7.5 x 10-5
2.5 x 10-5
8.3 x 10-6

Amine to thiol
6,000:1
18,000:1
54,000:1

After loading the thiol ligands onto the silica gel and washing away any unbound
thiol molecules, the surface-bound thiol groups were then allowed to undergo the place
exchange reaction with BtGNPs which were prepared using the Schiffrin reaction with an
average diameter of 2.2 nm. It was observed that after 8-12 hours of shaking at room
temperature, the silica gel clearly began to acquire a brown color. Sample A exhibited the
darkest color, while sample C was the lightest. After washing off any unbound
nanoparticles, the silica gel-bound nanoparticles were cleaved using a solution of 5%
acetic acid in dichloromethane for 5 minutes. The crude product was purified by washing
with petroleum ether followed by GPC to yield monocarboxyl GNPs with a yield of 60-
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90% (Calculated from the amount of nanoparticles loaded into the GPC column). Since
the nanoparticles were not covalently bound to the silica gel, the cleavage step could be
completed using very mild conditions in a much shorter period of time compared to
previous work using covalent bond-based solid-phase synthesis.
During the purification process it was observed that there were solubility
differences between the products obtained from the three different experimental
conditions. When sample A was purified by GPC, it was observed that about 50% of the
sample could be recollected using dichloromethane as the mobile phase. A second band
consisting of about 25% of the particles could then be collected when the solvent was
switched to 9:1 dichloromethane with acetic acid. The remaining sample could not be
collected unless pure acetic acid was added to the column. For sample B it was found that
most of the sample was soluble in dichloromethane, but a small portion remained
insoluble unless the 9:1 dichloromethane with acetic acid solution was used. For the case
of sample C, it was observed that acetic acid was not needed for solubility. The solubility
results indicate a clear difference between the products from the three experimental
conditions. The increased solubility of the nanoparticle product in pure dichloromethane
from sample C indicates that these nanoparticles have less carboxylic acid groups
compared to the nanoparticles collected in sample B and especially compared to sample
A. The higher number of carboxylic acid groups from samples A and B is a clear sign of
multiple place exchange reactions between the

BtGNP

nanoparticles and the bound 11-

mercaptoundecanoic acid ligands on the silica gel surface.
To further evaluate the success of this noncovalent interaction-based solid-phase
synthesis, the nanoparticles were reacted with ethylenediamine (EDA). If the
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nanoparticles contain a single carboxylic acid group, then one would expect a very low
percentage of nanoparticle trimers and larger aggregates.6 Figure 4-2 shows the TEM
images of the monofunctional GNPs after reacting with EDA for samples A and C. The
results indicate that a majority of the nanoparticles from Sample A appeared as trimers or
larger aggregates. In contrast, the TEM image for sample C indicates that less than 5-10%
of the nanoparticles appeared as trimers or larger aggregates, suggesting that these
nanoparticles have very few surface functional groups. In both TEM images, there are
also a substantial amount of single particles. These particles are believed to be particles
that have reacted with EDA (because large excess of EDA was added to drive the
reaction to completion), but not with other particles.

Figure 4- 2. TEM images of EDA coupled BtGNPCOOH COOH nanoparticles that were
prepared using amino group functionalized silica gel. (Copyright ® 2006 Wiley-VCHVerlag Gmbh & Co. KgaA, Weinheim)

In addition to amino group functionalized silica gel, Rink resin was also used for
the surface functionalization of GNPs. Rink resin is an amino group functionalized resin
consisting of a lightly crosslinked polystyrene matrix. To use the Rink resin, the amino
groups were first deprotected using a 20% solution of piperidine in DMF. The Rink resin
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was then used as a polymer support for the attachment of 11-mercaptoundecanoic acid
ligands and subsequent preparation of monofunctional nanoparticles. Following the same
synthesis and purification protocol as used in the case of silica gel support, the collected
nanoparticle product was found to be soluble in a solution of 9:1 dichloromethane with
methanol.

Figure 4- 3. TEM image of EDA coupled BtGNPCOOH COOH nanoparticles that were
prepared using Rink resin. (Copyright ® 2006 Wiley-VCH-Verlag Gmbh & Co. KgaA,
Weinheim)
Table 4- 2. XPS results of monofunctional GNPs prepared using Rink resin as the solid
support.
element
O

S

binding energy (eV)
531.7
532.7
533.8
162.3
163.9

normalized area
33.77
211.31
232.05
499.96
18.64

total area
717.21

518.59

assignment
COOH9
H2O10
SiO211
S-Au12
S-H12

Figure 4-3 is the TEM image of these nanoparticles after coupling with EDA. As
can be seen there are a large number of nanoparticle pairs and single particles with only a

93

few trimers. In addition to TEM analysis, these nanoparticles were also characterized by
X-Ray Photoelectron Spectroscopy (XPS) and the results are shown in Table 4-2 and
Figure 4-4. By comparing the normalized area of oxygen from the carboxylic acid
functional ligand to that of sulfur from all the thiolate ligands, it is possible to determine
how many carboxylic acid group ligands are on the nanoparticle surface. The results
indicate that approximately 3% of the ligands on the nanoparticle surface are 11mercaptoundecanoic acid (Table 4-2). This exchange level is consistent with what was
observed in our previously reported NMR study for monofunctional GNPs prepared
using Wang resin as the solid support, indicating that only a minimum number of
bifunctional thiol ligands were attached to nanoparticle surface.4 It should be noted here
that so far there is no analytical technique available to provide exclusive evidence on the
monofunctional group identity of these solid phase-modified GNPs. The key barrier is
that one can not obtain nanoparticles with absolute monodispersity at the nanometer scale
range using the existing chemical synthesis methods. Without a monodispersed size and
molecular weight of the nanoparticles, an accurate quantitative analysis of the number of
functional groups attached to the particle surface cannot be conducted. So far we found
that the most reliable method to determine the relative purity of monofunctional
nanoparticle product is by conducting a diamine coupling reaction to the solid phase
modified nanoparticles and using TEM to analyze the coupled product. The fewer
amounts of nanoparticle trimers, tetramers and other oligomers appeared in the TEM
images correspond to a higher purity of monofunctional nanoparticles in the product, as
explained in much detail in our previous work.6
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Figure 4- 4. O 1s and S 2p regions from the XPS spectrum of monofunctional GNPs
prepared from Rink resin. (Copyright ® 2006 Wiley-VCH-Verlag Gmbh & Co. KgaA,
Weinheim)
4.4 Conclusion
Through this study, we demonstrated that bifunctional thiol ligands can be
effectively loaded to polymer support by noncovalent interactions. After place exchange
reaction, GNPs with a single functional group on the surface were obtained as the major
product by cleaving from polymer support under very mild conditions. This mild
condition will allow the use of this solid phase method for controlled chemical
functionalization of a wider range of nanoparticles. The purification process was also
simplified significantly. Compared to the previously reported solid-phase modification
based on covalent bond chemistry, the current modification can be completed in a much
shorter period of time and is much more cost effective. The scale-up preparation of
monofunctional nanoparticles with reasonable quantities is becoming possible.
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CHAPTER 5. EXTINCTION AND SCATTERING
PROPERTIES OF GOLD NANOPARTICLES AT THEIR
SURFACE PLASMA RESONANCE BAND
5.1 Introduction
GNPs are among one of the most extensively studied nanomaterials. Since the
first report of gold colloids more than 100 years ago by Faraday,1,2 numerous studies
have been reported on the synthesis, property study and application development of gold
clusters, colloids, and nanoparticles.3-6 GNPs exhibit many unique and interesting
physical and optical properties such as surface plasmon resonance (SPR), surface
enhanced Raman scattering (SERS), nonlinear optical properties (NLO), and quantized
charging effect.7-9 The surface plasmon resonance of GNPs is an optical property that
holds promising potentials in biosensing, molecular imaging, and photothermal treatment
of diseases. Mirkin et al. demonstrated the use of GNPs as an optical probe to detect
DNA molecules based on the color change of individually scattered nanoparticles and the
complementary DNA-hybridized nanoparticle aggregates.10 Recently the photothermal
conversion property of GNPs and nanoshells has attracted a keen interest from the
scientific community.11 GNPs or nanoshells that are irradiated by a laser beam at a
wavelength around the SPR band can efficiently convert the photon energy to thermal
energy, which leads to the destruction of biological cells such as tumor and bacteria.12,13
The analysis of SPR band can also provide valuable information on the size, structure and
aggregation properties of GNPs. We herein present in our study of using UV-Vis
absorption spectroscopy and transmission electron microscopy to determine the
extinction coefficients of GNPs with different sizes and different capping ligand
monolayer. The extinction coefficient is an important parameter that can be used to
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calculate the nanoparticle concentration or estimate the nanoparticle size. Although this
may appear to be a trivial issue, the accurate calculation or estimation of the molar
concentration of nanoparticles is actually a challenge. The main reason is that
nanoparticles are not monodispersed. For some particles synthesized from one batch to
another, the size and size dispersity may vary significantly. Recently, El-Sayed et al.
reported a theoretical calculation of extinction coefficient of GNPs and its dependence on
the nanoparticle size.14 Experimental studies reported by the same group earlier on a
citrate-stabilized GNPs were in accordance with these theoretical calculations.15 In our
study, we examined three different types of GNPs, citrate-stabilized GNPs with size
ranging from approximately 5 to 250 nm; oleylamide-protected GNPs with an average
diameter around 8 nm; and a decanethiol-stabilized gold nanoparticle with an average
core diameter of 4 nm. Our analysis revealed that despite the different capping ligands
and the solvents used to dissolve GNPs, the logarithms of extinction coefficient and
nanoparticle core diameter follow a linear relationship. This correlation can be used as an
effective rule-of-thumb to estimate nanoparticle concentration or core size.
5.2 Experimental
5.2.1 Chemicals and materials
Citrate stabilized GNPs (CiGNPs) (with sizes at ~5 nm, ~10 nm, 20 nm, 40 nm,
60 nm, 80 nm, 100 nm, 150 nm, 200 nm and 250 nm) were purchased from Aldrich.
Oleylamine (C19H37NH2; tech., 70%), decanethiol, tetraoctylammonium bromide, sodium
borohydride, trisodium citrate and all solvents (ACS Reagents) were purchased from
Aldrich (Milwaukee, WI). Hydrogen tetrachloroaurate (III) hydrate (HAuCl4·xH2O) was
purchased from Strem Chemicals (Newburyport, MA).
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5.2.2 Synthesis of DtGNPs, OAGNPs and CiGNPs
1-Decanethiol protected GNPs (DtGNPs) were synthesized according to a
modified Brust-Schiffrin reaction.16 Briefly, HAuCl4·xH2O (310 mg, 1 equiv) was
dissolved in 25 mL nanopure water and phase transferred to 80 mL toluene using 1.5 g of
tetraoctylammonium bromide. Following the addition of 1-decanethiol (17 μL, 1/11
equiv) and aqueous solution of NaBH4 (0.38 g, 10 equiv, in 25 mL nanopure water) into
the organic phase, the reaction solution was stirred at room temperature for 3h.
Oleylamide-protected GNPs (OAGNPs) were synthesized by following a reported
method .17 Typically, 35 mg of HAuCl4·xH2O was dissolved in 80 mL nanopure water
and heated up to 80 oC before addition of 200 μL oleylamine by a syringe. The reaction
was allowed to continue for 3h. After the reaction mixture was cooled down to room
temperature, 240 mL methanol was added to the solution and nanoparticles were
collected by precipitation and washing a few times with a copious amount of methanol.
The 25.67 nm and 34.36 nm CiGNPs were synthesized according to Turkevich method.18
5.2.3 High Resolution Transmission Electron Microscopy (HRTEM)
TEM grids were treated with polylysine solution first before depositing
nanosphere water solutions onto grids. The HRTEM images of each sample were
obtained using a FEI TECNAI F30 transmission electron microscope. The accelerating
voltage used in the measurement was 300 keV. The 400 mesh carbon/formvar-coated
copper grids for citrate-stabilized nanoparticles were first treated with a poly-L-lysine
(M.W. 93800, Sigma) solution (0.0381 g/mL in 1:3 H2O: MeOH mixture solvents). TEM
sample grids were then prepared by extracting 5 μL sample solution, casting onto
polylysine treated grids and vacuum dried. Average gold core diameter (D), size
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distributions and standard deviations were calculated for each nanoparticle sample by
averaging 200 particles from the TEM images using ImageJ software (developed at the
National Institutes of Health).
5.2.4 UV-Vis spectroscopy
All UV-Vis spectra were recorded using a Cary 300 Bio double-beam UV-Vis
spectrophotometer at a 300 nm/min scanning rate from 300-700 nm. For each sample,
UV-vis spectra at five different concentrations were recorded by directly diluting the asprepared nanoparticle solution with appropriate solvents to the expected relative
concentrations. For

CiGNPs

samples (diameters at 4.61, 8.55, 20.6, 25.67, 34.46 nm),

solutions with relative concentrations of 1.0, 0.8, 0.6, 0.4, and 0.2 to the initial
concentrations were prepared using Nanopure water as solvent. For CiGNPs at other sizes,
the original solutions were measured. For DtGNPs, relative concentrations of 0.088, 0.070,
0.053, 0.035 and 0.018 to the initial concentration of the as-prepared sample were
obtained by diluting the sample with toluene. For

OAGNPs

sample, THF was used as the

solvent to dilute the as-prepared sample to achieve relative concentrations of 0.064, 0.124,
0.244, 0.515 and 1.040 to the initial concentration. The extinction coefficient at the
corresponding SPR peak wavelength was calculated according to the Beer’s Law.
5.2.5 Size and scattering intensity measurements of

CiGNPs

solutions by Dynamic

Light Scattering
Solutions of

CiGNPs

at sizes 40, 60, 80, 100, 150, 200, and 250 nm were

measured by a Malvern ZetaSizer NanoZS DLS system. All DLS measurements were
done under the same parameter setup: sample volume 40 µL, measurement angle 13o,
fixed sample position 4.65 µm, and fixed attenuation 11. The intact
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CiGNPs

solutions

were diluted to different concentrations. The concentrations of GNPs were calculated
according to the product description from the vendor and also the dilution factors used in
this study. For each sample measured by DLS, the size and the DLS scattering intensity
were recorded. Detection limits of GNPs by DLS were calculated using the standard 3σ
method.
5.3 Results and Discussions
5.3.1 Calculation of average number of gold atoms per GNP
The average number of gold atoms per nanoparticle may be calculated from TEM
analysis. The HRTEM images of four nanoparticle product synthesized in this study are
shown in Figure 5-1. Using ImageJ software, the average core diameters of the particles
(D/nm) were measured and summarized in Table 5-1. Assuming a spherical shape and a
uniform fcc structure,19 the average number of gold atoms (N) for each type of
nanosphere was calculated by equation (5-1), where ρ is the density for fcc gold (19.3
g/cm3) and M stands for atomic weight of gold (197 g/mol).20,21
N=

C=

π ρD 3
6 M

N A = 30.89602 × D 3

(5-1)

N Total
N ×V × N A

(5-2)
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Figure 5- 1. High resolution transmission electron microscopy images of (a) 3.76 nm 1decanethiol-capped AuNPs; (b) 4.61 nm citrate-stabilized AuNPs; (c) 7.58 nm
oleylamide-protected AuNPs and (d) 25.67 nm citrate-stabilized AuNPs. (Copyright ®
2007 Elsevier B.V.)

5.3.2 Determination of molar concentrations of nanoparticle solution
The molar concentration of the nanosphere solutions were calculated by dividing the
total number of gold atoms (Ntotal, equivalent to the initial amount of gold salt added to
the reaction solution) over the average number of gold atoms per nanosphere (N)
according to equation (5-2), where V is the volume of the reaction solution in liter and NA
is the Avogadro’s constant. It is assumed that the reduction from gold (III) to gold (0)
was 100% complete. The concentrations of each diluted solution may be calculated from
this initial concentration according to their relative concentration as stated in the
experimental section. Concentrations of all sizes GNPs were calculated by either this
method or as provided by the product vendor (Table 5-1).
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Table 5- 1. The extinction coefficients (ε) of gold nanoparticles with different core sizes
and capping ligands determined in this study
Surface
ligand

Solvent

GNP
Diameter D
(nm) a

SPR band
Peak λmax
(nm)

Original
concentration (M)

Extinction Coefficient ε
(M-1cm-1)

Decanethiol
Citrate
Citrate
Oleylamine
Citrate
Citrate
Citrate
Citrate
Citrate
Citrate
Citrate
Citrate
Citrate
Citrate
Citrate

Toluene
Water
Water
THF
Water
Water
Water
Water
Water
Water
Water
Water
Water
Water
Water

3.76±0.65
4.61±0.48
8.55±0.79
8.76±1.11
20
20.60±1.62
25.67±5.62
34.46±4.34
40
60
80
100
150
200
250

506
517
517
520
521
521
526
529
530
531
545
564
642
571
600

9.45E-06b
9.42E-08 b
1.49E-88 b
1.30E-07 b
1.16E-09c
1.07E-09 b
4.92E-10 b
2.22E-10 b
1.49E-10 c
4.32E-11 c
1.83E-11 c
9.30E-12 c
2.82E-12 c
1.16E-12 c
5.98E-13 c

(3.61±0.08) E+6
(8.56±0.09) E+6
(5.14±0.07) E+7
(8.79±0.03E+7
7.62E+08
(8.78±0.06) E+8
(2.93±0.02E+9
(6.06±0.03) E+9
7.07E+09
2.92E+10
5.58E+10
9.14E+10
1.47E+11
3.15E+11
4.78E+11

a

Values with standard deviations were the average size of 200 GNPs from TEM images,
respectively for each size GNPs. Values without standard deviations were cited from the
product description provided by the vendor.
b
Values obtained according to Equations (5-1) and (5-2).
c
Values obtained according to the product description provided by the vendor.

5.3.3 Extinction coefficients
5.3.3.1 Calculations of extinction coefficients
The extinction coefficient of each nanoparticle sample was determined according to
Lambert-Beer Law, equation (5-3). The as-prepared or purchased GNP solution was
diluted into solutions into different concentrations as stated in the experimental section.
The absorption spectrum of each solution was measured. The absorbance at 506 nm was
recorded for each sample and plotted versus the molar concentration of the solution. The
extinction coefficient can be obtained from the slope of the linear region of the
absorbance-concentration curve. Other samples were analyzed in the similar way.
A = εbC

(5-3)
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(a)

(b)

(c)

(d)

Figure 5- 2. Extinction spectra of (a)1-decanethiol and (c) oleylamide-protected gold
nanoparticles at different relative concentrations. (b) and (d) are plots of experimental
data of maximum extinction around 520 nm versus corresponding concentration and the
linear fitting curves for decanethiol and oleylamide-protected gold nanoparticles,
respectively. (Copyright ® 2007 Elsevier B.V.)
Figure 5-2a-d is an illustration of the UV-Vis absorption spectra and the linear
fitting curve of absorbance-concentration plots for decanethiol and oleylamide-protected
GNPs. Both curves are linear with a correlation coefficient very close to 1.0. A good
linear fitting of the experimental data was found for all other nanoparticle samples. The
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types of nanoparticles analyzed and the extinction coefficients calculated from the linear
fitting curve were summarized in Table 5-1.

SPR peak wavelength (nm)

5.3.3.2 Shift of the SPR extinction peak

640

600

560

520

0

40

80

120

160

GNP size (nm)
Figure 5- 3. Changes the SPR peak wavelengths of GNPs at increased GNP sizes (3.76
nm to 150 nm) (Lorentz fitting: Y=485.01704+(2*148589.239/π)*(85.20574/(4*(X255.01039)2+85.205742)); R2=0.98777)
The SPR band peak wavelength (λmax)of GNPs showed a red-shift from 506 nm
for the 3.76 GNPs to 642 nm for the 150 nm GNPs. This red-shift trend is in accordence
with theoretical calculations made by Yuegubide et al.24 They calculated that λmax will
increased from 535 nm for 20 nm GNPs to the maxima of 665 nm for 160 nm (Table 1-1).
Our results illustrated the red-shift tread but showed lower λmax values than predicted,
probably due to effects from surface ligands of GNPs and the solvent. For the size range
between 3.76 nm to 150 nm, the change of the λmax over the GNP size can be fitted very
well with Lorentz fitting, as shown in Figure 5-3. For GNPs with sizes larger than 150
nm, λmax showed a blue-shift, which agrees with the trend predicted in theory.
5.3.3.3 Intensity of extinction coefficients
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From Table 5-1, one can notice immediately that the extinction coefficients of
GNPs are orders of magnitude higher than organic dye molecules. The measured
extinction coefficients of citrate-stabilized GNPs are approximately in line with what has
been reported by El-Sayed et al.14 For example, the extinction coefficient values for a 20
nm citrate-stabilized gold nanoparticle obtained from this study, the experimental and
theoretical study by El-Sayed et al are 8.8E8, 1.36E9, and 7.6E7 M-1cm-1, respectively.
Between the three values, there is approximately an order of magnitude difference. Our
data is between the experimental and theoretical value as reported by El-Sayed et al.
From Table 5-1, another important result to notice is that the increase in core
diameter of GNPs introduced dramatic and continuous increase in the extinction
coefficients. From a core diameter of ~4 nm to 35 nm, the extinction coefficient increased
three orders of magnitude. From the double logarithm plot of extinction coefficient
against the nanoparticle size in diameter, a good linear relationship was found and can be
expressed in equation (5-4), Where ε is extinction coefficient in M-1cm-1, D is the core
diameter of the nanoparticles, and k=2.85232, a=11.86382. The linear fitting of the
experimental data gives a correlation coefficient of 0.99324.
ln ε = k ln D + a

(5-4)
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Figure 5- 4. The linear correlation between the extinction and the GNP size in double
log scale. (ln(ε)=11.86382+2.85232lnD; R2=0.99324)
This finding is also in accordance with the Mie theory as well as the study
reported by El-Sayed et al. The k and a value obtained from our study is 3.32 and 10.8,
respectively, while the values for these two parameters are 2.75 and 11.7 from the
experimental study, and 3.36 and 8.1 from the theoretical study as reported by El-Sayed
et al. Comparing these values, it appears that our experimental result is closer to the
theoretical value as calculated by El-Sayed et al. The discrepancy between different
studies is most likely due to the slight difference in the average core size and size
dispersity of the nanoparticles.15
The experimental study reported by El-Sayed was on citrate-stabilized GNPs that
were soluble in water. Our results suggest that the linear relationship of the double
logarithm of extinction coefficient versus nanoparticle core diameter can be extended to
most GNPs independent of the capping ligands used to protect the nanoparticles and the
solvents used to dissolve the nanoparticles. The solvents used to dissolve the three types
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of nanoparticles synthesized in this study, toluene for decanethiol-protected nanoparticles,
THF for oleylamide-protected nanoparticles, and water for citrate-stabilized nanoparticles,
have very different dielectric constants (as listed in Table 5-1), varying from 2.4 to 78.
The stabilization effect by the capping agents for these three types of nanoparticles is also
quite different. The citrate-stabilized nanoparticles rely on electrostatic interactions
between the ligands and the nanoparticle core. The decanethiol-protected GNPs are
stabilized by covalent bonding between thiolate groups and surface gold atoms, while the
oleylamide-protected GNPs depend on hydrogen bonding network formation between
amide groups to create a stable environment for nanoparticle core. Although Mie theory
indicates that the plasmon resonance absorption of a nanoparticle is related to the
dielectric constant of the environmental media around the nanoparticles (which include
both solvents and the capping ligands), these effects do not appear to make significant
contribution to the extinction coefficient of the surface plasmon resonance band.7,22
5.3.3.4 Application of extinction coefficients for GNP concentration determination
Because of the general applicability of the relation of nanoparticle extinction
coefficient versus nanoparticle size, one can use the extinction coefficient-core diameter
double logarithm curve established in this study as a calibration curve to calculate or
estimate the nanoparticle concentration or average diameter of a nanoparticle solution
sample. For example, by determine the average size of a nanoparticle sample using TEM,
one can obtain the extinction coefficient of the sample. By taking UV-Vis absorption
spectra of the sample, the concentration of the sample can be calculated. This will be
useful for determining the concentration of biomolecules such as proteins when labeled
with GNPs.23 Most organic molecules and biomolecules have much lower extinction
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coefficient than GNPs. By labeling biomolecules with GNPs, the biomolecules can be
detected at concentrations as low as sub- nanomolar to picomolar range. This could lead
to a very powerful tool at detection of biomarker molecules using a simple
spectrophotometer. On the other hand, if the concentration and extinction coefficient of a
nanoparticle sample can be determined, the size of the particle may be estimated without
imaging analysis by TEM.
5.3.4 Light scattering property of GNPs studied using DLS
After investigating the extinction property of GNPs around their SPR band, we
studied the light scattering property of GNPs using DLS. For each size GNP solution, the
scattered light intensities at different concentrations were recorded by DLS. The results
for GNPs at various sizes ranging from 40 nm to 250 nm were summarized in Figure 5-5.

DLS intensity (kcps)

500

40 nm
60 nm
80 nm
100 nm
150 nm
200 nm
250 nm

400
300
200
100

0.0

2.0x10-12

4.0x10-12

6.0x10-12

[GNP] (M)
Figure 5- 5. The linear relationship between the DLS intensity and the concentration,
respectively for each size GNP
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There are some important points to be discussed from Figure 5-5 about the light
scattering property of GNPs. First, it can be seen that the light scattering intensity
increased linearly along GNP concentration increases. Such linear relationships were
observed for GNPs at all sizes investigated in this study. Linear regression curves for the
scattering intensity and the GNP concentration were summarized in Table 5-2. These
results were different from reported results by reported by Yuegubide et al.24 In Figure 111, the light scattering intensity was linearly dependent with the GNP concentration in
double logarithmic scales, respectively for 52, 78, 87 and 118 nm GNPs. In our study,
however, the light scattering intensity was directly linearly related to the GNP
concentration, respectively for GNPs at sizes from 40 to 250 nm. The discrepancy
between these two studies may come from the differences in the experimental setup for
the light scattering intensity measurements.

Table 5- 2. GNP detection limits under DLS measurements and linear regression curves
between the DLS intensity and the GNP concentration
Y=A+BX
GNP size (nm)
LLOD* (M)
A
B
R2
40
5.95E-13
0.8593
2.37E+12
0.9998
60
1.79E-13
0.784
8.30E+12
0.99739
80
1.73E-14
0.91723
7.80E+13
0.99952
100
3.97E-15
0.80292
3.69E+14
0.99972
150
1.25E-15
0.8739
1.12E+15
0.99883
200
5.14E-16
0.85075
2.76E+15
0.99811
250
1.60E-16
0.85743
8.82E+15
0.98628
*LLOD: Low limit of detection; Y: DLS intensity (kcps); X: GNP concentration (M)

Second, we can see that the light scattering intensity was different for GNPs
solutions at the same concentration but different sizes. Larger size GNPs showed higher
light scattering intensity values. According to the Rayleigh theory, the light scattering
cross section of a small GNP (D<0.05 λ) is proportional to the 6th power of its diameter
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(equation 1-8). As a result, when the size of GNP increases, the scattering intensity
increases dramatically. For large GNPs (D<0.05 λ), the scattering cross section still
increases along the particle size with a correlation smaller that 6th power. In our study, the
relative light scattering efficiency for GNPs from 40 to 250 nm was characterized by the
slope of the linear regression curve. Results were shown in Table 5-2 and plotted in
Figure 5-6. The correlation between the light scattering efficiency and the GNP size can
be fitted very well with Lorentz fitting. From Figure 5-6, the light scattering efficiency
increases along the GNP size. These results were in accordance with the theoretical
calculations by Yuegubide et al.24

Scattering efficient (kcps/M-1)

1x1016
8x1015
6x1015

Y=-7.666E14+
(2*5.2143E19/PI)*
(6.95496/(4*(X-327.52176)2+6.954962))
R2=0.99969

4x1015
2x1015
0
50

100

150

200
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GNP size (nm)
Figure 5- 6. Relative scattering efficiency of GNPs (red curve: Lorentz fitting).

Third, we need to notice that GNPs can be detected by DLS at very low
concentrations without any amplification steps. As shown in Figure 5-5, GNPs at
concentrations in the range of pM can be detected very easily by DLS. Detection limits of
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GNPs in this study were summarized in Table 5-2. For example, the detection limit for
100 nm GNPs is as low as ~4 fM. Such high sensitivities of GNPs detection by DLS are
due to the strong scattering property of GNPs. As discussed in section 1.3.2.1, the
scattering cross section of GNPs is 4-6 orders of magnitude larger than that of small
fluorescence molecules, polystyrene beads or biomolecules. As a result, under a laser
irradiation GNPs scatter more lights to be captured by the DLS detector. The strong light
scattering property of GNPs and thus the ultra sensitivity in DLS detection make them
very promising to be used as ultra sensitive probes in biomolecular detection applications.
Based on this, we investigated the applications of GNPs in biomolecular detection in
Chapter 6, Chapter 7, and Chapter 8.
5.4 Conclusion
In this work we studied the light extinction and scattering properties of GNPs
with core sizes ranging from ~4-250 nm. Extinction coefficients of GNPs were
determined by HRTEM analysis and UV-Vis absorption spectroscopic measurements.
Three different types of gold nanoparticles were prepared and studied: citrate-stabilized
nanoparticles in eleven different sizes; oleylamide-protected gold nanoparticles with a
core diameter of 8 nm, and a decanethiol-protected nanoparticle with a diameter of
around 4 nm. A linear relationship between the logarithms of extinction coefficients and
core diameters of gold particles was found independent of the capping ligands on the
particle surface and the solvents used to dissolve the nanoparticles. This linear relation
may be used as a calibration curve to determine the concentration or average size of an
unknown nanoparticle or nanoparticle-biomolecule conjugate sample. Following the
extinction studies, we investigated the light scattering property of GNPs using DLS. We
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found out that the light scattering of GNPs were very strong. Very low detection limits
were reported for GNPs by DLS detection. In addition, light scattering intensities of
GNPs were found to increase linearly along the GNP concentration and non-linearly
along the GNP size.
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CHAPTER 6. A WASHING-FREE AND AMPLIFICATIONFREE ONE-STEP HOMOGENEOUS ASSAY FOR PROTEIN
DETECTION USING GOLD NANOPARTICLE PROBES
6.1 Introduction
Protein detection and analysis plays an extremely important role in in-vitro
diagnostics. With the tremendous progresses made in proteomics in the last few decades,
there has been a growing demand for highly sensitive, fast and simple techniques for
protein analysis using minimum volume of samples and cost effective instrumentations.
Many protein biomarkers associated with cancer and other diseases exist in biological
fluids and systems with low abundance, typically in the range of fg/mL to ng/mL.1 How
to detect these low abundance biomarker proteins has raised tremendous challenges for
bioanalytical chemists. Traditional methods address this difficulty by using amplification
labels such as enzymes, radioactive isotopes or fluorescent probes to achieve the required
high sensitivity.2-3 These methods, however, often involve many steps in the assay,
including labeling, multiple washing and separation cycles, signal amplification and
measurement. These complicated procedures not only make it difficult to automate the
assay, but also increase the cost of protein analysis.
Since the middle 1990s, gold nanoparticles (GNP) have been investigated
extensively for biomolecular imaging and detection.4-9 The unique optical properties of
GNPs, including their strong absorption and intense light scattering at the surface
plasmon resonance wavelength region, aggregation-induced color change,4 and the
surface-enhanced Raman scattering,5 have been studied in much details in both direct and
amplified biomolecular assays.6 GNPs, when conjugated with a detector antibody, may
be used in a traditional heterogeneous sandwich-type immunoassay. The GNP probes
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immobilized on a surface due to antibody-antigen binding may be detected optically or
electrochemically.6,7 GNPs have also been used to develop homogeneous biomolecular
assays.4,9 Such assays are based on the detection of nanoparticle aggregation caused by
protein-protein interactions or DNA hybridization. GNP aggregation or de-aggregation
often leads to optical property changes such as wavelength shifts of the surface plasmon
resonance (SPR) bands (or color change),4 melting temperature increases of the
hybridized DNA,6 fluorescence quenching or enhancement,8 and surface enhanced
Raman scattering.5 Homogeneous assays offer some unique advantages compared to
heterogeneous assays, especially in the simplicity of the assay. However, the sensitivity
of homogeneous assays, including the assays involving GNPs as mentioned above, is
often not as high as heterogeneous amplification assays. Mirkin et al. developed a biobar-code amplification method using DNA bar-code modified GNPs for both protein and
DNA detection. Although this method has extremely high sensitivity, the assay involves a
complicated multiple-step process that is very difficult to conduct and automate.
Laser light scattering immunoassays (LIA) have been known for more than 3-4
decades.12,13 Most of these assays are based on immunoaffinity interaction-induced
particle aggregation. The level of particle aggregation may be measured using turbidity,
nephelometry, angle-dependent scattering intensity, or dynamic light scattering technique.
Turbidity and nephelometry are still used substantially in medical diagnostic and
environmental testing labs for biomolecule and microorganism detection. In these two
assays, light transmitted through or scattered from a turbid assay solution due to particle
aggregation is measured and correlated to analyte concentration. However, these two
assays typically have very low sensitivity, and are mostly used for high abundance

116

protein analysis. Dynamic light scattering (DLS), a technique used extensively for
characterizing particle size and size distribution, was also applied for particle
agglutination-based immunoassays in late 1970s.13 However, this technique never took
off as a main stream immunoassay method for protein analysis due to multiple limitations.
First and most important above all, these LIAs including DLS, turbidity, and
nephelometry assays, use micron or submicron polymer beads such as latex particles as
light scattering enhancers. The light scattering intensity of polymer latex particles,
although substantially stronger than biomacromolecules, is still not strong enough to
overcome the background scattering from sample matrices. Biological fluids such as
blood serum or plasma contain large amounts of nanoparticles and micron scale particles.
The intense light scattering from these matrix particles can cause significant interference
to the assay. Second, when early attempts were made on using DLS for latex particlebased light scattering immunoassays, DLS was still a relatively high cost instrument,
difficult to operate, with limited sensitivity and data analysis capability. Due to these
multiple reasons, DLS was not considered as a promising tool for immunoassay
applications.
Recently, the extensive study and further understanding on the optical properties
of gold nanoparticles (GNPs) has opened many new doors in biomolecular imaging and
detection. Gold nanoparticles, including spherical particles, nanorods and nanoshells with
a size ranging from 10s to 100s nanometers, are known to have a large light absorption
and scattering cross section in the surface plasmon resonance (SPR) wavelength region.14
In normalized terms, the scattering cross section of a 30 nm gold particle at its SPR
region is about 250 times larger than a 30 nm polystyrene particle. As compared to
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fluorophores, the scattering light intensity from a 60 nm gold nanoparticle is four to five
orders of magnitude higher than a strongly fluorescent fluorescein molecule.14
Furthermore, the scattering light from nanoparticles does not suffer from the many
problems of fluorophores, such as photobleaching, extreme sensitivity to environmental
changes. The strong light scattering of gold nanoparticles has enabled many important
and promising applications in biomedical field, such as molecular and cell imaging,15
biosensing, and bioassays.16

Scheme 6- 1. Illustration of a one-step homogeneous biomolecular assay using gold
nanoparticle probes as light scattering enhancers coupled with dynamic light scattering
detection

With its strong light scattering, we hypothesized that GNPs could be an excellent
light scattering enhancer to replace polymer latex particles for immunoassay development
using light scattering techniques. We recently conducted some exploratory studies to
demonstrate the proof-of-concept of using GNPs for light scattering assay of both
proteins and DNA targets as illustrated in Scheme 6-1. Using a non-competitive assay
format, a sandwich type antibody-antigen binding or DNA hybridization was transduced
into GNP aggregation formation, which was detected by DLS and subsequently
correlated to the target analyte concentration. Due to the extremely strong light scattering
intensity of GNPs around their SPR band region, this assay can potentially become a
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highly sensitive for biomolecular detection and analysis. It is a single-step, washing-free
and amplification free process, therefore, very easy to conduct and automate. In addition,
the assay involves the use of very small volumes of samples and GNP probes (total 10 µL
or less), which can lead to substantial cost reduction. High throughput 96- or 384microtiter plate reader is becoming a standard feature of current DLS instruments, which
means the new assay developed in our research can be easily adapted for high throughput
biomolecular analysis.
In the present work, we conducted a systematic study to examine the sensitivity
and dynamic range of this new immunoassay technique, and further developed two
formats of competitive and non-competitive homogeneous assays using mouse IgG and
goat anti-mouse IgG as a pair of model proteins. This study also revealed some important
insights on the nanoparticle aggregation kinetics and its effects on the performance of the
immunoassay, especially the dynamic range of the assay. We demonstrated that by
properly adjusting the probe concentration and assay conditions, protein analytes may be
detected at concentrations as low as pg/mL without any amplification steps.
6.2 Experimental Section
6.2.1 Chemicals and materials
0.01M phosphate buffer saline (NaCl 0.138 M; KCl 0.0027 M, pH 7.4), bovine
serum albumin (BSA) powder, and Sepharose CL-2B gel and BiotinTagTM biotinylation
kit (cat# B-TAG) were purchased from Sigma-Aldrich (Milwaukee, WI). ChromPure
Mouse IgG (whole molecule, IgG concentration 5.5 mg/mL, buffer: 10 mM sodium
phosphate, 250 mM NaCl, pH 7.6, preservative: none) was from Jackson
ImmunoResearch Laboratories, Inc. (West Grove, PA). Citrate-stabilized GNPs (core
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diameter 100 nm), goat anti-mouse IgG (H+L) (AH)-conjugated GNPs (GNP-anti-IgG,
core diameter of 40 nm) and streptavidin-conjugated GNPs (GNP-STV, core diameter 40
nm) were purchased from Ted Pella Inc. (Redding, CA). Nanopure water with a
conductivity of 18 MΩ·cm was obtained from a Nanopure DiamondTM system (Barnstead
International, Dubuque, Iowa).
6.2.2 Preparation of mouse IgG conjugated GNPs (GNP-IgG) and bovine serum
albumin-conjugated GNPs (GNP-BSA)
Mouse IgG was labeled with biotin by following the instruction of the
biotinylation kit BiotinTagTM from Sigma. 0.75 mL of purified biotin-labeled mouse IgG
solution was obtained at a concentration of ~0.7 mg/mL using this kit. To 0.5 mL of 0.1
nM streptavidin-stabilized GNP in PBS buffer, 7 µL of biotin-labeled mouse IgG was
added and incubated for 1 h, then centrifuged at 9000 rpm for 4 min and recovered into
PBS buffer solution. Bovine serum albumin conjugated gold nanoparticles (GNP-BSA)
were prepared using citrate protected 40 nm gold nanoparticles according to a literature
report.10
6.2.3 Instrumentation
A set of micropipettes (0.5-10 µL, 10-100 µL and 100-1000 µL) from Eppendorf
International (Hamburg, Germany) was used for liquid transfer and dilution. A Cary 300
Bio UV-Visible spectrophotometer from Varian Inc. (Palo Alto, CA) was used for UVVis spectroscopic study. A PD2000DLSPLUS Dynamic Light Scattering Detector and
PDDLS/CoolBatch 40T Dynamic Light Scattering detector system from Precision
Detectors Inc. (Bellingham, MA) was used for DLS measurement. The DLS instrument
was operated under the following conditions: temperature 20oC, detector angle 90o,
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incident laser wavelength 683 nm, laser power 100 mW. The DLS data was processed
using the Precision Deconvolution software. Each assay solution was diluted into 1.50
mL of nanopure water to the appropriate concentrations and mixed well for 2 min before
DLS measurement.
6.2.4 Sensitivity study of a 100 nm GNP by dynamic light scattering
The initial concentration of the 100 nm GNPs as purchased from Ted Pella, Inc.
was determined by UV-Vis spectroscopy according to a reported method.11 The light
scattering intensities of nanoparticles at serial dilutions were then measured by DLS with
three repeats for each concentration. Lower limit of detection (LLOD) of the 100 nm
GNP was calculated from linear fitting curve using s+3σ method.
6.2.5 Kinetic study and temperature effect on the aggregation of goat anti-mouse
IgG conjugated GNPs (GNP-anti-IgG) and mouse IgG conjugated GNP (GNP-IgG)
100 µL of 0.1 nM GNP-anti-IgG and 100 µL of 0.1 nM GNP-IgG solutions were
mixed together and incubated at 37 °C from 1 min up to 19 h. The average diameter of
GNPs in solution was monitored by DLS periodically during this time. A control sample
was prepared by substituting GNP-IgG with streptavidin-conjugated GNP-STV. Each
concentration was run in duplicates. For temperature effect study, an equal volume
mixture of GNP-IgG and GNP-anti-IgG was incubated at 4, 25 and 37 °C, respectively.
The average diameter of GNPs in the mixture solution was regularly recorded from 1 min
up to 24 hours.
6.2.6 A direct assay for mouse IgG using GNP-anti-IgG probes
A mouse IgG stock solution with a concentration of 5.5 mg/mL was used to
prepare mouse IgG solutions at concentrations 50000, 5000, 500, 50, 5.0, 0.50, 0.05, and
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0.005 ng/mL by serial dilutions. In the process, a 0.1% BSA solution (buffer: 10 mM
PBS, 0.154 M NaCl, pH=7.4) after filtering through a 0.2 µm membrane was used as the
sample dilutant and also as the control sample. The stock solution of 1 nM GNP-anti-IgG
was purified by column chromatography using a Sepharose CL-2B gel column to
eliminate any non-conjugated goat anti-mouse IgG. The purified solution was filtered
through a 0.2 µm membrane and then diluted into 0.1, 0.01 and 0.001 nM solutions. In a
first assay, 20 µL of mouse IgG solution was mixed with 60 µL of GNP-anti-IgG probe
solution at a concentration of 0.1 nM, and the assay solution was incubated at 37 °C for 2
hours. The average hydrodynamic diameter of the assay solution between 20 and 400 nm,
Dh, was then measured by DLS. Particles with sizes beyond this range were not included
in the data analysis. A control study was performed under the same conditions using BSA
conjugated GNP probes (GNP-BSA). In a second and third assay, the concentration of
GNP-anti-IgG was reduced to 0.01 nM or 0.001 nM by 0.1% BSA solution, with all other
conditions remained the same as used in the first assay.
6.2.7 A competitive assay for mouse IgG detection
60 µL of 0.1 nM GNP-anti-IgG solution, 60 µL of 0.1 nM GNP-IgG, and 20 µL
of mouse IgG solutions with different concentration were mixed together and incubated
at room temperature for 4.5 h. Particle size of the incubated solution was then measured
by DLS.
6.3 Results and Discussions
6.3.1. Sensitivity of GNP detection by dynamic light scattering
We previously reported that the detection limits for a 40 nm spherical GNP, and a
10 by 40 nm gold nanorod (GNR) can reach 0.02 and 0.4 pM, respectively. In the present
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study, we further examined the detection limit of a 100 nm spherical GNP by DLS. For
our assay purpose, what actually needs to be detected is nanoparticle aggregates instead
of individual gold nanoparticles. Since the GNP probes used in this study has an average
diameter of 40 nm, a GNP with a diameter of 100 nm can be viewed as approximately
equivalent to a dimer of a 40 nm GNP, the smallest aggregate to be present in the assay
solution. Therefore, the detection limit of 100 nm GNPs is a good indication of the
potential sensitivity of the immunoassay investigated in this study. The detection limit
study of the 100 nm GNPs is shown in Figure 6-1. Similar to smaller size GNPs, there is
a linear relationship between nanoparticle concentration and scattered light intensity. The
lower limit of detection (LLOD) of this 100 nm GNP was determined to be around 0.7
fM, a 30 fold improvement compared to the 40 nm GNP. According to theoretical
calculations,14 the light scattering cross section of GNPs increases dramatically when the
diameter of GNPs is above 80-100 nm. The sensitivity of DLS for GNP detection is also
related to the wavelength and power of the laser. By increasing the gold nanoparticle size
and varying the instrumental set-up, it is possible that GNPs can be detected at
concentrations lower than fM, even at attomolar and zeptomolar (aM and zM) ranges.
Furthermore, because the light scattering intensity is proportional to the particle size, the
sensitivity of DLS for nanoparticle aggregation can be significantly higher than
individual nanoparticles. Gold nanoparticles should be excellent light scattering
enhancers to replace polymer latex particles for laser light scattering immunoassay
applications.
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Figure 6- 1. Light scattering intensity of a 100 nm gold nanoparticle at different
concentrations as determined from DLS measurement. (y=0.02758+119.47x,
2
R =0.99212; LLOQ=0.7 fM according to 3σ, error bar: standard deviation; each data is
the average result of three measurements) (Copyright ® 2009 Elsevier B.V.)

Figure 6- 2. Particle size and size distribution of a 1:1 mole ratio mixture of goat antimouse IgG conjugated GNPs (GNP-anti-IgG) and mouse IgG conjugated GNPs (GNPIgG) measured immediately after mixing and after incubation at room temperature for 24
hours (the concentration of both GNP probes was 0.1 nM) (Copyright ® 2009 Elsevier
B.V.)
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6.3.2 Kinetics of nanoparticle aggregation between two complementary GNP
immunoprobes
In particle agglutination immuoassays, a good understanding on the whole
nanoparticle aggregation process is ultimately important for the assay development.
Using a pair of primary and secondary antibody as model proteins, we first studied the
aggregation kinetics of two GNP particles: one is GNPs conjugated with goat anti-mouse
IgG (GNP-anti-IgG), and the other one is GNPs conjugated with mouse IgG (GNP-IgG).
The GNP-IgG particles were prepared by conjugating biotinylated mouse IgG to a
streptavidin-coated GNPs. The core diameter of the GNP probes is around 40 nm. When
these two particles are mixed together, the binding between mouse IgG and goat antimouse IgG should cause nanoparticle aggregation. Shown in Figure 6-2 is a size
distribution graph of the mixed particle solution as measured by DLS. With increased
incubation time, the average size of the particle solution increased clearly. Figure 6-3 is
the measured average particle size, expressed in hydrodynamic diameter Dh, of the
solution recorded at different time. Over 24 hours, the average particle size increased
almost linearly from 42 nm to 90 nm. In a control experiment, when GNP-anti-IgG was
mixed with streptavidin-coated GNPs (GNP-STV) and incubated for the same amount of
time, the average particle size of the solution remained the same as the initial solution
through out the whole incubation period. This experiment demonstrates the capability of
DLS to quantitatively detect and monitor the immunoaffinity interaction-induced
nanoparticle aggregation process. We also examined the incubation temperature effect on
this process. An equal amount of mixture of GNP-IgG and GNP-anti-IgG was incubated
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at three temperatures: 4, 25, and 37 oC, respectively. At elevated temperature, the
nanoparticles aggregated much faster than at lower temperatures (Figure 6-4).

Figure 6- 3. The hydrodynamic diameter change of gold nanoparticle in two mixed
nanoparticle probe solutions over 19 hours of incubation at ambient conditions. (-○-:
mixture of GNP-anti-IgG and GNP-IgG; -□-: mixture of GNP-anti-IgG and GNP-STV.
Linear fitting from 1 to 250 min: y=44.20632+0.11925x, R2=0.98915; error bar: standard
deviation; each data point is the average result of two experiments) (Copyright ® 2009
Elsevier B.V.)

Figure 6- 4. The growth of nanoparticle size for an equal volume mixture of 0.1 nM
GNP-anti-IgG and 0.1 nM GNP-IgG incubated at different temperatures for up to 24
hours. (-□-: 4 oC; -○-: 25 oC; -∆-: 37 oC; error bar: standard deviation; each data is the
average of three experiments) (Copyright ® 2009 Elsevier B.V.)
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Figure 6- 5. The hydrodynamic diameter change of assay solutions of mouse IgG mixed
with two different gold nanoparticle probes after incubating at 37 oC for 2 hours. (-□-: a
control made of mouse IgG with 0.1 nM BSA conjugated GNPs; -∆-: mouse IgG mixed
with a 0.1 nM goat-anti mouse conjugated GNPs; rrror bar: standard deviation; each data
is the average of two experiments) (Copyright ® 2009 Elsevier B.V.)
6.3.3 Detection of mouse IgG using goat anti-mouse IgG conjugated GNPs
Goat anti-mouse IgG, a secondary antibody, can bind with primary antibody
mouse IgG on its Fab, Fab’ or Fc region. Because of these multiple binding sites, mouse
IgG can cross link nanoparticle probes into oligomers or larger aggregates. A
homogeneous immunoassay for mouse IgG can be designed and developed using the
secondary antibody conjugated GNPs. Mouse IgG solutions with concentrations covering
a six-orders of magnitude range from 0 ng/mL to 50,000 ng/mL were assayed. The assay
solution was incubated at room temperature for 2h. As shown in Figure 6-5, overall, the
nanoparticle size increased with increasing mouse IgG concentration. From mouse IgG
concentration 0.05 to 50 ng/mL, the particle size increase was rather limited, and between
50 to 500 ng/mL, the particle size increase became significant. When the concentration of
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mouse IgG was further increased to 5,000 and 50,000 ng/mL, the particle size actually
decreased, leading to an interesting bell-shaped curve. Such a response curve is similar to
a well known immuno-precipitation assay curve from antigen-antibody binding and
referred to as the Heidelberger-Kendall curve.16 This phenomenon is also known as the
“hook effect”, which is commonly observed in particle agglutination immunoassays. The
antibody-antigen binding-induced particle aggregation process can be divided into three
different zones. At relatively low antigen concentrations (here is the mouse IgG), the
particles will form relatively small oligomers/clusters due to the crosslinking effect of
small amount of antigens. In this zone, the average particle size increases linearly or
logarithmically with increased antigen concentration. At a certain antigen concentration,
such nanoparticle size increase will reach a maximum, the so-called “hook point”.
Further increase of antigen concentration will lead to a decreased degree of particle
aggregation, because there are enough antigens to bind with each antibody on the
nanoparticle surface, therefore, less particle crosslinking will occur. The relative ratio of
the nanoparticle probes versus antigen in an assay solution determines when the “hook
point” shall occur.
For particle agglutination assays, the “hook point” is approximately the upper limit
of the dynamic range of the assay. The “hook point” for the assay as shown in Figure 6-5
appeared at a mouse IgG concentration around 500 ng/mL. “Hook point” also affects the
precision of an assay. When substantial nanoparticle aggregation starts to form, the
precision of the analysis through particle size measurement will typically decrease. This
was clearly noticed from the results as shown in both Figure 6-3 and 6-4. However, at
relatively low antigen concentration, the particle size change of the assay solution was

128

not very significant, as the case shown in Figure 6-5, due to relatively high concentration
of probe particles.

Figure 6- 6. A direct assay for mouse IgG detection using 0.01 nM goat anti-mouse IgG
conjugated GNPs. Measured data was fitted into a logistic model using a four parameter
Logistic fitting without weighting. (LLOD=0.0078 ng/mL, 3σ, R=2;
y=187.55435+(35.46758-187.55435)/(1+x/46.97037)0.6302, R2=0.9994; error bar:
standard deviation; each data is the average of two experiments) (Copyright ® 2009
Elsevier B.V.)

To improve the sensitivity of the assay at low analyte concentration range, we
diluted the GNP probes 10 times from 0.1 nM to 0.01 nM and mouse IgG solutions with
a concentration from 0 to 50 ng/mL were assayed. As shown in Figure 6-6, the particle
size increase at low mouse IgG concentrations became much more obvious. At the same
antigen concentration, the percentage of nanoparticle aggregation increases naturally with
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a lower nanoparticle probe concentration, leading to improved sensitivity of the
detection. The growth of the nanoparticle hydrodynamic diameter Dh can be fitted into a
Logistic model, with a CV% of the fitting curve below 10% for all points.18 The dynamic
range of this assay for mouse IgG is estimated to cover four to five orders of magnitude
from 0.0078 to 50 ng/mL. This dynamic range and the sensitivity are on par with or
substantially better than ELISA and some other sandwich immunoassays. This example
of study illustrates that by selecting the appropriate nanoparticle probe concentration, one
can adjust the sensitivity and dynamic range of the assay rather conveniently.

Figure 6- 7. A competitive assay for mouse IgG detection using two nanoparticle probes,
GNP-IgG and GNP-anti-IgG. The concentration of both GNP probes was 0.1 nM. Each
assay solution was incubated at room temperature for 4.5 hours. Measured data was fitted
into a logistic model using a four parameter Logistic fitting without weighting.
(LLOD=283.0036 ng/mL, 3σ, R=2; y=42.21247+(71.12096-
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42.21247)/(1+x/5023.40461)0.76428, R2=0.9895, error bar: standard deviation; each data is
the average of two experiments) (Copyright ® 2009 Elsevier B.V.)
6.3.4 A competitive immunoassay for mouse IgG using two nanoparticle probes
Other than adjusting the nanoparticle probe concentration and manipulating the
assay conditions, an alternative approach to eliminate the problem of “hook effect” is to
use a competitive assay format. Competitive assays have been reported previously for
microparticle or nanoparticle-based assays.4,9,12 In this study, a one step competitive
homogenous assay for mouse IgG detection was performed by using two matching GNP
probes, GNP-IgG and GNP-anti-IgG. Aggregation of these two GNP probes would reach
the maximum when there is no mouse IgG in the sample solution, while no aggregation
should be observed when there are excess amounts of mouse IgG in the sample solution.
Indeed, as revealed from particle size measurement as shown in Figure 6-7, the average
hydrodynamic diameter of the assay solution decreased with increased mouse IgG
concentration. The particle size decrease versus analyte concentration curve may also be
fitted into a logistic model, with a relative CV% less than 10% for all the data points.18
Although the decrease of particle size at low analyte concentration is relatively small and
the sensitivity of the assay is not as good as the sandwich-type assays, this approach
avoided the “hook effect” encountered in the non-competitive assay. Another advantage
of competitive assays is that the assay does not require at least two independent binding
sites on the analyte molecules or two matched monoclonal antibodies. This advantage is
especially useful when only one antibody is available for a target antigen. In principal, a
secondary antibody-conjugated GNP and a primary antibody conjugated-GNP can be
paired together to develop competitive assay for essentially any protein antigen
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molecules. With these two important advantages, competitive assays are as promising as
non-competitive assays and merit further investigation and development.
6.4 Conclusion
In summary, through this study, we demonstrate that gold nanoparticles with their
strong light scattering property can be used as a highly sensitive optical probe to replace
traditional polymer latex particles for laser light scattering immunoassay applications.
The sensitivity and dynamic range of such assays can be adjusted very conveniently to
the expected range by selecting appropriate nanoparticle probe concentrations and assay
conditions. Both competitive and non-competitive assay formats may be considered in
the actual assay development for each individual protein analyte. With the extremely high
sensitivity of DLS for gold nanoparticle and nanoparticle aggregation detection,
modernized DLS instruments and high throughput sample handling capability, we believe
laser light scattering immunoassay can be re-vitalized into a very powerful bioanalytical
technique for protein analysis.
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CHAPTER 7. A ONE-STEP HOMOEGENOUS
IMMUNOASSAY FOR CANCER BIOMARKER
DETECTION USING GOLD NANOPARTICLE PROBES
COUPLED WITH DYNAMCI LIGHT SCATTERING
7.1 Introduction
Highly sensitive detection and accurate analysis of biomarker molecules in human
fluid samples are essential for early detection, treatment and management of cancer. For a
typical sandwich-type immunoassay which is routinely used for protein biomarker
detection, a capture antibody against a specific biomarker protein is first immobilized on
a microtiter plate. After the binding of antigen from a sample solution, a labeled detector
antibody is allowed to bind with the immobilized antigen. The concentration of the
antigen can then be determined by indirectly measuring the concentration of the probe
attached to the detector antibody, which include enzymes, fluorescence tags, DNAbarcodes, etc.1 A typical heterogeneous immunoassay involves antibody immobilization,
multiple steps of incubation and washing cycles, followed by the signal amplification and
reading step. From the initial antibody immobilization to the final reading of the assay
results, the entire immunoassay can usually take hours to days to complete. A traditional
immunoassay is rather time-consuming and labor-intensive. To overcome these
problems, the development of single-step, washing-free homogeneous immunoassays has
been of tremendous interest and value to the scientific community.2
GNPs, including spherical particles, nanorods and nanoshells with a size ranging
from 10s to 100s nanometers, are known to have a large light absorption and scattering
cross section in the surface plasmon resonance wavelength region.3 The magnitude of
light scattering by a gold nanoparticle can be orders of magnitude higher than light
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emission from strongly fluorescing dyes. This unique property has enabled many
important and promising applications of metal nanoparticles in biomedical field, such as
molecular and cell imaging, biosensing, bioassays, and photothermal therapy.4 However,
the strong light scattering property of GNPs has been mainly applied to optical
microscopic imaging of biological cells for qualitative evaluation, but much less
frequently for quantitative analysis and assays.
Dynamic light scattering (DLS), also known as photon correlation spectroscopy
or quasi elastic light scattering, is a technique used widely for particle size and size
distribution studies. This technique is based on the Brownian motion of spherical
particles which causes a Doppler shift of incident laser light. The diffusion constant of
particles are measured and the size of the particles is calculated according to the StokesEinstein relation.5 DLS is used routinely to analyze the size and size distribution of
polymers, proteins, colloids and nanoparticles. Because of the strong light scattering
property of GNPs, it is natural to hypothesize that DLS can be a very sensitive technique
for quantitative detection and analysis of nanoparticle probes at low concentration.6
Indeed, it has been demonstrated that DLS can be used to monitor the gold nanoshell
concentration in whole blood samples after intravenous injection of nanoparticles in a
murine tumor model6a and enzyme to quantum dots interactions.6b Although extensive
studies have been reported on bioconjugation of GNPs and biomolecular interactiondirected nanoparticle assembling, to our surprise, DLS has not been used in conjunction
with gold nanoparticle probes for homogeneous and quantitative immunoassay. DLS can
distinguish individual nanoparticles versus nanoparticle dimers, oligomers or aggregates
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because of their particle size differences, and this capability makes DLS a potential
analytical tool for a quantitative immunoassay.

Scheme 7- 1. A schematic illustration of a homogeneous immunoassay using antibodyconjugated nanoparticles and nanorods coupled with dynamic light scattering
measurement (GNP: citrate-protected GNPs, DAB: anti-f-PSA detector antibody, GNR:
gold nanorods, CAB: anti-f-PSA capture antibody)

Prostate specific antigen (PSA), is an FDA-approved biomarker for prostate
cancer diagnosis. The total PSA concentration of a healthy male is in the range of a few
ng/mL and the free PSA (f-PSA) concentration is typically less than 1 ng/mL, in the
range of 10% of the total PSA.7 Free PSA is the unbound form of prostate specific
antigen. Studies have shown that the percentage of f-PSA in total PSA is lower in patients
with prostate cancer than those with benign prostate hyperplasia. The free to total PSA
ratio is now being introduced and studied as an additional tool for prostate cancer
diagnosis. We herein report the development of a highly sensitive one-step homogeneous
immunoassay for free PSA detection using gold nanoparticle probes coupled with
dynamic light scattering analysis. As illustrated in Scheme 7-1, two different types of
GNPs (here one is a spherical nanoparticle and one is a nanorod), are to be conjugated
with an anti-f-PSA antibody pair, one with a capture antibody and one with a detector
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antibody. When these two bioconjugated nanoparticles are mixed in a sample solution
that contains antigen f-PSA, the binding of f-PSA will cause nanoparticles to form
dimers, oligomers, or aggregates, depending on the concentration of the antigen. Through
DLS analysis, the relative ratio of nanoparticle dimers, oligomers, or aggregates versus
individual nanoparticles can be measured quantitatively. This ratio should increase
accordingly with increased amount of antigen in sample solution, and such a correlation
will form the analytical basis of a homogeneous immunoassay.
7.2 Experimental
7.2.1 Chemicals and materials
Hydrogen tetrachloroaurate(III) hydrate (HAuCl4) was purchased from Strem
Chemicals (Newburyport, MA). Trisodium citrate, 0.01M phosphate buffer saline (NaCl
0.138 M; KCl 0.0027 M, pH 7.4), poly-L-lysine (M.W. 93,800), dialysis tubing cellulose
membrane (MWCO 3,500) and 70% nitric acid (redistilled, 99.999+%) were purchased
from Sigma-Aldrich (Milwaukee, WI). Goat anti-mouse IgG (H+L) (AH) conjugated 5
nm GNPs (product #: 15750) were purchased from Ted Pella Inc. (Redding, CA). Mouse
anti-human PSA monoclonal antibody (capture antibody) (cat. # T40081A, clone #
CHYH1), mouse anti-human PSA monoclonal antibody (detector antibody) (cat. #
T40081B, clone # CHYH2), ELISA kits for human free-PSA (Cat.# 10050) and ELISA
kits for CA125 were obtained from Anogen-YES Biotech Laboratories Ltd. (Mississauga,
Canada). The 10 ng/mL free-PSA standard solution was used for preparation of free-PSA
solutions with lower concentrations obtained using sample dilutant provided in the
ELISA kit. The 10 ng/mL free-PSA standard solution was prepared in a protein matrix
solution according to the WHO standard by the vendor. Free-PSA antigen standards,
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CA125 antigen standards, and monoclonal antibodies were reconstituted with appropriate
volumes of nanopure water according to the procedure provided by the vendor. Nanopure
water was obtained from a Nanopure DiamondTM system (Barnstead International,
Dubuque, Iowa). Aqueous solutions of 1.0% magnesium nitrate and 0.2% palladium
nitrate were purchased from Buck Scientific (East Norwalk, CT) and used for the
preparation of matrix modifier solutions for graphite furnace atomic absorption
spectroscopy (GFAAS) analysis of GNPs.
7.2.2 Instrumentation
A set of micropipettes (0.5-10 uL, 10-100 uL and 100-1000 uL) from Eppendorf
International (Hamburg, Germany) was used for liquid transfer and dilution. A
conductivity meter, TwinCond Conductivity Meter B-173 (Horiba, Japan), was used to
monitor the purification of GNPs from residual ions in product solution. High resolution
transmission electron microscopic study (HRTEM) was conducted on a FEI Tecnai F30
TEM (FEI Company) at an acceleration voltage of 200 keV. Samples for HRTEM
analysis were prepared by pipeting 5 uL sample solution on a poly-L-lysine (0.0381 g/mL
in 1:3 H2O:MeOH mixture solvent) treated 400 mesh carbon/formvarcoated copper grids
followed by vacuum drying for 30 min and put in room temperature for at least one
overnight before HRTEM measurements. Average size and size distribution of GNPs and
gold nanorods were analyzed by ImageJ software. A Cary 300 Bio UV-Visible
spectrophotometer from Varian Inc. (Palo Alto, CA) was used for UV-Vis spectroscopic
study. A PD2000DLSPLUS Dynamic Light Scattering Detector and a PDDLS/CoolBatch
4oT Dynamic Light Scattering detector system from Precision Detectors Inc.
(Bellingham, MA) were used for dynamic light scattering (DLS) measurement. The DLS
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instrument was operated under the following conditions: temperature 20oC, detector
angle 90o, incident laser wavelength 683 nm, laser power 100 mW. The DLS data
without molecular normalization was processed using the Precision Deconvolve software.
Samples for DLS analysis were diluted in 1.50 mL nanopure water to the appropriate
concentration and mixed well and sit for 2 min before each measurement. The graphite
furnace atomic absorption spectroscopy (GFAAS) analysis of gold nanoparticle and
nanorod products was conducted using a Model 210-VGF Atomic Absorption
Spectrometer from Buck Scientific (East Norwalk, CT). Matrix modifier for GFAAS
analysis was prepared by mixing 1.00 mL of 1.0% magnesium nitrate solution, 1.00 mL
of 0.2% palladium nitrate solution and 2.00 mL of wt.2% nitric acid solution (70%,
redistilled, 99.999+%). The atomization temperature was set as 2300 oC for gold element
analysis. For each measurement, 20.0 uL of samples solution was mixed with 5.0 uL of
matrix modifier into the furnace tube to optimize atomic absorption intensities.
7.2.3 Gold nanoparticle (GNP) synthesis, purification and conjugation to antibodies
Citrate-stabilized GNPs with an average diameter 37 nm were synthesized
according to Turkevich method (1, 2). Briefly, 6 mg of hydrogen tetrachloroaurate(III)
hydrate was dissolved in 50 mL of nanopure water in a round bottom flask and boiled for
15 minutes, followed by addition of 0.5 mL 38 mM trisodium citrate solution in nanopure
water. Boiling was extended for another 15 minutes and then the solution was cooled
down to ambient temperature. Residual free ions in solution were removed by dialysis of
the solution using a cellulose membrane (MWCO=3500) against nanopure water for 2
days and monitored with ionic conductivity measurement. Conductivity of the
nanoparticle solution was measured to be 18 ms/cm before dialysis and below 1 μs/cm
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after dialysis was completed. TEM and DLS analysis revealed an average diameter of 37
nm of the nanoparticle product.
To prepare nanoparticle-antibody conjugates, 500 uL of the citrate-stabilized
nanoparticle solution was added dropwise into a 1.00 mL of diluted detector antibody
(DAB) solution, which was prepared from dilution of 100 uL of rehydrolyzed DAB
solution at 1.0 mg/mL with 900 uL of 0.01 M phosphate buffer saline (NaCl 0.138 M;
KCl 0.0027 M, pH 7.4). After gentle shaking, the mixture solution was incubated at 37 oC
for 30 min and then centrifuged for 10 min at 6000 rpm for 3 times (washing buffer: 1%
BSA in 0.01M PBS at pH=7.4 after centrifugation 15 min at 8000 rpm).
The concentration of GNP and GNP-DAB conjugates was calculated according to
the elemental gold content as determined by GFAAS. The average weight of each
individual gold nanoparticle was first estimated from the following equation by assuming
GNPs are in spherical shape and fcc crystal structure:
4
4 D
π
m = ρ × V = ρ × ( πR 3 ) = ρ × ( π ( ) 3 ) = ρD 3
3
3 2
6

(7-1)

where m is the average weight of one gold nanoparticle, ρ is the density of GNPs (19.3
g/cm3 for fcc structure), V is the average volume of GNPs, R is the average radius of
nanoparticles, and D is the average diameter of nanoparticles. The average diameter of
GNPs was calculated from the average of 200 GNPs on HRTEM micrographs using the
ImageJ software (NIH). The average weight of one gold nanoparticle is thus calculated to
be 5.12×10-7 ng for GNPs with average diameter of 37 nm. Then, the gold nanoparticle
solution was diluted to an appropriate concentration (10-100 ppb) by 2% of nitric acid
solution (70%, redistilled, 99.999+%) and the gold content in 20 μL of sample solution
was analyzed by GFAAS. Each sample was repeated for three times and the average was
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taken to calculate the gold content (in the unit of ppb) in diluted sample solution. The
gold content in initial solution was calculated by multiplying the gold content in the
diluted solution with the dilution factor. The concentration of GNPs in initial solution
was then calculated by:
c=

m'
m× NA

(7-2)

where c is the concentration of GNPs (mol/mL), m’ is the gold content in the purified
gold nanoparticle solution as determined by GFAAS (in the unit of ppb or ng/mL), m is
5.12×10-7 ng for 37 nm GNPs and NA is 6.023×1023.The concentration of GNP-dAb was
determined in the same way as pure GNPs.
7.2.4 Gold nanorods (GNR) synthesis, purification and conjugation to antibodies
GNRs with a longitudinal length of 40 nm and an aspect ratio 4:1 were
synthesized according to a literature report (3) and purified by the similar way as used for
GNPs. Gold nanorod to capture antibody conjugate (GNR-CAB) solution was prepared
by adding 200 uL of the as-prepared GNR solution dropwise to 1.00 mL of 0.1 mg/mL
capture antibody solution (cAb) in 0.01 M phosphate buffer saline (NaCl 0.138 M; KCl
0.0027 M, pH 7.4) with gentle shaking. The GNR-cAb conjugates were purified by
centrifugation 3 times at 6000 rpm for 10 min (washing buffer: 1% BSA in 0.01M PBS at
pH=7.4 after centrifugation 15 min at 8000 rpm). The concentration of the GNR and
GNR- CAB conjugates were determined using the similar method as used for GNP-DAB
conjugates and described above, but the average volume of gold nanorods was calculated
differently from GNPs:
1 4
V ' = πR 2 × ( L − 2 R) + 2 × ( × πR 3 ))
2 3

(7-3)
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where V’ is the average volume of one gold nanorod, R is the average transverse radius of
the nanorods (10 nm), and L is the average longitude length of nanorods (40 nm). The
average weight of one gold nanorod was calculated using equation (1) and (3). The
concentrations of GNRs and GNR-CAB were determined in the same way as used for
GNPs and GNP-DAB (2).
7.2.5 Immunoassay of free-PSA using GNP-DAB and GNR-CAB conjugates
A volume of 20 μL of 0.10 nM GNP-DAB conjugate solution and 20 μL of 0.25
nM GNR-CAB conjugates were added into a 1.5 mL sterilized polypropylene tube and
mixed well. To each mixed nanoprobe solution, 20 μL solution of free-PSA antigen
standard at different concentrations was added, mixed well and incubated for 30 min at
37 oC. Five free-PSA sample solutions at the following concentrations were tested: 0, 0.1,
0.5, 1.0, 10.0 ng/mL and an unknown concentration (0.5 ng/mL, prepared by a different
researcher). All standards were prepared from diluting the thawed 10 ng/mL standards
with sample dilutant solution provided in the ELISA kit. Each concentration was repeated
three times. After incubation, sample solutions were analyzed by DLS. DLS samples
were prepared by diluting 10 uL of the assay solution into 1.5 mL of nanopure water in a
plastic curvette (c=0.5 cm). After standing for 2 min, the sample solution was analyzed
twice by DLS. The numeric ratio of nanoparticle oligomers versus individual particles at
each concentration was calculated according to size distribution curve. Each data was an
average of total 6 data points (from two DLS measurements of three samples).
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7.2.6 DLS data processing and calculation of numeric ratios of nanoprobe oligomers
to individual nanoprobes
DLS measurements recorded the hydrodynamic diameters, size distributions, and
relative scattering intensity percentages of particles in the analyzed sample solution. DLS
data file for each sample was exported to ASCII file. The numeric ratios of nanoprobe
oligomers versus individual nanoprobes were calculated by EXCEL software (Microsoft,
Redmond, WA) or Origin (OriginLab Corp., Northampton, MA) from the exported
ASCII file as following: (a) Particles were first classified into two groups according to
their hydrodynamic diameter: individual nanoprobes (20-60 nm) and nanoprobe
oligomers (60-500 nm). (b) For each group, the sum of multiples of 3rd order of each
recorded hydrodynamic diameter and its corresponding relative light scattering intensity
was calculated. (c) The numeric ratios of nanoprobe oligomers to individual nanoprobes
were obtained by dividing the sum of multiples from the nanoprobe oligomer group by
the sum of multiples from the individual nanoprobe group:

∑I
R=
∑I

m

× Dm

n

× Dn

3

m

(7-4)

3

n

Where

R is the numeric ratio of nanoprobe oligomers to individual nanoprobes, Im is the

intensity percentage of nanoprobe oligomers at each corresponding hydrodynamic
diameter Dm, and In is the intensity percentage of individual nanoprobes at each
corresponding hydrodynamic diameter Dm.
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7.2.7 Comparative immunoassay of CA125 using GNP-DAB and GNR-CAB
conjugates
The procedure of comparative assay of CA125 was the same as that of free-PSA
immunoassay. 20 μL of 0.10 nM GNP-DAB conjugate solution and 20 μL of 0.25 nM
GNR-CAB conjugates were added into a 1.5 mL sterilized polypropylene tube and mixed
well. Four CA-125 antigen standards, 0 UmL, 15 U/mL, 100 U/mL and 400 U/mL, were
reconstituted by nanopure water according to the provided procedure. To each mixed
nanoprobe solution, 20 μL of CA125 antigen standard solution with different
concentrations was added, mixed well and incubated for 30 min at 37 oC. Each
concentration was repeated for three times. After incubation, DLS samples were prepared
by diluting 10 uL of the assay solution into 1.5 mL of nanopure water in a plastic curvette
(c=0.5 cm). After standing for 2 min, the sample solution was analyzed twice by DLS.
The numeric ratio at each concentration was calculated as the average of the 3 repeating
samples (each sample was analyzed twice by DLS) using the same protocol as described
above.
7.2.8 Conjugation of 5 nm GNPs onto nanoprobe oligomers
10 μL goat anti-mouse IgG (H+L) (AH) 5 nm gold conjugates were added into 20
μL nanoprobe oligomers solution and incubated for 1 h at 37oC. Nanoprobe oligomers
solutions were prepared at four f-PSA antigen concentrations: 0.1 ng/mL, 0.5 ng/mL, 1
ng/mL and 2 ng/mL. Solutions after incubation were centrifuged 3 times at 6000rpm for
10 min, washed by the washing buffer (1% BSA in 0.01M PBS at pH=7.4) and recovered
back to 0.01M PBS buffer. Solution was further diluted and ~5 μL of diluted solution
were casted on a poly-L-lysine (0.0381 g/mL in 1:3 H2O:MeOH mixture solvent) treated
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400 mesh carbon/formvar coated copper grid. After vacuum drying for 30 min and
standing in ambient conditions for at least 12 hours, the sample was analyzed under
HRTEM.
7.3 Results and Discussions
7.3.1 Sensitivity of GNPs by DLS measurements
To demonstrate the feasibility and sensitivity of DLS for immunoassay using gold
nanoparticle probes, we first conducted a DLS analysis of nanoparticle materials used in
this study. Two types of GNPs, a citrate-stabilized gold nanoparticle (GNP) and a
cetyltrimethyl ammonium bromide (CTAB)-protected gold nanorod (GNR), were
synthesized following the literature procedures.8 The GNPs have an average core
diameter of 37 nm, and the nanorods have a dimension of 10 by 40 nm, as determined
from TEM analysis (Figure 7-1a and b). The actual concentrations of the as-synthesized
GNPs and nanorods were determined by a graphite furnace atomic absorption
spectroscopy, combined with UV-Vis absorption spectroscopy. The nanoparticle and
nanorod solutions were then diluted to appropriate concentrations for DLS analysis.
Figure 7-1c is the plots of the average scattered light intensity versus nanoparticle and
nanorod concentration as measured by DLS. Both GNPs and nanorods demonstrate a
linear increase of scattered light intensity versus concentration in the picomolar range. A
detection limit of 0.02 pM (low fM range) for GNPs and 0.4 pM for gold nanorods was
established, which is similar to the reported result of gold nanoshell.6a These detection
limits are nine magnitudes lower than protein or DNA molecules and four magnitude
lower than sensors based on light absorption.9 By attaching a metal nanoparticle probe to
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biomacromolecules such as antibody, it is possible to develop a highly sensitive
immunoassay using the DLS technique.

Figure 7- 1. TEM micrographs of (a) GNPs (scale bar: 50 nm), (b) gold nanorods (scale
bar: 60 nm), and (c) DLS intensity responses and detection limits for different
nanoparticles (-□-: 40 nm×10 nm gold nanorods, LLOQ=0.4 pM, y=0.04717+0.16099x,
R2=0.99559; -○-: 37 nm GNPs, LLOQ=0.02 pM, y=0.10525+0.28012x, R2=0.99564; -◊-:
40 nm silver nanoparticles, LLOQ=0.21 pM, y=0.06337+0.23509x, R2=0.99061; -∆-: 98
nm GNPs, LLOQ=0.7 fM, y=0.02758+119.47x, R2=0.99212). (Linear fitting, 3σ, R=5 for
all groups) (Copyright ® 2008 American Chemical Society)
7.3.2 Conjugation of antibodies to GNP probes
For the immunoassay development, the citrate-protected spherical nanoparticles
were conjugated with a detector antibody (GNP-DAB), while the CTAB-protected gold
nanorods were conjugated with the capture antibody (GNR-CAB).10 Through our study,
it was found that because of the surface positive charge of the CTAB-stabilized gold
nanorods, the capture antibody can be conjugated more effectively to nanorods than the
citrate-stabilized nanoparticles, while the detector antibody can be conjugated more
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effectively to the negatively charged citrate-stabilized GNPs. The successful conjugation
of nanoparticles with detector antibody and nanorods with capture antibody was first
confirmed by DLS measurement and UV-Vis spectral analysis (Figure 7-2 and Figure 73). After conjugation with the primary antibodies, the average diameter of GNPs
increased from 37 to 57 nm, while the hydrodynamic dimension of nanorods increased
from 30 to 37 nm. The UV-Vis spectra revealed a slight shift of the surface plasmon
resonance in both intensity and wavelength. For GNPs, the SPR band shifted from 535
nm to 541 nm upon antibody conjugation. This shift is most likely caused by the surface
chemistry change of the nanoparticles from a citrate-ligand layer to an antibody layer. For
the gold nanorods, changes in the SPR band peak wavelengths as well as relative ratio of
the two SPR bands were observed. The longitudinal SPR band at 733 nm blue shifted to
725 nm and the transverse SPR band at 516 nm red shifted to 518 nm. The relative
intensity of the longitudinal versus the transverse band decreased from 2.7 to 1.6,
corresponding to what has been observed previously from a gold nanorod bioconjugate
reported by Rayavarpu et al.11

Figure 7- 2. UV-Vis spectra of GNPs and gold nanorods and their conjugates with
primary antibodies: (a) citrate-protected GNPs (GNP); (b) f-PSA detector antibody
conjugated GNPs (GNP-DAB); (c) CTAB-protected gold nanorods (GNR); and (d) fPSA capture antibody conjugated gold nanorods (GNR-CAB) (Copyright ® 2008
American Chemical Society)
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Figure 7- 3. Sizes and size distributions of nanoprobes measured by DLS: (a) 5 pM
citrate-protected GNPs (GNP), (b) 5 pM gold nanorods (GNR), and their corresponding
correlation functions for (c) GNPs and (d) gold nanorods. (Copyright ® 2008 American
Chemical Society)
To further confirm the successful conjugation of the two antibodies to the
nanoparticles and nanorods, we analyzed the coupling product of the nanoparticle probes
with antigen f-PSA in solution using TEM. A 1:2.5 mixture solution of the two
nanoprobes, GNP-DAB:GNR-CAB, was added to a buffer solution of f-PSA with a
concentration of 2 ng/mL. The mixed solution was incubated for 30 min at 37 oC, and
then drop cast on a copper grid and examined by TEM. During the imaging, we observed
a large amount of nanoparticle-nanorod dimers as shown in Figure 7-4a. These
nanoparticle dimer and oligomers are believed to be formed through antigen binding with
capture antibodies from the nanorods and detector antibodies from the spherical
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nanoparticles. With increased f-PSA concentration, the amount of such nanoparticlenanorod pairs and aggregates increased accordingly. To further verify that the
nanoparticle-nanorod pairs and oligomers were formed from the binding between antigen
f-PSA and the primary antibodies attached to nanoprobes, we added a secondary antimouse IgG-labeled gold nanoparticle (5 nm) into the mixed nanoparticle, nanorods and fPSA solution. After incubation for 60 min, the solution was cast on a copper grid and
examined by TEM. The TEM micrographs as shown in Figure 7-4d revealed that most 5
nm GNPs appeared on the surface or vicinity of large nanoparticles and nanorods, due to
the binding of secondary antibody from the 5 nm nanoparticles to the primary antibodies
on the surface of large nanoparticles and nanorods.

Figure 7- 4. TEM micrographs of: (a-c) nanoparticle oligomers formed from a mixture of
primary antibodies conjugated GNPs and gold nanorods with the addition of f-PSA
antigens (2 ng/mL) in the mixed nanoprobe solution; and (d-f) same nanoparticle
oligomers, but with additional conjugations of 2nd antibody-coated 5 nm GNPs to the
oligomers (Scale bar: 20 nm, except for d, which is 10 nm). (Copyright ® 2008 American
Chemical Society)
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Figure 7- 5. Hydrodynamic diameter distribution plots as determined by DLS
measurements: (a) nanoparticle-detector antibody conjugates (GNP-DAB, 5 pM); (b)
nanorod-capture antibody conjugates (GNR-CAB, 5 pM); (c) a 1:2.5 mixture of GNPDAB:GNR-CAB in the presence of f-PSA (1.0 ng/mL); and (d) the calculated numerical
ratio of nanoparticle oligomers in the size range of 60-500 nm (peak area A) versus
individual particles in the size range of 20-60 nm (peak area B) according to DLS
measurement at different f-PSA level (the unknown sample has a concentration of 0.5
ng/ml, data labeled with an asterisk). (Copyright ® 2008 American Chemical Society)
7.3.3 Immunoassay for f-PSA using antibody coated GNP probes
The homogeneous immunoassay of f-PSA was then conducted in solution using
the conjugated nanoparticles and nanorods coupled with dynamic light scattering
measurement. The two nanoprobes were mixed in 1:2.5 (GNP-DAB:GNR-CAB) ratio
and then added to the standard f-PSA solutions with different concentrations. After
incubating for 30 min, the solutions were diluted to appropriate concentrations for DLS
analysis. Figure 7-5 a and b are the size distribution of pure conjugated nanoparticles and
nanorods, respectively, while Figure 7-5 c is the size distribution of mixed nanoprobe
solution in the presence of 1 ng/mL of f-PSA. For the pure nanoparticle and nanorod
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conjugates, only one size of particles was observed from the distribution. With f-PSA
added to the nanoprobe solution, DLS measurement detected two particle sizes (peak area
A and B), one is centered at below 60 nm representing individual nanoparticles and
nanorods, and one above 100 nm corresponding to nanoparticle-nanorod oligomers. The
relative ratio of nanoparticle oligomers in the size range of 60-500 nm versus individual
nanoparticles in the size range of 20-60 nm range can be numerically calculated from the
size distribution curve. Figure 7-5 d is the plot of this numerical ratio versus f-PSA
concentration. With increased concentration of f-PSA, the relative percentage of
nanoparticle oligomers increased while the percentage of individual nanoprobes
decreased. Using the same nanoprobes in buffer solution, we conducted the analysis of an
unknown sample solution (f-PSA concentration at 0.5 ng/mL). The determined
concentration corresponds very well to the true concentration of the sample (Figure 7-5 d,
data indicated with an asterisk). It is very important to mention here that the standard f-PSA
solutions, including the control solution, were actually prepared in a protein matrix
solution to simulate the protein content of human serum samples. It was noticeable that
when the two nanoprobes were added to the control solution with 0 ng/mL f-PSA, a
certain level of nanoparticle oligomer formation was observed, according to DLS analysis.
The aggregation is most likely caused by the high content of proteins and high ionic
strength of the matrix solution. However, our study demonstrated that even with a small
level of nanoparticle instability and aggregation, a quantitative immunoassay is still
possible in complex biological fluids using our developed approach. Recently, it was
reported by Liu C.-H. et al.2e that the light scattering by metal nanoparticles can be
detected directly by a fluorescence spectrometer and further used for quantitative DNA
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detection. In this study, we obtained the average scattered light intensity of each assay
solution from DLS measurement; however, we did not find a clear correlation between
the average scattered light intensity versus antigen concentration in solution. The
comparative ratio of nanoparticle oligomers versus individual particles as determined by
DLS measurement appears to provide a more accurate bioassay.
We also conducted a control experiment to demonstrate the selectivity of the
assay. The mixed nanoprobe solution was added to solutions that contain a different
cancer biomarker, CA125. The oligomer versus individual nanoparticle ratio remained
unchanged at different concentrations of CA125 (Figure 7-6). This comparison study
revealed a good selectivity of the nanoprobe immunoassay.

Ratio
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Figure 7- 6. A comparative immunoassay of biomarker CA125 using GNP-DAB and
GNR-CAB (the DAB and CAB are anti f-PSA primary antibodies): the calculated
numerical ratio of nanoprobe oligomers in the size range of 60-500 nm versus individual
nanoprobes in the size range of 20-60 nm according to DLS measurements. Three sample
solutions were prepared for each antigen concentration, and each sample solution was
measurement twice by DLS. Each data presented here is the average of six data points.
(Copyright ® 2008 American Chemical Society)
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7.4 Conclusion
In summary, we demonstrated here a promising one-step homogeneous
immunoassay. By taking advantage of the large scattering cross section of GNPs and the
high sensitivity of DLS measurement, biomarker proteins or other biotargets can be
detected at very low concentration using gold nanoparticle probes. As opposed to the
traditional plate-based immunoassay, our assay is conducted in solution, which allows a
much better mixing and antibody-antigen interaction. The assay does not involve any
washing cycle and the assay result can be read as soon as the nanoprobe-sample
incubation is completed. Moreover, extremely small amount of samples are needed for
the assay. With further improvement on the stability of nanoparticle bioconjugates and
the light scattering intensity of nanoparticle probes, the accuracy and detection limit of
the assay can be further improved. The research on cancer biomarker detection directly
from human serum samples using the method reported here is currently underway.
References:
________________________________

1 (a) Yu, F.; Persson, B.; Lofas, S.; Knoll, W. Anal. Chem. 2004, 76, 6765-6770. (b) Healy, D.A.; Hayes,
C.J.; Leonard, P.; McKenna, L.; O’Kennedy, R. TRENDS in Biotech. 2007, 25, 125-131. (c) Das, J.; Aziz,
M.A.; Yang, H. J. Am. Chem. Soc. 2006, 128, 16022-16023.
2 (a) Warnick, G.R.; Nauck, M.; Rifai, N. Clin. Chem. 2001, 47, 1579-1596. (b) Weigum, S.E.; Floriano,
P.N.; Christodoulides, N.; McDevitt, J.T. Lab on a Chip 2007, 7, 995-1003. (c) Kokko, T.; Kokko, L.;
Soukka, T.; Lovgren, T. Anal. Chim. Acta 2007, 585, 120-125. (d) Xu, X.; Georganopoulou, D.G.; Hill,
H.D.; Mirkin, C.A. Anal. Chem. 2007, 79, 6650-6654. (e) Du, B.-A.; Li, Z.-P.; Liu C-H. Angew. Chem.
Int. Ed. 2006, 45, 8022-8025.
3 (a) Nikoobakht, B.; El-Sayed, M. Chem. Mater. 2003, 15, 1957-1962. (b) Link, S.; El-Sayed, M.A. J.
Phys. Chem. B. 1999, 103, 8410-8426. (c) Sun, Y.; Xia, Y. Science 2002, 298, 2176-2179.

154

4 (a) Katz, E.; Willner, I. Angew. Chem. Int. Ed. 2004, 43, 6042-6108. (b) El-sayed, I.H.; Huang, X.; ElSayed, M.A. Nano Lett. 2005, 5, 829-834. (c) Huang, X.; El-sayed. I.H.; Qian, W.; and El-sayed M.A. J.
Am. Chem. Soc. 2006, 128, 2115-2120.
5 Berne, B.J.; Pecora, R. Dynamic ligh scattering: with applications to chemistry, biology, and physics;
Wiley: New York, 1976.
6 (a) Xie, H.; Gill-Sharp, K.L; O’Neal, D.P. Nanomedicine: Nanotechnology, Biology, and Medicine 2007,
3, 89-94. (b) Ipe, B.I.; Shukla, A.; Lu, H.; Zou, B.; Rehage, H.; Niemeyer, C.M. ChemPhysChem 2006, 7,
1112-1118.
7 Sahab, Z.J.; Semaan, S.M.; Sang Q.-X.A. Biomarker Insights 2007, 2, 21-43.
8 (a) Frens, G. Nat. Phys. Sci. 1971, 241, 20-22. (b) Nikoobakht, B.; El-Sayed, M.A. Chem. Mater. 2003,
15, 1957-1962.
9 (a) Pecora, R. J. of Nanoparticle Research 2000, 2, 123-131. (b) Sorlie, S.S.; Pecora, R. Macromolecules
1998, 21, 1437-1449. (c) Hirsch, L.R.; Jackson, J.B.; Lee. A.; Halas, N.J.; West, J.L. Anal. Chem. 2003,
75, 2377-2381.
10 (a) Roe, C.D.; Courtoy, P.J.; Baudhuin, P. J. of Hisochem. and Cytochem. 1987, 35, 1191-1198. (b)
Brewer, S.H.; Glomm, W.R.; Johnson, M.C.; Knag, M.K.; Franzen, S. Langmuir 2005, 21, 9303-9307. (c)
Ackerson, C.J.; Jadzinsky, P.D.; Jensen, G.J.; Kornberg, R.D. J. Am. Chem. Soc. 2006, 128, 2635-2640.
11 Rayavarpu, R.G.; Petersen, W.; Ungureanu, C.; Post, J.N.; Leeuwen, T.G.; Manohar, S. Int. J. of
Biomedical Imaging 2007, 29817.

155

CHAPTER 8. SURFACE MODIFICATION OF GOLD
NANOPARTICLES BY POLY(ETHYLENE GLYCOL)
POLYMERS AND APPLICATIONS IN BIOMOLECULAR
DETECTION
8.1 Introduction
GNPs are a class of plasmonic materials under intense research and development
for broad biological applications, especially in ultrasensitive biomolecular detection. 1
Since 1990s, investigations on controlled synthesis and functionalization of GNPs have
grown exponentially.2 GNPs can be synthesized with strictly controlled geometries and
sizes, ranging from a few to several hundreds of nanometers in both aqueous solution as
well as in organic solvents.3 GNPs after synthesis are normally protected by a shell of
stabilizing molecules, through either physical adsorptions or chemical interactions to
GNP surface. For example, GNPs prepared by the well-known citrate reduction method
are protected with physically adsorbed citrate ions.4 These surface molecules are crucial
to keep GNPs dispersed in solution. The success in synthetic preparation and stabilization
by surface ligands provides essential colloidal GNP probes for applications.
To apply GNPs for biological applications, GNPs need to be conjugated with
biomolecules. A type of commonly used methods to conjugate biomolecules with GNPs
is through physical adsorption. For example, proteins, with charges on their surface, can
be adsorbed onto GNP surface through electrostatic interactions.5 This method is widely
used due to the easy procedure. Commercially available antibody-conjugated GNP
probes (referred as “immunogold”) are prepared through physical adsorption methods
and have been applied for cell imaging and flow cytometry applications. 6 Substantial
studies using GNP probes prepared by physical adsorption methods were reported for the
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detection of proteins, DNA, aptamers, etc.7 In Chapter 6 and Chapter 7, we have used the
physical adsorption method in the preparation of antibody-conjugated spherical 40 nm
GNPs and 40 nm by 10 nm gold nanorods and applied these GNP probes in sensitive
detection of mouse IgG and PSA antigens.
While physical adsorption methods possess the advantage of procedure simplicity,
there are several limitations existing for these methods. Protein-GNP conjugates prepared
by these adsorption methods rely on the equilibrium between GNP-conjugated antibodies
and free antibodies in the solution. These GNP probes have low protein repellency and
are susceptible to dissociation of original proteins from the GNP surface. This can result
to diminished labeling efficiency. GNP probes tend to aggregate out from the solution
due to non-specific interactions of proteins or dissociation of proteins. 8 Moreover,
because these conjugates are based on non-specific electrostatic interactions, they are not
resistant to high ionic strength or extreme pH conditions in solution thus lack the long
term stability. Such prepared GNP probes are then not very stable in buffer solutions or
biological fluids. As a consequence, these limitations on stability and biomolecular
conjugation for physically adsorbed GNP probes will inevitably cause serious problems
in biomolecular assays.
To improve the stability and bio-specific functionality of biomoleculesconjugated GNP probes, surface modification on GNPs is necessary.

9

Surface

modifications generally result to a dense layer of molecules on the GNP surface with
higher binding affinity between the GNP surface and surface ligands. In one approach,
original stabilizing molecules on GNPs can be place exchanged by polymers. 10 For
example, thiolated polymers can be anchored onto GNPs, by replacing original citrate
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molecules on GNPs due to the strong binding affinity between gold surface and thiol
groups. Polymers can thus form a protecting layer on GNP surface and contribute to
improve colloidal stability of GNPs probes.10
In addition to surface modification of GNP surface, covalently conjugate proteins
to GNPs can help in preparing stable and biospecific GNP probes with resistance to
nonspecific interactions or aggregations.9 In a comparison to nonspecific interactions in
physiadsorption methods, covalent bondings between GNPs and biomolecules are much
less susceptive to solution condition variations, such as other proteins, solution ionic
strength or pH values. These covalently conjugated GNP probes can maintain high
stability as well as bio-specificity. Surface biomolecules are not in equilibrium with free
biomolecules in solution. GNP probes prepared through such a covalent coupling
methods have been demonstrated to be more stable and robust in biological
applications.10b
The combination of surface modifications and covalent coupling of biomolecules
to GNPs has been proven to be effective in using robust GNP probes for biological
applications. However, yet there is no systematic and quantitative study on the effects of
surface modification to the stability of GNPs with respects to GNP sizes and solution
conditions. Motivated by this, in this study we prepared polymer modified GNPs and
investigated their stabilities at different GNP core sizes and solution conditions. Through
this study, we aimed to reveal the effects of different solution conditions to the stability
of GNP probes and to provide pratical guides in the preparation of robust GNP probes.
Thiolated bi-functional poly(ethylene glycol) (PEG) polymers were chosen as polymeric
supports due to their proven effectiveness to render nonspecific interactions between
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biomolecules and to improve bio-compatibility and stability of GNPs in biological
environment.10b The stability of all tested PEG-GNPs showed substantial increases over
unmodified citrate-stabilized GNPs.
To further investigate the performance of these PEG-GNP probes and to apply
them in biological detection applications, we conjugated these PEG-GNPs with
antibodies through covalent coupling reactions and applied them in the detection of fPSA antigens. The covalent conjugation of antibodies to PEG-GNP was verified in a
simple and effective aggregation assay. We then applied the 100 nm PEG-GNPs as
immunoassay probes for the detection of f-PSA antigens, with a one-step immunoassay
format similar to these demonstrated in Chapter 6 and Chapter 7. Sensitivity and
reproducibility of the immunoassay using PEG-GNPs were improved significantly.
8.2 Experimental
8.2.1 Chemicals, materials and instruments
Citrate-protected GNPs (CiGNPs) in a range of core sizes and 40 nm goat antimouse IgG conjugated GNPs (GNP-anti-IgG) were purchased from Ted-Pella. Thiolated
and carboxylated poly(ethylene glycol) polymer (COOH-PEG-SH) (M.W.=3000) were
obtained from RAPP Polymere. The ELISA kit and antibodies for PSA or f-PSA were
from Anogen Inc. All other materials were from Aldrich.
8.2.2 Preparation and purification of poly(ethylene glycol) coated GNPs
Poly(ethylene glycol) polymer coated GNPs (PEG-GNPs) were prepared by
adding 1.5 mL COOH-PEG-SH solution (0.6 mg/mL) into 10 mL intact CiGNPs solution
and keeping in gentle shaking for one week.
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In stability tests, the as-prepared PEG-GNPs were purified by centrifugation and
washed by DI water for three times. Different centrifugation conditions were used for
PEG-GNPs at different sizes (20 and 40 nm: 13.4k rpm for 6 min; 60 and 80 nm: 13k
rpm for 3 min; 100, 150, 200, and 250 nm: 8k rpm for 2 min).
In biomolecular conjugation and immunoassays, the crude 40 nm or 100 nm PEGGNPs were purified by column chromatography instead of centrifugation. A volume of
400 μL PEG-GNP solution was passed through a Sepharose CL-2B column, with a gel
height of ~10 cm and PBS buffer (PBS 10 mM; NaCl 0.138 M; KCl 0.0027 M, pH 7.4)
as the mobile phase. The collected PEG-GNPs were filtered by a membrane (hole size:
200 nm) to exclude large aggregates. UV-Vis and DLS were used in the purification and
antibody conjugation process to monitor the size and stability of PEG-GNPs probes.
8.2.3 Stability tests for PEG-GNPs at various NaCl concentrations
NaCl solutions at concentrations 0, 0.2, 0.3, 0.4, 0.8 M were prepared. The
stability test was performed as following: 100 μL centrifugation purified PEG-GNP
solution and 100 μL NaCl solution were mixed in a well and the absorbance of each
mixed solution at corresponding SPR peak wavelength (according to Table 5-1) was
measured, respectively at each GNP size and each NaCl concentration. Each sample was
duplicated and the average hydrodynamic diameter was calculated.
8.2.4 Stability tests for PEG-GNPs at various pH values or buffer conditions
The pH values of centrifugation purified PEG-GNP solutions were adjusted from
4 to 10 using 1 M HCl or 1 M NaOH solutions (Table 8-2). For buffer solutions, equal
volume of purified PEG-GNP solution and the buffer solution (PBS or Tris buffer) were
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mixed. The absorbance of each sample at the corresponding SPR peak wavelength was
monitored, respectively.
8.2.5 Biomolecular conjugation and aggregation assay of 40 nm PEG-GNPs
The 40 nm -COOH functionalized PEG-GNPs were conjugated to two PSA
antibodies (PSA-CAB and PSA-DAB, respectively), with the use of covalent coupling
reagents EDC (Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride) and sulfoNHS (N-hydroxysulfosuccinimide). The purified PEG-GNP probe solution 450 μL was
added by 5 μL EDC/sulfo-NHS mixture solution (25.7 mM/51 mM) and gently shaked
for 30 min, then passed through a Sephadex G-25 column. Solutions were equally
divided into two portions, with each portion added by 5 μL of PSA antibody solutions,
respectively for PSA-CAB and PSA-DAB. Solutions were gently shaked for 3 hours at
RT and purified using a Sepharose 4B column.
The aggregation assay was performed by mixing 100 μL of 40 nm GNP-anti-IgG
solution (0.1 nM) with 100 μL PEG-GNP probes (respectively for PEG-GNP-CAB and
PEG-GNP-DAB). Mixture solutions were incubated at 37 oC and the average size of the
GNP probes in each mixture solution was monitored by DLS along time. All
measurements were performed at a detection angle of 90o.
8.2.6 Immunoassay of for f-PSA detection using 100 nm PEG-GNPs
The purified 100 nm PEG-GNP solution 450 μL was covalently conjugated with
two paired anti-f-PSA antibodies, denoted as CAB and DAB respectively. The procedure
of conjugation and purification was similar to the one in section 8.2.5. These two PEGGNP probes were then used in the immunoassay for the detection of f-PSA antigens. The
procedure was similar to that in section 7.2.5. The f-PSA antigen solutions with f-PSA
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levels lower than 0.1 ng/mL were prepared from serial dilutions of 10 ng/mL f-PSA stock
solution. After the anti-f-PSA conjugated PEG-GNP probes and f-PSA antigen solutions
were prepared, the one-step immunoassay was performed. At each f-PSA concentration,
30 μL of each of the two PEG-GNP probe solutions were mixed and added by 10 μL of
antigen solution to a total volume of 70 μL. Samples were incubated at 37 oC for 1 hour
and read out by DLS at a measurement angle of 13o. The test was triplicated at each fPSA concentration.
8.3 Results and Discussions
8.3.1 Improved stability of PEG-GNPs
Citrate-protected GNPs are known to form irreversible aggregates upon addition
of salts into the solution. The aggregation process results to a decrease in the SPR
absorbance intensity and also a broadening of the SPR band.11 For example, the SPR
peak absorbance of 40 nm
NaCl concentration in the

CiGNPs

CiGNP

shows a significant drop within minutes when the

solution is above 20 mM. Meanwhile, an observable

color change for the GNP solution from purplish to blue can be seen. However, covering
the surface of GNPs with thiol molecules, polymers or biomolecules could improve the
GNP stability significantly. Applications based on this property have been investigated
for the detection of metal ions, thiol molecules such as cystein, or biomolecules.7,12 The
monitoring, or the detection, in these early studies relied on visible color changes as a
qualitative standard or quantitative measurement with UV-Vis spectrometers. These
detection assays showed easiness in material preparation and procedure, but lack the
ultra-high sensitivity and detection reproducibility. They also implied that ultrahigh
sensitivity is possible with better prepared GNP probes. In this study, we measured the
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UV-Vis spectra of surface-modified PEG-GNPs at various GNP sizes and solution to
study the stability of these PEG-GNPs.

Table 8- 1. Relative absorbance of 100 nm PEG-GNPs in NaCl solutions
Relative Absorbance
(%)
20 min
30 min
40 min
60 min
120 min
180 min
19 hours

[NaCl] in mixture solution (mM)
100
150
200
96%
98%
98%
94%
95%
94%
93%
94%
95%
93%
95%
95%
91%
93%
94%
91%
92%
92%
86%
87%
89%

0
100%
96%
98%
99%
97%
95%
100%

400
98%
95%
96%
96%
94%
92%
91%

100%
80%
60%
40%

Relative
absorbance at 570
nm (%)

20%

20 min

30 min

40 min

60 min

120 min

19 hours

180 min

0%

0
100 mM
150 mM
200 mM
[NaCl]
400 mM

Mixing Time

Figure 8- 1. Relative absorbance of 100 nm PEG-GNPs in NaCl solutions along mixing
time
8.3.1.1 Stability of 100 nm PEG-GNPs in NaCl solutions
We first tested the stability of 100 nm PEG-GNPs along time in various NaCl
solutions. From Table 8-1 and Figure 8-1, we can see that the 100 nm PEG-GNPs
pertained >90% of their original absorbances at all four tested NaCl concentrations up to
3 hours. At the time 19 hours, the absorbances decreased more but were still at least 86%
to the control. These results were in a sharp comparison to that of bare CiGNPs in NaCl
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solutions and revealed out the excellent salt resistance and colloidal stability of 100 nm
PEG-GNPs. Furthermore, there were no significant differences in the stability of 100 nm
PEG-GNPs at [NaCl] from 100 mM to 400 mM. Considering that biological fluids have
NaCl concentrations within the tested range, such robust PEG-GNPs are promising to
have excellent colloidal stability in biological fluids.
8.3.1.2 Stability of different size PEG-GNPs in NaCl solutions
The high stability of 100 nm PEG-GNPs in NaCl solutions indicated that surface
modification by PEG polymers to

CiGNPs

is very useful in the preparation for robust

GNP probes. Following this, we extended the investigation to differently sized PEGGNPs. Table 8-2 and Figure 8-2 summarize the relative absorbance of different size
PEG-GNPs at their corresponding SPR peak wavelengths when mixed with NaCl
solutions. PEG-GNPs with sizes up to 100 nm were shown to be stable at all tested NaCl
concentrations. However, for large size PEG-GNPs (core diameter >100 nm), significant
decreases in their SPR peak absorbances were observed, indicating that 150, 200 and 250
nm PEG-GNPs did not have as good stability as smaller size PEG-GNPs. These results
imply that thiolated PEG polymers with a molecular weight of 3000 can effectively
protect GNPs in high NaCl concentration solutions for GNPs with sizes up to 100 nm.
The reduced stability for larger size PEG-GNPs is possibly related to the surface
coverage percentage and the packing density of PEG polymers on the GNP surface.
Because larger size GNPs have larger surface areas which are proportional to the square
of the GNP diameter, it would become more difficult for PEG polymers to fully shield
the surface of larger size GNPs and to protect them from attacks by salt ions in solution.
Due to this, the packing density of PEG polymers on larger PEG-GNP surface and results
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to higher susceptibility to salt attacks. These observations and analyses can be helpful in
the selections of GNP core size and PEG polymer length during robust PEG-GNP
preparations.

Table 8- 2. Relative absorbance of PEG-GNPs at various NaCl concentrations
PEG-GNP size (nm)
20
60
40
80
100
150
200
250

Abs wavelength
525 nm
533 nm
535 nm
549 nm
570 nm
639 nm
572 nm
608 nm

0
100%
100%
100%
100%
100%
100%
100%
100%

[NaCl] (mM)
100 150 200
97% 95% 95%
96% 98% 97%
99% 97% 99%
97% 99% 93%
97% 94% 95%
67% 76% 77%
73% 71% 69%
80% 80% 84%

400
98%
95%
98%
92%
91%
76%
69%
83%

100%
80%
60%

Relative absorbance
(%)

40%
20%
0
0%

150
[NaCl] (mM)
400
250

200

150

100

80

40

60

20

PEG-GNP Size (nm)

Figure 8- 2. Relative absorbance of PEG-GNPs in solutions at different NaCl
concentrations measured by UV-Vis

8.3.1.3 Stability of PEG-GNPs in solutions at different pH values or buffer conditions
After examining the stability of PEG-GNPs in NaCl solutions, we evaluated the
stability of PEG-GNPs in solution at different pH or buffer conditions. Table 8-3 and
Figure 8-3 show the relative absorbance of PEG-GNPs in pH 4-10 solutions and two
buffer solutions. PEG-GNPs solutions at pH=7 were used as controls. From these results,
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it can be seen that PEG-GNPs at all tested sizes were stable in solutions with pH values
6-10. However, in pH 4 or 5 solutions, PEG-GNPs were not very stable and showed large
decreases in the absorbance. This indicated that these carboxylic group functionalized
PEG-GNPs did not prefer acidic conditions. In the pH range 6-10, the stability of PEGGNPs was found to be related to the GNP size. PEG-GNPs with sizes from 20 to 150 nm
are stable in this pH range, but larger size 200 nm and 250 nm PEG-GNPs were not as
stable as smaller size PEG-GNPs. These results revealed that PEG polymers used in this
study can stabilize GNPs with sizes up to 150 nm in pH 6-10 solutions.
The stability of PEG-GNPs in buffer solutions was exemplified by testing them in
two of the most common buffers, PBS and Tris buffers (Table 8-3 and Figure 8-3). Note
that the 100 nm PEG-GNP showed the highest stability in these two buffers, while all
other size PEG-GNPs had obvious stability decreases in either one or both buffers. Such
superior stability of 100 nm PEG-GNPs in all these tested ionic strength, pH and buffer
conditions suggests that the 100 nm PEG-GNPs as prepared here are very promising to be
used as robust GNP probes in biological applications.

Table 8- 3. Relative absorbance of PEG-GNPs in solutions at different pH or buffer
condition after mixed for 4 h
Size (nm)
20
40
60
80
100
150
200
250

4
69.2%
60.7%
93.4%
72.9%
67.1%
93.2%
77.5%
94.6%

5
84.6%
66.4%
83.7%
82.0%
83.1%
70.0%
70.3%

6
101.3%
100.9%
105.5%
100.0%
103.0%
89.8%
67.5%
91.9%

pH
7
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
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8
101.3%
100.9%
101.6%
99.2%
103.0%
101.7%
92.5%
102.7%

9
98.7%
101.9%
100.5%
102.3%
102.4%
101.7%
85.0%
97.3%

10
100.0%
100.9%
101.6%
101.6%
100.0%
98.3%
72.5%
83.8%

PBS
76.9%
72.0%
88.5%
89.9%
94.0%
89.8%
55.0%
73.0%

Tris
79.5%
65.4%
94.0%
97.7%
94.0%
89.8%
50.0%
94.6%

pH=4
pH=5

100.0%

pH=6
pH=7
ph=8

80.0%

pH=9
PBS
Tris

60.0%
250
200
150
100

40.0%
20.0%

80

pH=5

pH=6

ph=8

PBS

Tris

20

pH=9

40

pH=4

0.0%

60

pH=7

PEG-GNP size (nm)

Relative
absorbance (%)

pH and buffer

Figure 8- 3. Relative absorbance of PEG-GNPs in solutions at different pH or buffer
condition after mixed for 4 h

We interpret the substantial stability improvement of PEG-GNPs due to four main
reasons. First, the strong gold-thiol binding can protect the GNP core from outside ion
attack. Second, the thiol end group on the PEG polymer can anchor the polymer molecule
to the GNP surface firmly.2,5 Third, PEG polymers on PEG-GNPs can form a steric layer
to prevent PEG-GNPs from ion attacks and thus render PEG-GNPs more difficult to
aggregate out.13 Fourth, the backbone of PEG polymers is neutral in charge, which makes
PEG-GNPs less sensitive to salt concentrations or pH value changes. Due to the
combination of these four effects, the stability of PEG-GNPs showed significant
improvements. In addition, these PEG polymers have another advantage in minimizing
non-specific interactions for biomolecules. These excellent properties, including robust
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colloidal stability and low non-specific bimolecular interactions, motivated us to use
PEG-GNPs probes in biological detection applications.
8.3.2 Covalent conjugation of antibodies to PEG-GNPs
Antibodies conjugated PEG-GNPs probes were prepared through a simple
covalent conjugation procedure, by an amide reaction between the carboxyl groups on the
PEG ligands and the amino groups on antibodies through the EDC/sulfo-NHS protocol.
To verify that antibodies can preserve their bioactivity and bio-specificity after covalently
conjugated to PEG-GNPs, two GNP aggregation reactions were designed. 40 nm PEGGNPs were conjugated with a pair of mouse anti-human PSA antibodies, CAB and DAB
respectively. The two kinds of PEG-GNP probes were named as PEG-GNP-CAB and
PEG-GNP-DAB (Figure 8-4). The size of 40 nm was chosen to match the size of the
other GNP probe, whish was the goat anti-mouse IgG antibody conjugated 40 nm GNPs
(GNP-anti-IgG) purchased from Ted Pella. Note that these GNP-anti-IgG probes were
prepared through physical adsorption methods but not surface modified with PEG
polymers.
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Dh (nm)

90

70

50
GNP-anti-IgG+PEG-GNP-CAB
GNP-anti-IgG+PEG-GNP-DAB
30
0

60

120

180

Time (min)
Figure 8- 4. The aggregation assay between 40 nm goat anti-mouse IgG conjugated
GNPs (anti-mouse-GNP) and 40 nm mouse anti-human PSA antibody conjugated PEGGNPs (CAB and DAB are matched pair antibodies for human PSA)

If the covalent conjugation was successful, the PEG-GNP-CAB (or the PEGGNP-DAB) should form aggregates when mixing with GNP-anti-IgG probes. The
aggregation reactions are through the specific bio-recognition reactions between the
mouse IgG antibody on the PEG-GNP-CAB surface (or the PEG-GNP-DAB surface) and
the goat anti-mouse IgG antibody on the GNP-anti-IgG surface. The aggregation reaction
will result to size increases of GNP probes. Such size changes of GNP probes can be
sensitively monitored by DLS. The results shown in Figure 8-4 revealed out the kinetic
growth of the GNP aggregates in two probe solutions up to 3 h, respectively for PEGGNP-CAB and PEG-GNP-DAB. The average hydrodynamic diameters of GNP probes
increased continuously from the original ~40 nm to ~80 nm during 3 h. We conclude
such size increases were due to the oligomer formation of PEG-GNP probes. These
oligomers were dimmers, trimers, and higher order aggregates and they grew along time
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to larger sizes. Through these results, we confirmed that the bioactivity and specificity of
antibodies on PEG-GNPs were preserved. In a closer comparison for PEG-GNP-CAB
and PEG-GNP-DAB probes solutions, we can also see that these two kinds of antibodyconjugated GNP probes had similar size increasing rates, while PEG-GNP-DAB showed
slightly faster size increasing rate. This indicated that PEG-GNP-DAB had slight higher
activity than PEG-GNP-CAB to goat anti-mouse IgG antibodies. These two aggregation
reactions may be used in applications of fast antibody activity studies.
8.3.3 Immunoassay application of 100 nm PEG-GNPs for free-PSA (f-PSA)
detection
From the above results in 8.3.1 and 8.3.2, we have showed that the improved
stability of PEG-GNPs and successful covalent antibody conjugation to PEG-GNPs. We
then applied these PEG-GNPs in bimolecular detection applications. We used the 100 nm
PEG-GNPs for the detection of f-PSA antigen using a one-step amplification-free and
washing-free assay format.
The core size of 100 nm was selected due to a balance between the colloidal
stability and sensitivity of the immunoassay. From results in section 8.3.2, the 100 nm
PEG-GNPs have the highest stability in NaCl solutions, acidic or basic solutions or buffer
solutions. Such excellent colloidal stability is essential in using PEG-GNPs for biological
applications. In the other side, DLS detection prefers larger size GNPs. Larger size GNPs
can scatter light stronger so have better sensitivity in DLS detection. This is beneficial to
improve the sensitivity of GNP-based immunoassays. The three larger size 150, 200 or
250 nm are better for this purpose but they had lower colloidal stability in tested salt and
pH conditions so were not used in the immunoassay applications in this study.
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Table 8- 4. Immunoassay for f-PSA using 100 nm PEG-GNP probes
f-PSA (ng/mL)
0.000
0.001
0.010
0.100
1.000
2.000
5.000
10.000

D (nm)
171.8
173.9
186.3
206.4
245.1
280.7
337.5
339.6

Stdev (nm)
8.7
18.9
21.1
37.4
34.5
60.5
26.3
156.6

0.100

1.000

500.0

Dh (nm)

400.0
300.0
200.0
100.0
0.0
0.000

0.001

0.010

2.000

5.000

10.000

f-PSA (ng/mL)

Figure 8- 5. Immunoassay for f-PSA detection using 100 nm PEG-GNP probes (second
order exponential decay fitting: y = -168.858*exp(-x/3.00203) + -27.5137*exp(x/0.01413) + 368.1954; R2= 0.99933; LLOD: 0.046 ng/mL)
As already discussed in section 7.1, f-PSA is the unbound form of PSA. While
the PSA level for normal male is <4 ng/mL, the f-PSA level is typical lower than PSA
and in the range of 10% of the PSA level.14 It is thus more difficult to precisely measure
the f-PSA level in biofluids than to measure the PSA level. Due to this, we focused on the
challenges to use 100 nm PEG-GNPs for the detection of f-PSA antigens and
demonstrate the superior stability, bioactivity and specificity of PEG-GNP probes. The
principle of the immunoassay was based on a sandwich type reaction between f-PSA
antigens and the two mouse anti-f-PSA antibodies-conjugated PEG-GNP probes, similar
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to the reaction as illustrated in Scheme 7-1. Because all PEG-GNPs were multi-covalent,
the addition of f-PSA solution into the mixture of the two probe solution can introduce
the aggregation of PEG-GNPs. The extent of the aggregation reaction was correlated with
the concentration of the f-PSA and the size changes of these PEG-GNPs were shown in
Table 8-4 and Figure 8-5.
By increasing the level of f-PSA in the solution from 0 to 10 ng/mL, the average
size of the PEG-GNP probes in solution increased from 171 nm to 340 nm. The
correlation between the size and the f-PSA level can be best fitted with a second order
exponential decay (Figure 8-5, caption). Ultrahigh sensitivity as well as a good dynamic
range for f-PSA detection were demonstrated in this simple and fast immunoassay. Using
the standard 3σ method, the lower limit of detection (LLOD) of the immunoassay was
determined to be 0.046 ng/mL. The immunoassay showed a dynamic range from 0.046
ng/mL to 5 ng/mL. To our best knowledge, such sensitivity has not been reported in an
amplification-free and washing-free assay. In fact, such sensitivity and dynamic range are
close to those of currently commonly used methods, such as ELISA. For example, the
ELISA kit from Anogen for f-PSA measurements has a claimed sensitivity of 0.022
ng/mL and a dynamic range up to 10 ng/mL. However, such sensitivity and dynamic
range are achieved with multiple sample washing and signal amplification steps. The new
immunoassay in our study showed comparable sensitivity and dynamic range but had
much simplified procedure as well as much reduced sample volume (from 50 µL to 10
µL). Thus the new PEG-GNP based immunoassay is very promising for fast and simple
detection of f-PSA antigens.
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In the current study, we only exemplified the biological detection applications of
PEG-GNP probes in f-PSA detection. However, with slightly modified protocols, the
immunoassay should fit for the detection of other biomolecules as well. The general and
simple biomolecular conjugation protocol for PSA and f-PSA antibodies can be applied
easily to other biomolecules. For immunoassays, the simple one-step assay would also
dramatically shorten the assay development time because it avoids many issues in
traditional heterogeneous immunoassay development, such as substrate selection, enzyme
selection and conjugation. Considering that these selection and optimization steps
typically will take 4-6 months, the new immunoassay in this work would greatly save the
assay development time and cost, while also providing better reliability due to less
parameters to be optimized.15 In addition, the sensitivity of the new immunoassay can
fulfill the requirements in bimolecular detection. In fact, the diagnostic ranges of many
clinical important protein biomarkers identified yet fall into the pg/mL-ng/mL range.
Such sensitivity and dynamic range were demonstrated to be achievable in the new
immunoassay. We believe these advantages would make the new immunoassay to be
very competitive to traditional assays in biomolecular detection and other biological
applications.
8.4 Conclusions
In this contribution, we reported the stability improvements of GNPs after surface
modification by thiolated PEG polymer and exemplified biomolecular detection
applications of these PEG-GNP probes using f-PSA as an example target analyte. It was
found that PEGlylation significantly improved the stability of GNPs in NaCl solutions
(with [NaCl] up to 400mM), acidic or basic solutions (pH from 6 to 10) and buffer
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solutions. The 100 nm PEG-GNPs were found to have the best stability in all tested
conditions. After PEGlylation, we demonstrated that antibodies could be conjugated with
PEG-GNPs through a simple covalent coupling reaction. The 100 nm PEG-GNPs
conjugated with anti-f-PSA antibodies were then used in a one-step washing-free and
amplification-free immunoassay for the detection of f-PSA antigens. The immunoassay
showed an ultra sensitivity to as low as 0.046 ng/mL, which is comparable with the
sensitivity of commercial products but with a much simplified procedure and reduced
sample volume. This new immunoassay shows promises in meeting the highly desired
demand for a simple, fast, small sample consumption, and cost-effective in situ
immunoassay.
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CHAPTER 9. ENHANCED IMAGING AND ACCELERATED
PHOTOTHERMALYSIS OF A540 HUMAN LUNG CANCER
CELLS BY GOLD NANOSPHERES UNDER LASER
IRRADIATION
9.1 Introduction
Since 1999, cancer has surpassed heart disease and become the number one cause
of mortality for people younger than 85 years old in US.1, 2 In 2008, it is estimated that
1.2 million people will be diagnosed with cancer. By far, lung and bronchus cancer
represents about 29% of all cancer cases, and lung cancer has the highest death rate
among cancer patients in both men (31%) and women (26%).3 The early detection and
effective treatment of lung cancer has remained as a significant challenge. New imaging
techniques and therapeutic methods/agents, including nanomaterials and nanotechnology,
are being explored extensively for cancer study and treatment.4-10
GNPs, including nanospheres, nanorods and nanoshells with a size ranging from 1
to 100 nanometers, are known to have large light absorption and scattering cross sections
in the surface plasmon resonance (SPR) wavelength region.11 The light absorption and
scattering cross sections around the SPR band of a gold nanoparticle can be a few orders
of magnitude higher than the fluorescence emission of traditional organic dyes. The
strong absorption of GNPs, and nanoparticle aggregation-induced SPR wavelength shift,
has been studied extensively for biosensor and immunoassay applications.12,13 As a strong
light scatterer, GNPs are being used effectively for optoacoustic imaging and dark field
imaging of biological cells.14, 15 Recently, the light scattering property of GNPs has been
reported for the development of a homogeneous immunoassay using dynamic light
scattering (DLS).16 In addition to elastic scattering, inelastic scattering such as surface-
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enhanced Raman scattering is another area of strong interest.13,17 Relatively large GNPs
with a diameter above 10 nm, are not photo luminescent. Therefore, GNPs are excellent
photothermal energy converters and have been explored for photothermal therapy of
tumor cells and for controlled destruction of bacteria and protein aggregates.18-21 The dual
function of GNPs, namely, the strong light scattering property for dark field optical
imaging and the highly efficient photothermal energy conversion for photothermalysis of
cancer cells, make GNPs particularly attractive for cancer research.
In this study, we investigated the use of a gold nanoparticle probe for optical
imaging and accelerated photothermalysis of the human lung cancer cell A549. A549
cells are derived from lung carcinoma with properties of type II alveolar epithelial cells,
and may serve as well established cell model in the studies of lung cancer biomarkers.21,22
GNPs used in this study were conjugated with a layer of anti-human IgG on the surface.
After incubating the cells with the GNPs, the loading of GNPs by tumor cells was imaged
using a dark field optical microscope. The photothermalysis of tumor cells with and
without the loading of GNPs was studied using a viability test kit under a confocal
microscope.
9.2 Materials and Methods
9.2.1 GNPs and characterizations
Goat anti-human IgG conjugated GNPs (Prod # 15775D-4G) were purchased
from Ted Pella (Redding, CA). The nanoparticle concentration was adjusted to 5 fM in a
pH=7.4 PBS saline solution (NaCl 0.138 M; KCl 0.0027 M) by the vendor. High
resolution transmission electron microscopic study (HRTEM) of the nanoparticles was
conducted on a FEI Tecnai F30 TEM (FEI Company) at an acceleration voltage of 200
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keV. Samples for HRTEM analysis were prepared by pipeting 5 uL of sample solution to
the surface of a poly-L-lysine (0.0381 g/mL in 1:3 H2O:MeOH mixture solvent) treated
400 mesh carbon/formvar coated copper grid. Following vacuum drying for 30 min, the
grid was placed in a desiccator at room temperature for at least overnight before
conducting HRTEM analysis. A Cary 300 Bio UV-Visible spectrophotometer from
Varian Inc. (Palo Alto, CA) was used for UV-Vis spectroscopic study. A
PD2000DLSPLUS Dynamic Light Scattering Detector and a PDDLS/CoolBatch 40T
Dynamic Light Scattering detector system from Precision Detectors Inc. (Bellingham,
MA) were used for the particle size measurement. The DLS instrument was operated
under the following conditions: temperature 20oC, detector angle 90o, incident laser
wavelength 683 nm, laser power 100 mW. The DLS data was processed using the
Precision Deconvolve software. Samples for DLS analysis were diluted in 1.50 mL
nanopure water to appropriate concentrations, mixed well and stabilized before
measurement.16
9.2.2 Cell line culture
A549 (ATCC. No. CCL-185) human lung cancer cell line, derived from
adenocarcinoma of the male lung, was cultured in a Roswell Park Memorial Institute
(RPMI) media with 10% Fetal Bovine Serum, 1% L-Glutamine, 1% Hepes, and 1%
penicillin-streptomycin. All cultures were maintained in humidified incubators at 37 °C
in an atmosphere of 5.0% CO2. 24 Hours prior to laser irradiation treatments, the cells
were plated on round cover slips (Bioptechs, 40 mm, Butler, PA) in culture plates (60
mm × 15 mm Fisherbrand, Pittsburgh, PA) and treated with GNPs for each treatment
regimen. The controls were untreated A549 cells, incubated in culture media without
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GNPs. The cell concentration was 10 million cells per ml of the media for all cell study
experiments. In the regimen with gold nanoparticle treatment, A549 cells were incubated
in the same amount of culture media as the controls, with the addition of GNPs to a final
concentration of 0.25 pM. The plated cells were incubated in humidified incubators at
37 °C in atmosphere of 5.0% CO2 for 24 hours.
9.2.3 Dark field imaging
The cells on plates were washed with PBS saline 5 times and dried in ambient
condition before being mounted on a glass slide. Dark field images were obtained using
an Olympus U-DCW condenser and an UPlanFL N 100x/1.30 oil iris with an Olympus
BX51 microscope. All dark field images were taken by the Analysis Imager 5.0 software
at the exactly same imaging conditions (incident light intensity, gain, exposure time, etc.).
9.2.4 Laser irradiation condition and viability assay
A549 cells, after being exposed in the cell culture with GNPs for 24 hours, were
stained using a Violet Live/Dead Viability Fixable Assay Kit (Invitrogen, Carlsbad, CA
Cat# 34955) for half an hour. According to the protocol, 1 uL of dilutant with violet dye
was added to 1 mL of media in plates containing cover slips seeded with live cells and
incubated for 30 minutes. Cover slips with cells on them were transferred to a Live Cell
Microscopy Environmental Control System from Bioptechs (Butler PA). Viability tests
for both control cells and samples cells after gold nanoparticle exposure were monitored
with a DMI6000 inverted Leica TCS AOBS SP5 tandem scanning confocal microscope
with a 63x/1.40NA oil immersion objective. A 52.5 mW 405 nm diode laser (Lasos, San
Jose, CA) tuned to a 1% output power (0.525 mW) was used to excite the violet viability
stain, and the fluorescence emission at 450 nm was collected. A Helium-Neon 5 mW

179

diode laser at 633 nm (Lasos, San Jose, CA) (1.0 W/cm2) was used for irradiation of the
cells. Images, Z-stacks and time lapse experiments were performed with dual
photomultiplier detectors and the LAS AF version 1.5.1.889 software suite. Cell death
was assessed in real time by imaging the cells constantly at a 400Hz rate of one
1024x1024 frame, which refreshes a newly scanned image every 5.179 seconds for the
length of the time lapse. Images over time were converted to .avi files for ease of
comparison and viewing. Image Pro Plus V6.2.0 (Media Cybernetics, Bethesda, MD) was
used to quantify the intensity of individual cells in every fifth frame of the time lapse.
Total cellular intensity was determined by the average of dynamic range values for each
pixel within individual cells. Viability tests for both control and sample cells were
studied at different power levels of 633 nm laser (0.50 mW, 1.25 mW, 2.50 mW, 3.75
mW and 5.00 mW).
9.2.5 Relative viability drop curves and normalized relative viability drop rate
curves
Relative viability of cells at each imaging time was computed as the relative
percentage of fluorescence intensity at specified irradiation time over the initial
fluorescence intensity by the Microsoft® Office EXCEL 2003 SP3 and the OriginPro
SR1 v7.5776 (B776) software. Relative viability drop curves for both control cells and
sample cells after gold nanoparticle exposure were plotted along the irradiation time of
633 nm laser. For each different power level irradiation, the corresponding curve was
established. The relative viability drop curves at 0 mW for both control cells and samples
cells were taken as baselines for the following calculations of normalized viability drop
rate curves, respectively. The relative viability drop rate curves were constructed by
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calculating the slopes of each relative viability drop at corresponding irradiation time and
plotted over irradiation time up to 58 seconds. The normalized viability drop rate curves
were obtained after subtracting corresponding baselines, for control cells and sample cells
after gold nanoparticle exposure, respectively.
9.3 Results and Discussions
In this work, gold nanospheres were chosen for the dark field imaging and
photothermalysis study of cancer cells. Compared to many other types of nanoparticles
such as quantum dots, gold nanorods and nanoshells etc., gold nanospheres are more
stable, easy to make, and have low cytotoxicity.10,17,18 Although the SPR of individual
gold nanospheres is in the visible light region, 520-530 nm, this band can red-shift to near
infrared region upon nanoparticle aggregation. Spherical GNPs therefore are still very
attractive optical probes for cell imaging and photothermalysis study.22,23 Gold
nanospheres with a core diameter of 40 nm were chosen for this study. This size was
previously reported as the optimum size for photothermalysis of cancer cells.23,25 The
gold nanospheres were prepared by coating a layer of goat anti-human IgG antibody on
the surface of a citrate-protected gold nanoparticle (from the Vendor’s product
information). The citrate-protected gold nanospheres are not stable in high salt content
buffer solutions such as cell culture media, and quickly precipitate out of the solution at
salt concentration above 30 mM. The anti-human IgG layer makes the nanospheres stable
in the cell culture media. Furthermore, the anti-human IgG from the nanoparticles can
bind with the human IgG molecules on the surface or inside the tumor cells, allowing
gold nanospheres to be loaded to the lung tumor cells.
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Figure 9- 1. Goat anti-human IgG conjugated gold nanospheres and their dark field
images. (A) Schematic illustration, (B) HRTEM micrograph, (C) size and size
distribution measured by DLS, (D)-(F) dark field images at incremental concentrations
from 1, 10 to 100 fM, respectively. (Copyright ® 2008 Future Medicine Ltd.)

A HRTEM image and UV-Vis absorption spectrum of gold nanoparticle
conjugates are shown in Figure 9-1 and Figure 9-2, respectively. The gold nanospheres
exhibit an SPR band centered at 530 nm. DLS measurement confirmed the narrow size
distribution of gold nanospheres used in the study (Figure 9-1c). The gold nanoparticle
solution was drop cast on a glass slide and then visualized under a dark field optical
microscope. The micrographs revealed bright nanoparticle dots on the glass slide.16 With
increased nanoparticle concentration, from Figure 9-1d to f, the number and the scattering
intensity of gold nanospheres increased significantly due to nanoparticle aggregation.
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Figure 9- 2. UV-Vis spectrum of well dispersed gold nanoparticle probes. UV-Vis
spectrum of 40 nm goat anti-human IgG conjugated gold nanospheres with a SPR band
peaked at 530 nm (irradiation laser wavelength at 633 nm, imaging laser wavelength at
405 nm). (Copyright ® 2008 Future Medicine Ltd.)

Dark field optical microscopy was then used to examine the loading of gold
nanospheres by cancer cells. Without incubation with gold nanospheres, it was found that
the cancer cells were weak light scatterers and could be visualized under the dark field
microscope (Figure 9-3a-c). However, the contrast of the images was rather poor. After
incubation with gold nanospheres in the cell culture media, the contrast of the images was
enhanced significantly when compared with images of cancer cells that were not exposed
to gold nanospheres in the cell culture media (Figure 9-3d-f). It needs to be noted here
that all images were taken under exactly the same conditions including incident light
intensity, gain, exposure time, etc. This enhancement effect is a strong indication of an
effective loading of gold nanospheres to the cancer cells. From these dark field images, it
is not discernable whether the gold nanospheres were mainly located on the surface or
inside the tumor cells. However, previous reports support that nanospheres are mainly
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located on the cell surface, with a small amount found inside the cells through
endocytosis.8,25 Because the gold nanospheres used in this study are coated with a layer
of anti-human IgG on the particle surface, gold nanospheres can be effectively loaded to
the tumor cells. The dark field images revealed that the uptake of gold nanospheres by the
nuclei was none or extremely low.

Figure 9- 3. Dark field images of lung tumor cell A549 without (a-c) and with (d-f) gold
nanospheres loaded to the cells. All images were obtained using exactly the same
imaging setup. The final concentration of gold nanospheres added to the lung tumor cell
culture was 0.25 pM for all three samples. (Copyright ® 2008 Future Medicine Ltd.)
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After verifying the effective loading of gold nanospheres by the A549 lung cancer
cells, confocal microscopy was used to study the photothermalysis of cancer cells under
the irradiation of a 5 mW 633 nm laser beam. The power of the laser was adjusted from 0
to 0.5, 1.25, 2.5, 3.75 and 5 mW to optimize the photothermalysis condition, respectively.
The viability drop of cells upon laser irradiation was monitored by a Violet Live/Dead
Viability Fixable Assay Kit with a 0.5 mW 405 nm laser for fluorescence excitation and
followed by emission detection at 450 nm. The assay used a fluorescent dye that is
reactive towards cellular amines. The dye can binds only to the surface amines of viable
cells, but react with free amines in both interior and cell surface of necrotic cells (product
description). When cell membrane destruction occurs, the accumulated dyes on the
cellular membrane will be dissociated and consequently result in a decrease of
fluorescence intensity on cell membrane. The decrease of fluorescence intensity, which
was monitored by imaging at each 5.179 seconds interval for up to 58 seconds, was
interpreted and assessed as the viability drop of cells in this study. Fluorescence emission
intensity information from such obtained images were extracted and plotted versus
irradiation time to give the relative viability drop curves.
As revealed from the UV-Vis spectrum of the gold nanospheres solution (Figure
9-2), gold nanospheres exhibited SPR band peaked around 530 nm and absorptions at
both 405 nm and 633 nm. During our initial study, it was found that a significant
interference to cell viability was arisen from the irradiation of the imaging laser (405
nm). Therefore, the imaging laser was operated at a significantly decreased power level
(0.525 mW). The viability drop curves for both control cells and nanoparticle-loaded
cancer cells caused by imaging laser irradiation at 405 nm were used as baselines and
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subtracted from viability drop curves under the 633 nm laser irradiations respectively to
give the normalized relative viability drop curves. Normalized relative viability drop rates
of cancer cells were then calculated according to the slopes of the normalized relative
viability drop curves.

Figure 9- 4. Effect of 633 nm laser irradiation on A549 tumor cells at different power
levels. Normalized relative viability drop rate of lung A549 cells during the irradiation
(square: control cells without gold nanopsphere incubation; circle: sample cells with gold
nanosphere incubation) (Copyright ® 2008 Future Medicine Ltd.)
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Although nanoparticle-enhanced photothermalysis effects for tumor cells were
reported previously, the kinetic characteristic behavior of the viability changes during
irradiation has not been examined closely.6-8,18 In this study, a real time monitoring of
cancer cell viability was performed. In Figure 9-4, normalized relative viability drop rates
versus irradiation time were summarized for both control cells and nanosphere-loaded
cells at different laser power levels. For control cells (black curves), the laser irradiation
at 633 nm caused a roughly constant small viability drop rate around 0.75 %/s during the
whole 58 seconds irradiation period for power levels from 0.5 mW to 3.75 mW. The
small viability drop rate was most probably coming from the photobleaching effect of
viability dyes under the 633 nm laser irradiation. At the power level of 5 mW, a large
viability drop rate was observed for control cells. This large viability drop rate could due
to an enhanced photobleaching of the viability dyes by 633 nm laser irradiation, or from
laser induced photothermalysis of cells. For gold nanosphere-loaded A549 cancer cells,
viability drop rates (red curves) were significantly higher than the rates of control cells,
especially within the first 30 seconds of irradiation. The initial relative viability drop rates
at zero seconds were observed to increase from 3.72 %/s to the maximum of 5.00 %/s
when the power of the laser was increased from 0.5 to 3.75 mW. In contrast, the relative
viability drop rates of control cells remained at ~0.75 %/s for power levels from 0.5 mW
to 3.75 mW. The photothermalysis of gold nanosphere-loaded cancer cells was
accelerated significantly due to the enhancement effect of gold nanospheres. Comparing
the relative viability drop rates for both control and nanospheres-loaded cells at different
power

levels,

the

optimum

power

level

for

gold

nanospheres

accelerated

photothermalysis of A549 human cancer cells was found to be 3.75 mW, at which level
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the initial relative viability drop rate was 5.00 %/s for nanoparticle-loaded cells and only
0.75 %/s for control cells. At this power level, the initial relative viability drop rate of
nanosphere-loaded tumor cells was accelerated by a factor of 6.6.

Figure 9- 5. Viability drop of tumor cells after irradiation for 58 seconds using a 633 nm
continuous wave laser under different power levels. (Copyright ® 2008 Future Medicine
Ltd.)

After irradiation by the 633 nm laser for 58 seconds, the accumulated relative
viability drops at different power levels for both control cells and gold nanospheresloaded cells are presented in Figure 9-5. The nanospheres-induced hyperthermia effect
and thus the accumulated destruction effect on cancer cells can be verified by comparing
the viabilities of control cells and sample cells. The relative viabilities of nanospheresloaded cells dropped to be around ~8-18% after irradiation for 58 seconds at laser power
between 0.5-3.75 mW, while the viabilities of control cells remained at 60% or above
after equivalent dose of irradiation. A minimum viability of 8% was observed from
nanosphere-loaded cells after irradiation at a laser power of 3.75 mW.
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Upon closer examination, it is noticed that at zero power of the irradiation laser
(633 nm), the viability of nanospheres-loaded cells decreased to 60% while the control
cells remained almost intact. It is believed that this difference is due to the nanosphereaccelerated photothermalysis of tumor cells under the irradiation of imaging laser at 405
nm. Although the maximum absorption of the SPR of gold nanospheres is centered at
520-530 nm, the nanospheres exhibit significant absorption at 405 nm as well, as
revealed from the UV-Vis spectrum of 40 nm gold nanospheres in Figure 9-2. This
absorption caused the accelerated death rate of the nanosphere-loaded cells.
When the power level of the irradiation laser was increased to 5 mW, it was found
that the relative viability drop rate was almost the same for control and nanoparticleloaded cells (Figure 9-4). At this power level, the viability of control cells decreased to
20%, close to what was observed from the nanosphere-loaded cells, 12% (Figure 9-5).
Two possible reasons may account for the observed large viability drop of the control
sample: one possibility is that the relatively high power of the 633 nm laser irradiation
induced a significant photobleaching to the fluorescence dye used for viability study,
which makes the cells appear to be dead. On the other hand, it is also possible that under
high power laser irradiation, photothermalysis of control cells has occurred. For
photothemal therapy, it is important to use a laser with a power level as low as possible to
avoid unexpected damages to healthy and normal tissues and cells. Based on our current
study, it can be seen that the photothemalysis of nanosphere-loaded tumor cells has
reached its maximum effect with a laser power level between 1.25-3.75 mW. There is no
need to further increase the power of the irradiation laser to beyond 3.75 mW. Our
conclusion is that by carefully controlling the power of the laser during photoirradiation,
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it is possible to selectively increase the photothermalysis of gold nanoparticle-loaded
tumor cells while minimize the photothermalysis of normal cells without or with less
nanospheres.
The mechanism of gold nanosphere-accelerated photothermalysis of tumor cells
was reported to start from the photon energy absorption from laser beam irradiation by
gold nanospheres and their aggregates.23,
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The conversion of the photon energy to

thermal energy by gold nanospheres and their clusters introduced a hyperthermia effect
around the local cell membrane. This effect resulted in the formation of micrometer sized
cavities on the cell membrane. A recent study revealed that extracellular calcium cations
played a critical role in cavity formation during gold nanorods-assisted photothermalysis
of tumor cells.10 The growing of these cavities was found to be the main cause for lysis of
cells, besides the hyperthermia effect. For individual gold nanospheres, irradiation at the
SPR band peak wavelength should have the highest photothermal conversion efficiency.
In this study, the wavelength of laser irradiation beam for viability tests was at 633 nm
instead of 530 nm. However, the accelerated photothermalysis of A549 tumor cells by
gold nanospheres was still significant. We believe this effect is a result of the formation
of nanosphere aggregates around the cell membranes, as supported by the dark field
imaging study. Upon aggregation, the SPR band of nanoparticles can red-shift
significantly to higher wavelength.23,24
9.4 Conclusion
In conclusion, 40 nm gold nanospheres were used to accelerate the cell death of
A549 human lung cancer cells by laser irradiation at 633 nm. The loading of gold
nanospheres to tumor cells on cell membrane and partial internalization was observed
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under a dark field optical microscope. Viability tests of tumor cells under the irradiation
of a 633 nm laser showed that gold nanospheres could significantly accelerate the cell
death rates of tumor cells up to a factor of 6.6 compared to control cells. The kinetic
characteristics of the viability drop of tumor cells caused by gold nanoparticle-enhanced
photothermalysis

were

examined

closely.

The

optimized

laser

power

for

photothermalysis of A549 human cancer cells was found to be 1.25-3.75 mW. After 58
seconds of irradiation, the viability of gold nanoparticle-loaded tumor cells decreased to
only 8% of their original viability, while the majority of control cells were still alive.
We demonstrated here a potential application of gold nanospheres for the imaging
and treatment of human lung cancer cells. The stability and surface functionality of gold
nanospheres used in this study make them as suitable candidates for future in vivo
investigations. The strong scattering property of gold nanospheres enables their use as
optical probes for dark field microscopy imaging of tumor cells with much improved
contrast.

Compared to fluorescence probes, the light scattering of GNPs are not

subjected to photobleaching and many other interfering factors. The strong absorption
properties of nanospheres and aggregated clusters can significantly accelerate the
photothermalysis of tumor cells upon laser irradiation. Our next step is to prepare gold
nanosphere-antibody conjugates which can specifically target the A549 lung cancer cells
and further increase the efficiency and specificity of the photothermal therapy process.
The ultimate goal of this research is the development of a dual imaging/therapy method
which can allow a one-step imaging and eradication of lung tumor tissue through
photoirradiation using a single laser source with adjustable power.
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